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ABSTRACT

Subarachnoid hemorrhage (SAH) following cerebral aneurysm rupture is
associated with substantial morbidity and mortality. The ability of SAH to induce
vasospasm in large diameter pial arteries has been extensively studied, although the
contribution of this phenomenon to patient outcome is unclear. Conversely, little is
known regarding the impact of SAH on intracerebral (parenchymal) arterioles, which are
critical for regulation of cerebral blood flow. To assess the function of parenchymal
arterioles following SAH, measurements of diameter, intracellular Ca2+ ([Ca2+]i) and
membrane potential were performed in intact arterioles from unoperated (control), shamoperated and SAH model rats. At physiological intravascular pressure, parenchymal
arterioles from SAH animals exhibited significantly elevated [Ca2+]i and enhanced
constriction compared with arterioles from control and sham-operated animals. Elevated
[Ca2+]i and enhanced tone following SAH were observed in the absence of vascular
endothelium and were abolished by the L-type voltage-dependent Ca2+ channel (VDCC)
inhibitor nimodipine. Molecular assessment of the L-type VDCC CaV1.2 indicated
unchanged mRNA and protein expression in arterioles from SAH animals. Increased
CaV1.2 activity following SAH may also reflect enhanced pressure-induced membrane
potential depolarization of arteriolar smooth muscle. Membrane potential measurements
in arteriolar myocytes using intracellular microelectrodes revealed approximately 7 mV
depolarization at 40 mmHg in myocytes from SAH animals. Further, when membrane
potential was adjusted to similar values, arteriolar [Ca2+]i and tone were similar between
groups. These results demonstrate that greater pressure-dependent membrane potential
depolarization results in increased activity of CaV1.2 channels, elevated [Ca2+]i and
enhanced constriction of parenchymal arterioles from SAH animals. Thus, impaired
regulation of parenchymal arteriolar [Ca2+]i and diameter may restrict cerebral blood flow
in SAH patients.
Although nimodipine is used clinically to prevent delayed neurological deficits
in SAH patients, the use of this drug has been limited by hypotension and treatment
options remain inadequate. Therefore, our next objective was to explore strategies to
selectively suppress CaV1.2 channels in the cerebral vasculature. To do so, we examined
the physiological role of smooth muscle CaV1.2 splice variants containing the
alternatively-spliced exon 9* in cerebral artery constriction.
Using antisense
oligonucleotides, we demonstrate that suppression of exon 9*-containing CaV1.2 splice
variants results in substantially reduced cerebral artery constriction to elevated
extracellular [K+]. In addition, no further reduction in constriction was observed
following suppression of all Cav1.2 splice variants, suggesting that exon 9* splice
variants are functionally dominant in cerebral artery constriction. In summary, results
shown in this dissertation demonstrate that increased CaV1.2 activity following SAH
results in enhanced constriction of parenchymal arterioles. Furthermore, evidence is
provided supporting the concept that CaV1.2 splice variants with exon 9* are critical for
cerebral artery constriction and may provide a novel target for the prevention of delayed
ischemic deficits in SAH patients.
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CHAPTER 1: LITERATURE REVIEW

1

Introduction
Maintenance of adequate blood flow to the brain is essential for human life. Insufficient
delivery of oxygen and glucose to metabolically active regions of the brain quickly
results in neuronal necrosis, neurological impairment and death. Therefore, the function
of small diameter cerebral arteries and arterioles, which control blood flow, is highly
regulated.

Following intracranial aneurysm rupture and subarachnoid hemorrhage

(SAH), mechanisms mediating cerebral artery diameter may become compromised,
leading to enhanced vasoconstriction and reduced blood flow. Consequently, ischemia
leads to further morbidity and mortality in a large number of patients surviving the initial
intracranial bleed (Kassell et al., 1985). The complex mechanisms involved in arterial
narrowing and reduced blood flow associated with SAH are not well understood, but may
involve enhanced contraction of vascular smooth muscle.
The contractile state of smooth muscle is dictated by the concentration of global
cytosolic free Ca2+ ([Ca2+]i), representing averaged Ca2+ throughout the cell. In the
vasculature, smooth muscle [Ca2+]i is largely determined by membrane potential and the
degree of Ca2+ influx via plasmalemmal L-type voltage-dependent Ca2+ channels
(VDCCs). The L-type VDCC α1 pore-forming subunit in vascular smooth muscle is a
splice variant of the gene CaV1.2, which also encodes cardiac muscle and neuronal
VDCCs. Although the molecular identity of L-type VDCCs involved in cerebral artery
constriction is not known, evidence suggests that these channels may be more active
following SAH, leading to elevation of smooth muscle [Ca2+]i and enhanced
vasoconstriction (Faraci and Heistad, 1998; Wellman, 2006). Given their relevance in
2

cerebrovascular physiology, understanding the function of L-type VDCCs in cerebral
artery myocytes is critical for improvement of therapeutic strategies preventing reduced
cerebral blood flow following SAH.
This literature review will provide an overview of the regulation of
cerebrovascular tone in both normal conditions and in pathological conditions following
SAH. Part one will discuss mechanisms involved in vascular smooth muscle contraction,
with a focus on the role of intracellular Ca2+ and L-type VDCCs. Part two will discuss
prominent pathways involved in enhanced arterial constriction following SAH.

In

addition, this section will also review emerging evidence in support of SAH-induced
dysfunction of the cerebral microcirculation.

Part 1: Cerebrovascular physiology

General anatomy of the cerebral arterial blood supply
Blood is supplied to the human brain by two vertebral arteries and two internal carotid
arteries. The vertebral arteries enter the skull through the foramen magnum and converge
to form the basilar artery on the ventral brain stem. The internal carotid arteries enter
through the base of the skull and join the basilar artery to form an arterial circle on the
base of the brain called the Circle of Willis (Figure 1). The unique anatomic structure of
the Circle of Willis functions to provide collateral blood supply to the entire brain in the
event of occlusion of any of the arteries contributing to the circle.

3

Three major pairs of arteries supply blood to the cerebral hemispheres. The
anterior cerebral arteries (ACA) arise from the internal carotid arteries at the Circle of
Willis and supply the most medial portions of the frontal and parietal lobes. The major
branches supplying the majority of the lateral hemispheres are the middle cerebral
arteries (MCA).

The posterior cerebral arteries extend from the intersection of the

posterior communicating and basilar arteries and supply the inferior and medial regions
of the temporal and occipital lobes. Each major cerebral artery divides to form a highly
interconnected grid of surface or “pial” arteries and arterioles. It has been shown that
occlusion of a pial cerebral artery leads to only modest decreases in downstream blood
flow due to the reversal of flow in downstream communicating arterioles (Schaffer et al.,
2006). Therefore, redundant connections among pial arteries and arterioles may also
provide a source of collateral blood flow following arterial occlusion.
Penetrating arterioles arise from pial arteries and arterioles and enter the brain
parenchyma. The penetrating arterioles are surrounded by an invagination of the pia
mater, called the Virchow-Robin space, which is continuous with the subarachnoid space
(Figure 2). Downstream of penetrating arterioles and the Virchow-Robin space are
intracerebral or parenchymal arterioles.

Whereas an interconnected arterial network

exists in pial arteries on the surface of the brain, limited collateral flow exists between
penetrating and parenchymal arterioles (Nishimura et al., 2007). Hence, thrombosis in
penetrating arterioles results in greatly diminished downstream flow (Nishimura et al.,
2007) suggesting that ischemia may be most severe following enhanced constriction or
occlusion of these vessels.
4

Also distinguishing the parenchymal arterioles from pial vessels is a lack extrinsic
perivascular innervation (Cipolla et al., 2004; Handa et al., 1990). Consistent with this,
parenchymal arterioles do not respond to the neurotransmitters norepinephrine or
serotonin, which are potent vasoconstrictors in pial vessels (Cipolla et al., 2004). In
addition, parenchymal arterioles are almost completely encased by astrocytic endfeet and
are essential for coupling neuronal activity to local blood flow (“functional hyperemia”)
(Filosa et al., 2006; Iadecola and Nedergaard, 2007).

Thus, parenchymal arterioles

operate in a unique environment and are functionally distinct from pial vessels on the
brain surface.

Control of cerebral blood flow: cerebrovascular resistance
Blood moves through the circulatory system from regions of high pressure (i.e. aorta) to
regions of low pressure (i.e. capillaries) (Silverthorn, 2004). As this pressure gradient
(ΔP) increases, blood flow also increases. On the other hand, blood flow is opposed by
vascular resistance. Hence, blood flow is directly proportional to ΔP, and inversely
proportional to vascular resistance (R):
Flow  ΔP/R
Resistance is a function of length (L) and radius (r) of the vessel as well as the viscosity
(η) of the fluid moving through the vessel. Accordingly, resistance can be expressed by
the following equation, known as Poiseuille’s Law:
R=8Lη/r4
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Because the length of the circulatory system and blood viscosity are essentially constant,
this equation may also be expressed as:
R 1/r4
This equation states that vascular resistance is inversely proportional to radius to the
fourth power. In an example, a 20 percent decrease in arterial diameter will cause greater
than 50 percent reduction in blood flow. Thus, arterial diameter is a major determinant of
vascular resistance and small changes in diameter can have profound effects on blood
flow and organ perfusion.

Cerebral autoregulation and Ca2+-dependence of vascular tone
To maintain a constant level of blood flow to the brain during fluctuations in blood
pressure, the cerebral resistance vasculature constricts when intravascular pressure
increases and dilates when pressure is reduced. The phenomenon of arterial constriction
in response to increases in intravascular pressure, or “myogenic tone” was first described
by Bayliss in 1902 (Bayliss, 1902). Constrictions to increases in intravascular pressure
were found to be independent of neurogenic, humoral or endothelial influences (Falcone
et al., 1991; Knot and Nelson, 1995; McCarron et al., 1989). Thus, myogenic tone is an
intrinsic characteristic of vascular smooth muscle within the arterial wall. It is now
established that increasing intravascular pressure in the physiological range leads to
membrane potential depolarization of vascular smooth muscle, activation of voltagedependent Ca2+ channels (VDCCs), a rise in [Ca2+]i and contraction of vascular smooth
muscle (Brayden and Wellman, 1989; Harder, 1984; Knot and Nelson, 1998). In the
6

cerebral circulation, the degree of pressure-dependent constriction varies with diameter
and is more prominent in small diameter arteries and arterioles (Thorin-Trescases et al.,
1997). In addition, this physiological response to pressure is thought to maintain vessels
in a partially constricted state in vivo (Meininger and Davis, 1992), allowing various
vasoactive factors to increase or decrease arterial diameter and blood flow depending on
the metabolic demands of the brain.

Initiation of Smooth muscle contraction: Vascular smooth muscle contraction is a Ca2+dependent process. The first step in excitation-contraction coupling in arterial myocytes
is a rise in [Ca2+]i and activation of the ubiquitous Ca2+-binding protein calmodulin
(CaM) (Figure 3). Upon binding Ca2+ at two EF hand motifs on the N- and C-termini
(Gifford et al., 2007), CaM undergoes a conformational change that allows it to interact
with numerous proteins, including myosin light chain kinase (Walsh, 1981). CaMdependent activation of myosin light chain kinase leads to a subsequent increase in
phosphorylation at serine-19 on the 20 kDa regulatory myosin light chain protein
(Kamisoyama et al., 1994). This phosphorylation event induces a conformational change
in the myosin molecule which enhances myosin ATPase activity, actin binding and crossbridge cycling (Chacko et al., 1977). Shortening of the contractile filaments results in
force generation or increased muscle tension (Hai and Murphy, 1989). An increase in
crossbridge cycling and contraction may also result from an increase in the sensitivity of
the contractile machinery to intracellular Ca2+. For example, the regulatory proteins
caldesmon and calponin tonically inhibit myosin ATPase activity in smooth muscle
7

(Horowitz et al., 1996). This inhibition is relieved by phosphorylation and leads to
increased smooth muscle contraction and vascular tone independent of increases in
[Ca2+]i (Horowitz et al., 1996; Mino et al., 1995).
Relaxation of smooth muscle is triggered by a decrease in [Ca2+]i and
dephosphorylation of myosin light chain at serine-19 by myosin light chain phosphatase
(Murphy, 1982). Ca2+ ions are extruded from the cytoplasm by the plasmalemmal Ca2+
ATPase (PMCA) and Na+/Ca2+ exchanger, and sequestered into the SR by the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) (Floyd and Wray, 2007). PMCA and
SERCA both use energy from the hydrolysis of ATP to transport Ca2+ ions against a
chemical gradient. On the other hand, the Na+/Ca2+ exchanger uses the electrochemical
gradient for Na+, which is established by the Na+/K+ ATPase, to transport a single Ca2+
ion out of the cell in exchange for three Na+ ions into the cell (Blaustein and Lederer,
1999). Therefore, arterial myocytes expend energy in the form of ATP hydrolysis in
order to maintain cytosolic Ca2+ at low concentrations relative to extracellular levels.
Previous work using the ratiometric Ca2+-sensitive fluorescent dye fura-2 estimates that
smooth muscle [Ca2+]i of fully dilated middle cerebral arteries is ~50-100 nM (Knot and
Nelson, 1998). Further, the Ca2+ sensitivity of arterial diameter was found to be 1 µm/
nM [Ca2+]i with the entire range of arterial diameters associated with a change in arterial
wall Ca2+ of approximately 250 nM (Knot and Nelson, 1998). Thus, [Ca2+]i in vascular
smooth muscle is tightly regulated and small changes in the cytosolic concentration of
this ionic species can have a major impact on arterial diameter and blood flow.
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Regulation of vascular smooth muscle [Ca2+]i: L-type voltage-dependent
Ca2+ channels
Calcium ions enter the cytosol of vascular smooth muscle predominantly via voltagedependent calcium channels (VDCCs) in the plasma membrane and Ca2+ release channels
in the sarcoplasmic reticulum. Thus, [Ca2+]i in cerebral artery myocytes is determined by
the steady-state balance between Ca2+ influx from the extracellular fluid or intracellular
stores and Ca2+ extrusion from the cytoplasm or SR sequestration. In cerebrovascular
smooth muscle, Ca2+ influx via VDCCs is the major pathway by which [Ca2+]i increases
for initiation of contraction (Brayden and Wellman, 1989; Knot and Nelson, 1998;
Nelson et al., 1990; Nelson et al., 1988). Blocking VDCCs with the selective L-type
VDCC antagonist nisoldipine reduces [Ca2+]i to resting levels and abolishes pressureinduced constrictions (Figure 3), essentially uncoupling the relationship between
membrane potential and arterial diameter (Knot and Nelson, 1998). Thus, in cerebral
artery myocytes, [Ca2+]i is largely determined by the activity of dihydropyridine-sensitive
L-type VDCCs. Further, many vasoactive factors exert their effects on arterial diameter
and cerebral blood flow by directly altering VDCC gating or by changing membrane
potential (Nelson et al., 1988; Worley et al., 1991). This section will review the basic
structural, electrophysiological and pharmacological properties of VDCCs with a focus
on L-type VDCCs encoded by Cav1.2.

Structure: In 1984, Curtis and Catterall first purified voltage-dependent Ca2+ channels
from skeletal muscle transverse tubule membranes (Curtis and Catterall, 1984). It was
9

found that these channels were heterooligomeric complexes comprised of a pore-forming
α1 subunit in association with accessory β, α2-δ, and γ subunits (Catterall, 2000; Curtis
and Catterall, 1984). It is now known that the α1 subunit confers most functional
properties of the channel including voltage sensitivity, Ca2+ permeability, sensitivity to
pharmacological activators and inhibitors, and Ca2+-dependent inactivation (Catterall,
2000). Ten distinct α1 subunits have been described: CaV1.1-1.4 (“L-type”), CaV2.1-2.2
(“P- or Q-type”), CaV2.3 (“R-type”), and CaV3.1-3.3 (“T-type”). The α1 proteins (~2000
amino acids; ~190-240 kDa) consist of four repeat domains (I-IV), each containing six
transmembrane segments (S1-S6) (Tanabe et al., 1987).

The S4 transmembrane

segments each contain positively charged arginine and lysine residues and confer voltage
sensitivity to the channel. These segments rotate and move outward in response to
membrane depolarization, inducing a conformational change which opens the pore
(Tanabe et al., 1987; Yamaguchi et al., 1999). In addition to cytoplasmic N- and Ctermini, domains I-IV are connected in tandem by intracellular linker regions. The Cterminus, which contains sites of interaction for cAMP-dependent protein kinase (PKA)
and A-kinase anchoring protein (AKAP15), is proteolytically cleaved in vivo (De Jongh
et al., 1996; Hulme et al., 2003). Although the functional importance of this posttranslational modification is currently unclear, one report suggests that the cleaved Cterminal portion may remain associated with the remainder of the α1 subunit to regulate
channel function by formation of an autoinhibitory complex (Hulme et al., 2006).
Although α1 subunit expression is sufficient to produce functional VDCCs,
abnormal expression, kinetics and voltage-dependence of Ca2+ currents are observed in
10

the absence of auxiliary subunits. Non-covalent association between the α1 and cytosolic
β subunit appears to be most important in the modulation of VDCC expression and
function. The four known β subunits (β1-4) belong to the membrane-associated guanylate
kinase (MAGUK) family of scaffolding proteins and consist of two conserved central
alpha helix domains flanked by subtype-specific N- and C- termini (Cohen et al., 2005).
The guanylate kinase (GK) region of the β interactive domain (BID) is required for high
affinity interaction with the alpha interactive domain (Maeda et al.) within the I-II
intracellular linker of the α1 subunit (Pragnell et al., 1994). Coexpression of α1 and β
subunits leads to significantly increased transmembrane currents and causes channel
activation and inactivation at more negative membrane potentials (Kamp et al., 1996). It
is thought that this modulation of channel function may reflect both increased insertion of
the α1 subunit in the plasma membrane as well as a conformational change in the α1
subunit upon binding the β subunit (Chien et al., 1995; Kamp et al., 1996). Protein for
both β2 and β3 has been reported in the vasculature (Hullin et al., 1992; Murakami et al.,
2003). Aortic myocytes from mice lacking the β3 subunit exhibited significantly reduced
Ca2+ currents (Murakami et al., 2003). It was proposed that residual Ca2+ currents after
β3 gene ablation may represent a redundant role for the β2 subunit in channel trafficking
and gating. Altered channel function by β subunits may represent an important means of
integration of intracellular signals to alter Ca2+ influx. For example, β subunits contain
conserved sites for PKA-mediated phosphorylation (Puri et al., 1997). In cardiac muscle,
beta-adrenergic receptor activation and PKA-mediated stimulation of L-type Ca2+
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currents may be partially due to phorphorylation of the β2a subunit at serine 478 and
serine 479 (Bunemann et al., 1999).
While the expression profile and functional role of VDCC γ subunits in vascular
smooth muscle remain unclear (Sonkusare et al., 2006), the importance of the α2δ subunit
has recently been evaluated. Four genes encoding α2δ subunits have been cloned (α2δ14) (Davies et al., 2007). Each α2δ protein (~170 kDa) is the product of a single gene
which undergoes proteolytic cleavage and reassociates via a disulfide bond as an
extracellular α2 and transmembrane δ (Takahashi et al., 1987). One recent study found
that suppression of membrane bound α2δ-1 subunits in myocytes from resistance-sized
cerebral arteries inhibits membrane insertion of α1 subunits, decreases CaV1.2 currents
and causes prolonged vasodilation (Bannister et al., 2009).

Interestingly, it was

discovered that a class of drugs used to treat neuropathic pain, the gabapentenoids (i.e.
pregabalin), exert their effects through binding VDCC α2δ-1 and α2δ-2 subunits (Bian et
al., 2006). Hence, α2δ subunits may also play an important role in the functionality of
neuronal L-type VDCCs in addition to smooth muscle channels.

Physiological and Pharmacological Properties: VDCCs switch between open conducting
states to closed nonconducting states. As membrane potential becomes more positive, the
amount of time spent in the open state, or open-state probability (Popen), increases. In
vivo membrane potential of resistance artery myocytes (-55 to -40 mV) (Neild and Keef,
1985) is within the range in which the opening of L-type VDCCs is steeply voltagedependent (Nelson et al., 1988). For example, at membrane potentials negative to -40
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mV, VDCC activation is an exponential function of membrane potential with an
approximately e-fold increase in Popen per 8.5 mV depolarization (Figure 5) (Nelson et al.,
1990). At membrane potentials positive to -40 mV, increases in Popen are opposed by
long-term channel inactivation, which is both voltage- and Ca2+-dependent. Thus, Popen
can be expressed by (Nelson et al., 1990):
Popen=(Pact)(1-Pinact)(Pfunct)
where Pact is Popen in the absence of inactivation, 1-Pinact is the probability of the channel
not being in the inactivated state and Pfunct is the probability that the channel is functional.
It has been estimated that each cerebral artery myocyte has approximately 5000
functional channels (Rubart et al., 1996). Each channel has a measured conductance of 3
to 5 pS and can produce currents of 0.1 to 0.3 pA at 2 mM Ca2+ and physiological
membrane potentials (Gollasch et al., 1992; Rubart et al., 1996). It has been shown that a
depolarization from -40 mV to -20 mV causes approximately four-fold increase in
steady-state Ca2+ current, which is capable of raising [Ca2+]i 1.3 µM/second in the
absence of Ca2+ buffering and sequestration (Rubart et al., 1996).

Thus, altering

membrane potential can lead to substantial changes in the rate of Ca2+ influx in arterial
smooth muscle.
Since Ca2+ currents were first recorded in cardiac myocytes (Reuter, 1979), multiple
types of Ca2+ channels have been categorized by physiological as well as
pharmacological characteristics (Catterall, 2000).

In addition to their high voltage-

dependent activation and slow voltage-dependent inactivation, L-type VDCCs can be
defined pharmacologically by sensitivity to selective Ca2+ channel antagonists including
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dihydropyridines, phenylalkylamines, and benzothiazepines (Catterall, 2000; Reuter,
1983). Inhibition by dihydropyridine compounds is state-dependent and VDCCs become
more sensitive to these compounds as membrane potential is more depolarized
(Sanguinetti and Kass, 1984). The binding sites for L-type VDCC antagonists are located
on the α1 subunit and binding locks the channel in the inactive or closed state (Williams
and Tremble, 1982). Given the critical role of L-type VDCCs in cardiovascular function,
L-type VDCC antagonists are an important therapeutic option in the treatment of a
variety of disorders including several types of arrhythmia, hypertension, and angina
pectoris.
Several other VDCC subtypes have been reported in the vasculature including a
low-voltage activated (T-type; CaV3) (Nikitina et al., 2007), ω-agatoxin IVA-sensitive
(P/Q; CaV2.1) (Hansen et al., 2000), and a nifedipine-resistant high-voltage activated
Ca2+ channel (Itonaga et al., 2002; Morita et al., 1999). However, as dihydropyridine
compounds completely abolish pressure-induced as well as agonist-induced cerebral
artery constriction (Gokina et al., 1999; Knot and Nelson, 1998), L-type VDCCs are
widely accepted as the major route of Ca2+ influx in arterial smooth muscle.

Alternative splicing of mRNA encoding CaV1.2: In addition to vascular smooth muscle
contraction, CaV1.2 channels play a critical role in numerous physiological processes
such as cardiac muscle contraction, neurotransmitter release, gene expression and
hormone secretion. Transcript scanning of the human CaV1.2 gene indicated that 19 of
the 55 exons comprising the channel are subject to alternative splicing, suggesting that
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structural diversity among tissue-selective splice variants may account for functional
distinctions between cell types (Tang et al., 2004). The 40 identified splice variations at
12 splice loci of CaV1.2 are shown in Figure 6 (Liao et al., 2005).
The essential role of L-type VDCCs in cardiovascular function has been
demonstrated by embryonic fatality in homozygous knockout mice lacking CaV1.2
(Seisenberger et al., 2000) and severe hypotension and death in mice following
conditional smooth muscle-specific ablation of CaV1.2 (Moosmang et al., 2003). The
cardiac muscle form of CaV1.2 was proposed to consist of exons 1a/8a/31 while the
predominant smooth muscle form consists of exons 1c/8/32 with the addition of a 75
nucleotide cassette exon between exons 9 and 10 (termed exon 9*). These tissue-specific
combinatorial splicing patterns may underlie electrophysiological and pharmacological
distinctions between cardiac and smooth muscle channels. For example, dihydropyridine
calcium channel antagonists are potent vasodilators and are routinely used to treat
hypertension and angina pectoris. Although these agents bind with high affinity to
constitutively expressed residues at IIIS5, IIIS6, and IVS6, selective expression of exon 8
within IS6 of smooth muscle channels determines dihydropyridine sensitivity (Welling et
al., 1997). In addition, smooth muscle channels may be functionally specialized in order
to allow activation at physiological membrane potentials. An early study aiming to
determine the role of exon 9* in smooth muscle CaV1.2 found that 9* inclusion resulted
in a hyperpolarized shift in voltage-dependent activation when expressed in HEK293
cells (Liao et al., 2004). The authors of this study proposed that functional specialization
of VDCCs allowing activation at more hyperpolarized membrane potentials may be
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required for Ca2+ influx and smooth muscle tension to modest membrane potential
depolarization. Further studies have also shown that expression of the N-terminal exon
1c can produce a similar shift in voltage-dependent activation, but this effect is not
additive to the effect of exon 9* expression (Cheng et al., 2009). Although exon 1c and
exon 9* are within close proximity to the site of interaction between α1 and β subunits
(see Figure 6), whether these effects are dependent on β subtype is currently unknown.
Regardless, these studies together suggest that alternative splicing may be responsible for
generating significant functional diversity among cardiac and smooth muscle L-type
VDCCs. Further, alternative splicing patterns may become altered in pathophysiological
conditions as a shift in alternative exon expression has been observed in atheroschlerosis,
Timothy syndrome and hypertension (Tang et al., 2008a; Tiwari et al., 2006; Yarotskyy
et al., 2009). For example, cardiomyocytes of hypertrophic hearts from spontaneously
hypertensive rats were found to express channels with significantly altered combinations
of mutually exclusive exons 21/22 and 31/32 compared with cardiomyocytes isolated
from normotensive rats (Tang et al., 2008b). Although splice variants expressed in hearts
of hypertensive rats display distinct electrophysiological characteristics when expressed
in HEK293 cells, the functional importance of Cav1.2 molecular remodeling in
cardiovascular disease is currently unclear.
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Regulation of smooth muscle membrane potential
Smooth muscle Potassium channels
As described above, VDCC Popen and smooth muscle [Ca2+]i is determined by membrane
potential. Due to the relatively high permeability of the plasma membrane to K+ ions and
the chemical gradient for K+, the resting membrane potential is largely determined by the
intracellular and extracellular K+ concentrations.

Given that the intracellular

concentration of K+ ([K+]i ≈ 140 mM) is considerably greater than extracellular K+ ([K+]o
≈ 3 mM), the direction of the chemical driving force for K+ ions is toward the
extracellular fluid. However, efflux of K+ ions loss of positive charge increases the
electrical driving force, which is toward the intracellular fluid. The membrane potential
at which the inward and outward driving forces are zero and there is no net movement of
K+ ions is termed the K+ equilibrium potential (EK).

In arterial smooth muscle,

membrane potential is always positive to EK (Hulme et al.).

Thus, increasing the

permeability of the plasma membrane to K+ will result in efflux of K+ such that
membrane potential will hyperpolarize towards EK. Vascular smooth muscle is equipped
with various K+-selective channels to regulate membrane potential. This section briefly
reviews properties of K+ channels expressed by cerebral artery myocytes: voltagedependent (KV), large conductance Ca2+-activated (BK), ATP-sensitive (KATP), and
inwardly-rectifying (KIR) K+ channels.
Voltage-dependent K+ channels: Voltage-dependent K+ (Kv) channel subtypes expressed
in cerebral artery myocytes include KV1.2, KV1.3, KV1.5, KV2.1 (Xu et al., 1999).
Studies have also suggested expression of KV2.2 in canine cerebral artery myocytes
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(Jahromi et al., 2008a). However, heteromeric channels composed of KV1.2 and KV1.5
subunits have been shown to play a predominant role in the regulation of arterial diameter
(Albarwani et al., 2003; Plane et al., 2005). KV channels open in response to membrane
depolarization, resulting in K+ efflux and hyperpolarization. In addition to increasing the
open probability of KV channels, depolarization also increases the electrical driving force
for K+ efflux. Steady-state KV activity represents a balance between voltage-dependent
activation and inactivation, and currents are observed in cerebral artery myocytes at
physiological membrane potentials (Nelson and Quayle, 1995). Studies have suggested
that tonic KV channel activity in cerebral artery myocytes may represent an important
feedback mechanism in response to pressure-induced depolarization. Consistent with
this, application of the non-selective KV blocker 4-aminopyridine causes robust
constriction of pressurized cerebral arteries (Robertson and Nelson, 1994). In addition, a
number of vasodilators may function via activation of KV channels. Endogenous factors
resulting in activation of the cyclic adenosine monophosphate→PKA, or cyclic
guanosine monophosphate→PKG pathways (see below) may relax vascular smooth
muscle at least partially via increased activity of KV channels (Aiello et al., 1995; Keef et
al., 2001).

Large-conductance Ca2+-activated K+ channels:

Activation

of

large-conductance

Ca2+-activated K+ (BKCa) channels occurs in response to micromolar increases in Ca2+ as
well as membrane potential depolarization (Ledoux et al., 2006). Similar to blocking KV
channels, inhibition of BKCa channels with paxilline or iberiotoxin causes profound
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constriction of pressurized cerebral arteries (Knot et al., 1998), suggesting an important
feedback role for these channels in the regulation of cerebral artery tone. In smooth
muscle, the majority of BKCa activity occurs in response to transient localized increases
in Ca2+ release events from clusters of ryanodine receptors (RyR) in the sarcoplasmic
reticulum, or “Ca2+ sparks” (Wellman et al., 2002). Each spark can elevate local Ca2+ to
10-100 µM and activates ~20-100 plasmalemmal BKCa channels (Perez et al., 2001).
Thus, the frequency of transient outward currents via activation of BKCa channels is
directly proportional to Ca2+ spark frequency (Benham and Bolton, 1986; Nelson et al.,
1995). Studies in toad stomach smooth muscle have shown that Ca2+ spark frequency
can be modulated by the concentration of SR Ca2+ (ZhuGe et al., 1999), which reflects
changes in cytosolic Ca2+.

Thus, Ca2+ sparks, activation of BKCa channels and

subsequent hyperpolarization may also represent a feedback mechanism for a rise in
cytosolic Ca2+ following depolarization and activation of VDCCs.

Furthermore,

mechanisms which result in increased uptake of Ca2+ by the SR (i.e. PKA stimulated
phosphorylation of the SERCA regulatory protein phospholamban ) (Wellman et al.,
2001) may cause relaxation of smooth muscle through increased Ca2+ spark frequency
and BKCa activity.

Inwardly Rectifying K+ channels: Inwardly rectifying K+ channels pass K+ ions inward
more readily than outward.

When membrane potential is negative to EK, inward

conductance of K+ ions via KIR channels occurs. However, membrane potential of
cerebral artery myocytes in vivo (-50 mV to -35 mV) is positive to EK (approximately -85
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mV), yet currents through KIR channels at positive potentials is less than expected. This
inward rectification is caused by voltage-dependent intracellular block of the channel by
polyamines and Mg2+ ions (Nichols and Lopatin, 1997). KIR channels display voltagedependent block by relatively low external concentrations (Ki ≈ 5 μM) of Ba2+ ions.
Cerebral artery myocytes express mRNA transcripts for KIR2.1, and KIR currents are
absent in cerebral artery myocytes from genetically altered mice lacking this gene
(Zaritsky et al., 2000). Patch-clamp electrophysiology experiments have demonstrated
KIR currents in cerebral artery myocytes suggesting that these channels function to
regulate arterial tone in the cerebral circulation.
Inhibition of KIR channels by positively charged ions and proteins is relieved by
modest elevation in extracellular K+ ions (5-20 mM) (Nichols and Lopatin, 1997). Given
that membrane potential of cerebral artery myocytes is positive to EK at physiological
intravascular pressures, activation of K IR channels by external K+ results in K+ efflux and
hyperpolarization toward EK. These K+-induced dilations are inhibited by Ba2+ (Knot et
al., 1996) and are absent in knockout mice lacking K IR2.1 (Sobey and Faraci, 2000;
Zaritsky et al., 2000). This mechanism is thought to be important for coupling cerebral
blood flow to metabolic demands of the brain (Filosa et al., 2006; Paulson and Newman,
1987). For example, increases in neuronal activity can dilate local parenchymal arterioles
via activation of astrocytic BKCa channels, release of K+ ions and activation of vascular
smooth muscle KIR channels to induce hyperpolarization and relaxation (Filosa et al.,
2006). In addition, activation of KIR channels may result following release of K+ from
neurons and glial cells during hypoxia, ischemia and hypoglycemia (Sieber et al., 1993;
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Somjen, 1979). Thus, when oxygen and glucose delivery to metabolically active neurons
is compromised, K+-induced dilations via activation of KIR channels may represent an
important mechanism to increase cerebral blood flow to maintain neuronal viability.

ATP-sensitive K+ channels:

Adenosine 5’-triphosphate-sensitive K+ channels

(KATP) are also expressed in cerebral artery myocytes and are thought to couple metabolic
signals to blood flow. These channels open in response to reduced [ATP] i, Po2, or pH,
and increased Pco2 and prostacyclin, causing hyperpolarization and vasodilation (Faraci
and Heistad, 1998; Ko et al., 2008). KATP channels are heteromultimers comprised of
pore-forming subunits (typically KIR subunits) and sulfonylurea receptor subunits
(Babenko et al., 1998). KATP channels are selectively inhibited by sulfonylureas such as
glibenclamide (de Weille et al., 1988) and activated by synthetic compounds such as
cromakalim and pinacidil (Grover, 1997; Standen et al., 1989).

Intraparenchymal

injection of cromakalim produces an increase in local cerebral blood flow that is blocked
by glibenclamide (Reid et al., 1995), suggesting that KATP channels are present and
functional in cerebral vessels. However, application of glibenclamide does not alter
myogenic tone in basilar artery (Faraci and Heistad, 1993) or cerebral arterioles
(Armstead, 1996) suggesting that tonic KATP channel activity does not oppose pressuredependent constriction. However, KATP channels are reported to play an important role in
vasodilation produced by a number of endogenous compounds including calcitonin generelated peptide (CGRP) (Kitazono et al., 1993b), prostacyclin (Fredricks et al., 1994),
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adenosine (Armstead, 1997), norepinephrine (Kitazono et al., 1993a), and vasoactive
intestinal peptide (Faraci and Heistad, 1998; Standen et al., 1989).

Mechanosensitive ion channels:
Chloride channels: Considering intracellular [Cl-] of 40-70 mM and extracellular [Cl-] of
140 mM, the equilibrium potential for Cl- ions is in the range of -30 to -20 mV.
Therefore, it was postulated that activation of outward Cl- currents may represent a
mechanism for depolarization of smooth muscle in response to increased intravascular
pressure.

Consistent with this hypothesis, Ca2+-activated Cl- channels and volume-

regulated Cl- channels have been reported in vascular smooth muscle and increasing
intravascular pressure results in Cl- efflux (Doughty and Langton, 2001).

Further,

shifting ECl from -25 mV to -2 mV augments the myogenic tone response at
physiological intravascular pressures (Nelson et al., 1997). Inhibition of Cl- channels
with indanyloxyacetic acid (IAA-94) and 4,4’-diisothiocyanatostilbene-2,2’-disulfonic
acid (DIDS) hyperpolarizes and dilates pressurized (80 mmHg) cerebral arteries (Nelson
et al., 1997). It was also shown that the potent inhibitor of Ca2+-activated Cl- channels
niflumic acid had no effect on arterial tone suggesting that pressure-induced
depolarization of cerebral artery myocytes may be mediated by volume-regulated Clchannels. However, later isolation of a current induced by cell swelling was found to
shift with the equilibrium potential for Na+, rather than ECl (Welsh et al., 2000). Further,
these swelling-activated currents and pressure-induced depolarizations were blocked by
Gd3+ ions, a non-selective cation channel blocker. These findings argued against a role
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for Cl- conductance and instead indicated a direct role for non-selective cation channels
in pressure-induced depolarization of cerebral artery myocytes.

Non-selective cation channels: The mammalian TRP superfamily of cation channels are
grouped into the following major subfamilies: TRPC (canonical), TRPM (melastatin),
TRPV (vanilloid), TRPP (polycystin), TRPML (mucolipin) and TRPA (ankyrin)
(Clapham, 2003). With a few exceptions, TRP channels permeate both monovalent and
divalent cations. Vascular smooth muscle has been reported to express TRPC1, TRPC3,
TRPC4, TRPC6, TRPM4, TRPV2 and TRPV4 (Facemire et al., 2004; Inoue et al., 2006).
The finding that Gd3+ ions blocked swelling-induced currents in vascular smooth muscle
led to the hypothesis that mechanosensitive TRP channels may play a major role in
depolarization of cerebral artery myocytes to increasing intravascular pressure. Welsh
and colleagues were the first to demonstrate that downregulation of TRPC6 channels,
which are mechanosensitive and highly expressed in vascular smooth muscle, greatly
attenuates cation currents in response to swelling as well as pressure-induced
depolarization and constriction in rat cerebral arteries (Welsh et al., 2002).
Recent studies also indicate an important role for TRPM4 channels in pressureinduced depolarization of cerebral artery myocytes.

TRPM4 channels permeate

monovalent cations and are activated by intracellular Ca2+ and membrane stretch (Morita
et al., 2007; Owsianik et al., 2006). Cerebral artery myocyte depolarizations in response
to increased intravascular pressure are attenuated when TRPM4 channels are suppressed
in vitro (Earley et al., 2004). Furthermore, infusion of antisense oligonucleotides into the
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cerebral spinal fluid to suppress TRPM4 channels in vivo caused significantly increased
cerebral blood flow over a range of mean arterial pressures (Reading and Brayden, 2007)
suggesting disruption of autoregulatory function. Considering that suppression of either
TRPC6 or TRPM4 channels results in a similar reduction in pressure-induced
depolarization suggests that these channels may function in series rather than in parallel.
Hence, a current model of pressure-induced depolarization of cerebral artery myocytes
proposes that mechanical forces in response to increased pressure leads to Ca2+ entry via
TRPC6 channels (Brayden et al., 2008). The resulting increase in local Ca2+ thereby
activates TRPM4 channels leading to Na+ influx, depolarization, activation of VDCCs
and smooth muscle contraction.

Second messenger pathways involved in smooth muscle contraction
Cerebrovascular tone can also be modulated by the activity of several second messengers.
One particularly important signal transduction system in the control of vascular smooth
muscle contraction involves the generation of inositol 1,4,5 trisphosphate (IP3) and
diacylglycerol (DAG) following Gq-dependent activation of phopholipase C. Activators
of this pathway include intravascular pressure, vasoconstrictors circulating in the blood
(i.e. angiotensin II) as well as neurotransmitters (i.e. serotonin) (Gokina et al., 1999;
Mattiazzi, 1997; Parsons et al., 1996). Pharmacological inhibitors of PLC and PKC
reduce pressure-induced constrictions in cerebral artery segments (Osol et al., 1991).
Following activation of PLC, an increase in IP3 signals a release of Ca2+ from
intracellular stores via IP3 receptors on the SR (Johns et al., 1987). On the other hand,
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diacylglycerol is a potent endogenous activator of protein kinase C (PKC).

PKC-

mediated contraction of vascular smooth muscle can occur via direct phosphorylation of
myosin light chain kinase (Nishikawa et al., 1985), phosphorylation of actin binding
proteins (i.e. caldesmon, calponin) (Horowitz et al., 1996; Mino et al., 1995) and
decreased myosin light chain phosphatase activity (Masuo et al., 1994). All of these
effects increase the sensitivity of the smooth muscle contractile apparatus to Ca2+, a
process referred to as “Ca2+ sensitization”. Thus, an increase in smooth muscle PKC
activity results in a greater level of arterial constriction for a given level of cytosolic Ca2+.
However, it has been shown that cerebral artery constriction in response to the synthetic
PKC activator indolactam V is blocked by nisoldipine suggesting that constriction
following PKC stimulation requires VDCC-mediated Ca2+ influx (Gokina et al., 1999).
In addition, PKC activation can also have widespread effects on the activity of smooth
muscle ion channels to promote membrane potential depolarization and increased VDCC
activity. A number of endogenous vasoconstrictors have been suggested to stimulate
smooth muscle VDCC activity via a PKC-dependent mechanism (Gollasch and Nelson,
1997; Keef et al., 2001). For example, PKC activation can directly decrease the activity
of both KATP and KV channels (Aiello et al., 1996; Quayle et al., 1997) and indirectly
decrease BK channel activity via a reduction in Ca2+ spark frequency (Bonev et al.,
1997). In addition, constriction of cerebral arteries in response to PKC-stimulation is
attenuated following suppression of TRPM4 channels (Earley et al., 2007), suggesting
that mechanosensitive cation channels may also be a target of PKC.

Furthermore,

agonist-induced (i.e. phenylephrine, UTP) vasoconstriction may involve activation of
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TRPC channels by diacylglycerol in a PKC-independent manner (Inoue et al., 2001;
Reading et al., 2005). These effects of PLC/DAG/PKC activation would presumably
lead to enhanced depolarization and increased activity of VDCCs. Thus, agonists of Gqcoupled receptors lead to enhanced smooth muscle contraction via elevation of cytosolic
Ca2+ as well as increased Ca2+ sensitivity of the contractile machinery.
The small GTPase Rho can also regulate the function of vascular smooth muscle
through its downstream effector Rho-kinase. Rho-kinase activation leads to inhibition of
myosin light chain phosphatase via phosphorylation at the myosin binding subunit
(Kimura et al., 1996). A subsequent increase in myosin light chain phosphorylation
levels then enhances smooth muscle contraction and vasoconstriction. Thus, activation
of the Rho-kinase pathway reduces the calcium requirement for prolonged contraction.
Agonists of G protein coupled receptors such as serotonin, endothelin-1 and angiotensin
II may promote Ca2+-independent contraction via activation of Rho-kinase (Kawano et
al., 2002). Rho and Rho-kinase have now been implicated in several cardiovascular
disorders and are attracting interest as potential targets for future therapeutics (Hu and
Lee, 2003).
Cyclic nucleotides also play an important role in the regulation of cerebral blood
flow. A rise in the cytoplasmic concentration of cyclic guanosine 3’,5’ monophosphate
(cGMP) activates cGMP-dependent protein kinase (PKG) and triggers smooth muscle
relaxation and vasodilation by several mechanisms. PKG-mediated phosphorylation at
specific sites within the VDCC complex may inhibit the channel and reduce Ca2+ influx
(Jiang et al., 2000). Other potential mechanisms of PKG-induced relaxation of arterial
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smooth muscle involve direct activation of BKCa channels by PKG (Robertson et al.,
1993) as well as enhanced uptake of Ca2+ into the SR, resulting in increased Ca2+ spark
frequency and increased BKCa channel activity (Porter et al., 1998). Evidence suggests
that this vasodilatory pathway may also contribute to relaxation in response to Gs
stimulation, increased production of cyclic adenosine 3’,5’ monophosphate (cAMP) and
activation of cAMP-dependent protein kinase (PKA). Consistent with this, inhibitors of
Ca2+ sparks such as ryanodine, abolish both PKA and PKG-mediated increases in
transient BKCa channel activity (Porter et al., 1998). Studies have demonstrated that PKA
phosphorylates the SERCA regulatory protein phospholamban, leading to increased SR
Ca2+ uptake and Ca2+ spark frequency in myocytes of pressurized cerebral arteries
(Wellman et al., 2001). In addition to the effect on BK channel activity, the cAMP-PKA
pathway can also increase the activity of KATP and KV channels (Aiello et al., 1995;
Quayle et al., 1994), leading to membrane potential hyperpolarization and decreased
VDCC Popen.

Endothelial influences
For over one hundred years after their discovery in brain capillaries in 1845, endothelial
cells were regarded as the inactive lining of blood vessels and capillary walls. However,
the modulation of vascular tone by the release of vasoactive factors from endothelial cells
has been under intense investigation. Following is a brief overview of major mechanisms
in endothelial modulation of vascular smooth muscle contraction, focusing on major
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vasoacitve substances released by endothelial cells: Nitric oxide (NO), endotheliumdependent hyperpolarizing factor (EDHF), eicosanoids, and endothelin-1 (ET-1).

Nitric oxide: In 1978, Furchgott observed that acetylcholine, acting on muscarinic
receptors, stimulates the release of diffusible substances from the endothelium that cause
relaxation of vascular smooth muscle, or “endothelial-derived relaxing factor” (Furchgott
and Zawadzki, 1980). Later, Furchgott and Ignarro demonstrated that endotheliumderived relaxing factor was in fact nitric oxide (Furchgott, 1999). In independent studies
at the same time, Murad and colleagues found that the potent vasodilator nitroglycerin
exerts it effects by releasing nitric oxide, which relaxes vascular smooth muscle and
increases blood flow.
Nitric oxide is produced in the conversion of L-arginine to L-citrulline by nitric
oxide synthase (NOS) (Fleming and Busse, 1999). Three NOS isoforms have been
identified: neuronal (nNOS), endothelial (eNOS) and inducible (iNOS). Under normal
conditions, vascular endothelial cells express only eNOS.

Increased endothelial

Ca2+ causes eNOS activation and NO production by Ca2+/calmodulin-dependent
displacement of the eNOS protein from the inhibitory scaffolding protein caveolin-1
(Michel et al., 1997). eNOS can also be directly activated by the regulatory heat shock
protein (HSP90) (Khurana et al., 2000).

Studies suggest this mechanism may be

important for basal NO production as well as acetylcholine-mediated dilation (Xu et al.,
2002a).
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Diffusion of NO to smooth muscle results in activation of soluble guanylate
cyclase and increased production of cGMP (Murad, 2004).

PKG activation causes

increased activity of K+ channels, smooth muscle hyperpolarization, and decreased
VDCC activity (Faraci and Sobey, 1999). For example, PKG can increase BKCa channel
activity directly (Robertson et al., 1993), or indirectly by suppressing synthesis of the
BKCa inhibitor 20-HETE and increasing Ca2+ spark frequency (Alonso-Galicia et al.,
1997). A recent report also suggests that NO-mediated relaxation may occur via reducing
the sensitivity of contractile apparatus to Ca2+ (Lehen'kyi et al., 2005).
Release of NO by the endothelium represents an important vasodilator pathway
that contributes to modulation of vascular tone both in vitro and in vivo. Inhibition of
eNOS with L-NNA results in reduced cerebral blood flow in normal mice, but not in
mice lacking the gene for eNOS (Ayata et al., 1996; Ma et al., 1996). These findings
suggest that tonic release of NO from the endothelium is a major contributor to
cerebrovascular tone and cerebral blood flow.

EDHF: Following the discovery of nitric oxide as an endothelium-derived relaxing
factor, another endothelium-dependent vasodilatory mechanism was found which was
independent of NOS or cyclooxygenase (COX) (Hoeffner et al., 1989; Vanhoutte, 2004).
For example, substances such as UTP and ATP can maximally dilate cerebral arteries
following inhibition of NOS and COX (You et al., 1997; You et al., 1999). This
vasodilatory process, which may or may not be a diffusible factor, is referred to as
endothelium-derived

hyperpolarizing

factor
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(EDHF)

and

is

characterized

by

endothelium-dependence, hyperpolarization of vascular smooth muscle and activation of
endothelial Ca2+-activated K+ channels (Golding et al., 2002). EDHF-mediated dilation
requires an increase in endothelial Ca2+ and endothelial hyperpolarization.

This

hyperpolarization is blocked by application of TRAM-34, an inhibitor of intermediate
conductance Ca2+-activated K+ channels (Marrelli, 2001; Marrelli et al., 2003).

In

addition, studies also suggest that activity of apamin-sensitive endothelial small
conductance Ca2+-activated K+ (SKCa) channels may also contribute to endothelial
hyperpolarization involved in EDHF (Burnham et al., 2002; Eichler et al., 2003).
Although it is not clear how hyperpolarization of endothelial cells leads to smooth muscle
hyperpolarization, this may depend on myoendothelial gap junctions (Griffith et al.,
2004; Xu et al., 2002b) or SKCa/IKCa-mediated K+ release leading to activation of
smooth muscle KIR channels (McNeish et al., 2005).
Whereas NO is important in large diameter vessels, EDHF may play a more
prominent role as arterial diameter decreases (You et al., 1999). Dilations in response to
ATP in middle cerebral arteries are blocked by the NOS inhibitor nitro-L-arginine methyl
ester. However, these dilations in penetrating arterioles are resistant to NOS and COX
inhibition, but are completely abolished by the endothelial IKCa inhibitor charybdotoxin
(Xu et al., 2001). Heterogeneity in EDHF-mediated control of vascular tone may be
important for controlling blood flow to metabolically diverse brain regions.

Prostacyclin and other eicosanoids: The term eicosanoid collectively refers to
metabolites of arachidonic acid, which is liberated from the phopholipid membrane by
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the enzyme phospholipase A2. Arachidonic acid is metabolized by cyclooxygenase
(COX), lipoxygenase, epoxygenase, or Ω hydroxylase (Bogatcheva et al., 2005). The
COX pathway was the first arachidonic acid metabolism pathway to be discovered. In
the cerebrovascular endothelium, COX produces vasodilator products including
prostaglandin I2 (prostacyclin), prostaglandin E2 (Moore et al., 1988), and prostaglandin
D2 (Smith et al., 1996), and vasoconstrictor products including prostaglandin F2 and
thromboxane A2. The effects of the endothelial vasodilatory compound prostacyclin are
well established.

Upon prostacyclin binding to G-protein coupled receptors, GS

stimulates activation of adenylyl cyclase and increased cAMP (Bogatcheva et al., 2005).
A subsequent increase in PKA activity then enhances K+ channel activity, resulting in
smooth muscle hyperpolarization (Parkington et al., 2004). Vasoconstrictor eicosanoids
are thought to be elevated in brain injury (Dewitt et al., 1988; Shohami et al., 1987;
Yergey and Heyes, 1990) and may contribute to constriction following ischemia and
reperfusion (Cole et al., 1993).
Endothelial epoxygenase catalyzes the metabolism of arachidonic acid to
epoxyeicosatrienoic acids (EETs). EETs compounds relax vascular smooth muscle and
have been proposed to be one form of EDHF (Fleming and Busse, 2006). One recent
study has demonstrated that endothelial-derived 11,12 EET increases the frequency of
Ca2+ sparks and spontaneous BKCa currents in cerebral artery myocytes (Earley et al.,
2005). This effect was prevented by suppression of TRPV4 channels using antisense
oligonucleotides. Thus, 11,12 EETs activate TRPV4 channels and the resulting Ca2+
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influx induces Ca2+ release events from the SR. This increase in Ca2+ spark frequency
enhances activity in nearby BKCa channels and relaxes vascular smooth muscle.

Endothelin-1: The potent endothelium-derived vasoconstrictor endothelin-1 (ET-1) was
first characterized in 1988 by Yanagisawa and colleagues (Yanagisawa et al., 1988).
Under normal conditions, endothelin release does not significantly contribute to cerebral
blood flow (Koedel et al., 1998). However, ET-1 is increased and may contribute to
vascular dysfunction in several pathophysiological states including ischemia and
reperfusion (Matsuo et al., 2001; Petrov and Rafols, 2001), hyperoxia (Armstead, 1999),
and diabetes (Dumont et al., 2003).
ETA and ETB receptors are expressed in vascular smooth muscle and endothelial
cells, respectively (Arai et al., 1990; Sakurai et al., 1990). Binding of ET-1 to smooth
muscle ETA receptors causes vasoconstriction by several mechanisms (Faraci, 1989; Patel
et al., 1996; Pierre and Davenport, 1999; Sagher et al., 1994; Zhou et al., 2004). ETA
activation initially elevates [Ca2+]i via a mechanisms involving IP3-mediated Ca2+ release
from intracellular stores (Zubkov et al., 2004). On the other hand, a sustained Ca2+
increase that follows the initial phase is dependent on extracellular Ca2+ influx (Miyauchi
and Masaki, 1999; Zubkov et al., 2004). In addition, it has been shown that ET-1 can
activate the Rho/Rho-kinase pathway in rabbit basilar arteries, which may lead to
decreased activity of myosin light chain phosphatase (Zubkov et al., 2004).
Depolarization and increased VDCC-mediated Ca2+ may also result from ET-1 release
via activation of Cl- channels (Dai and Zhang, 2004). In contrast to activation of ETA
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receptors on smooth muscle, exposure of cerebral arteries to low concentrations of ET-1
causes vasodilation due to endothelial ETB receptor activation and NO release (Szok et
al., 2001).
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Part 2: Cerebrovascular pathophysiology associated with subarachnoid
hemorrhage.

Introduction
Subarachnoid hemorrhage (SAH) is defined as the extravasation of blood in the
subarachnoid space, or the area between the arachnoid membrane and pia mater (see
figure 2). Spontaneous SAH most commonly results from the rupture of an aneurysm, or
congenital weakness in arterial tunica media, in a cerebral artery on the brain surface.
Although the prevalence of unruptured intracranial aneurysms is controversial, reports
estimate rates as high as 6 % of the general population are harboring these vascular
abnormalities (McCormick and Nofzinger, 1965; Nakagawa and Hashi, 1994).
Intracranial aneurysm rupture occurs in approximately 30,000 individuals in the United
States each year (Kassell et al., 1985). Major risk factors for SAH include smoking,
hypertension, and alcohol consumption (Teunissen et al., 1996).
The consequences of aneurysm rupture and SAH are devastating, with 30 day
mortality rates as high as 50% (Kassell et al., 1985; Teunissen et al., 1996; Weir, 1995).
Immediately following rupture, the rapid discharge of blood into the subarachnoid space
is followed by an acute rise in intracranial pressure. Increased intracranial pressure above
the level of intravascular pressure in the cerebral circulation may result in cessation of
blood flow, global cerebral ischemia and death. Of the patients surviving the initial
hemorrhage, a significant portion develop delayed cognitive deficits that may lead to
further morbidity and mortality (Kassell et al., 1985). For decades, it has been widely
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accepted that a blood-induced delayed and sustained constriction of conduit arteries on
the brain surface (“cerebral vasospasm”) is the major contributor to death and disability
in patients surviving the initial hemorrhage. However, recent evidence suggests that
phenomena other than large artery vasospasm contribute to the development of
neurological deficits following SAH, including global transient ischemia, blood-brain
barrier disruption, activation of inflammatory pathways and vascular remodeling, and
dysfunction of the cerebral microcirculation (Ohkuma et al., 2000; Pluta et al., 2009). In
addition, pathological events independent of the cerebral vasculature may also contribute
to neurological impairment in SAH patients including early brain injury and cortical
spreading depression (Pluta et al., 2009).

This section will review major concepts

regarding mechanisms of enhanced cerebral artery constriction following SAH, focusing
on the role of elevated [Ca2+]i and enhanced smooth muscle contractility. In addition,
emerging evidence supporting a role for small diameter cerebral arteries and arterioles in
cerebral ischemia following SAH will also be discussed.

Experimental models of SAH
Experimental models of SAH aim to reproduce the human pathological condition.
However, this objective is compromised by the goal to achieve reproducibility and avoid
high mortality rates in animals.

In addition, certain aspects of human SAH (i.e.

spontaneous aneurysm rupture, etc.) are lacking in animal models, which use controlled
surgical procedures. Thus, although vasospasm has been reproducibly observed in a
variety of animal models, the issue of the most appropriate model for studying the impact
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of SAH on the cerebral vasculature has not been completely resolved. Primate and
canine SAH models are generally thought to most closely resemble pathology observed
in human SAH (Megyesi et al., 2000).

However, rodent SAH models are far less

expensive and also display many of the pathophysiological properties observed in
humans (Lee et al., 2008).
In 1965, Echlin demonstrated that application of clotted autologous blood into
the subarachnoid space produces marked spasm of primate basilar and vertebral arteries
(Echlin, 1965). Weir et al. reported chronic vasospasm and neurological deficits in these
animals over a similar time course to that seen in humans (Weir et al., 1970). In contrast,
Simeone and colleagues used small needles to puncture the intracranial internal carotid
artery in primates to mimic the rupture of an aneurysm and SAH (Simeone et al., 1968).
This method also caused prolonged angiographic vasospasm lasting up to four days.
Today, experimental animal models routinely employed to mimic the rupture of an
intracranial aneurysm and SAH are: 1) fresh non-clotted autologous blood injected into
the subarachnoid space (injection model) or 2) the internal carotid artery or basilar artery
is punctured using an endovascular filament (perforation model) (Kozniewska et al.,
2006). The perforation model has been limited by much higher mortality rates than the
injection model and results vary depending on the size of the blood clot and location of
the perforated vessel (Kozniewska et al., 2006; Lee et al., 2009). On the other hand,
procedures using a single intracisternal blood injection are associated with low mortality,
yet this model fails to reproducibly exhibit significant changes in the vasculature (Clower
et al., 1986; Megyesi et al., 2000). To overcome this, the injection model was first
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modified in dogs by Varsos et al. by performing a two successive injections of blood 48
hours apart (“double hemorrhage” model) to increase the severity and reproducibility of
vasospasm (Varsos et al., 1983). In a variety of species, the double hemorrhage model
has been found to exhibit many of the features of SAH found in humans including
vasospasm, behavioral deficits and reduced cortical blood flow (Lee et al., 2009; Vatter et
al., 2006). Thus, the double injection SAH model has become widely used to study
mechanisms of delayed cerebral vasospasm.

Mechanisms of enhanced smooth muscle contraction following SAH
Blood components: Whole blood consists of erythrocytes, leukocytes, platelets, soluble
proteins, glucose, hormones and gases. In the 1970’s, evidence was obtained supporting
the hypothesis that the occurrence of vasospasm was correlated with erythrocyte lysis and
levels of the blood component oxyhemoglobin in the cerebral spinal fluid (CSF).
Purified oxyhemoglobin alone is capable of producing sustained cerebral artery
constriction in vitro (Tanishima, 1980; Wellum et al., 1980).

Oxyhemoglobin

concentrations measured in the CSF of SAH patients are sufficient to produce significant
constriction of arteries in vitro and are correlated with development of vasospasm
(Kajikawa et al., 1979). Following erythrocyte lysis, oxyhemoglobin is oxidized to
methemoglobin and superoxide radical. Superoxide radical combines with water to form
hydrogen peroxide, which can react with ferrous iron of methemoglobin to form hydroxyl
radical. Subsequent hydroxyl radical-induced lipid peroxidation can lead to functional
and morphological changes and has been proposed as an important mechanism in the
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pathogenesis of vasospasm (Sakaki et al., 1986). In a primate SAH model, the inhibitor
of iron-dependent lipid peroxidation U74006F was shown to greatly attenuate vasospasm
(Steinke et al., 1989). However, clinical trials using this agent as well as the antioxidants
superoxide dismutase and catalase have failed to significantly benefit SAH patients
(Wellum et al., 1982; Zhang et al., 2010). As will be discussed, oxyhemoglobin may also
lead to enhanced cerebral artery constriction by interfering with the NO-cGMP signaling
pathway as well as inhibition of smooth muscle K+ channel activity.
In addition to erythrocyte lysis products, activated leukocytes and platelets have
also been implicated in inflammatory processes contributing to vascular dysfunction
following SAH. Activation of leukocytes and platelets following SAH may occur due to
the upregulated expression of specific adhesion molecules by endothelial cells or
disruption of the endothelial monolayer, exposing leukocytes and platelets to collagen,
elastin and basement membrane (Davies and Hagen, 1993; Vane et al., 1990). Studies
have shown the presence of platelet microthrombi surrounding vasospastic arteries as
well as polymorphonuclear leukocytes in the intima of cerebral arteries following SAH
(Minami et al., 1991; Suzuki et al., 1990). Activated platelets and leukocytes are capable
of releasing numerous vasoactive substances including thromboxane A2, endothelin-1, 5HT and ATP (Siminiak et al., 1995).

Thus, activation of these blood components

following SAH is likely to contribute to enhanced cerebral artery constriction.
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Role of [Ca2+]i
Although vascular smooth muscle contractility is largely determined by the concentration
of intracellular Ca2+, the role of elevated [Ca2+]i in cerebral artery myocytes leading to
enhanced constriction following SAH is controversial. In 1976, Peterson and Leblanc
first proposed that vasospasm following subarachnoid hemorrhage was dependent on
increased vascular smooth muscle [Ca2+]i caused by spasmogens in blood (Peterson and
Leblanc, 1976).

The authors additionally proposed that increasing the intracellular

concentration of cAMP may be effective for reversing vasospasm due to increased uptake
of Ca2+ into the SR. Later, the development of Ca2+ sensitive fluorescent dyes made it
possible to directly measure intracellular Ca2+ in vascular smooth muscle in spastic
arteries isolated from experimental SAH animals. Bulter et al. used the photoprotein
aequorin from the luminescent jellyfish Aequorea victoria to measure intracellular Ca2+
in vasospastic anterior spinal arteries isolated from a canine double-hemorrhage SAH
model (Bulter et al., 1996). It was found that [Ca2+]i in vasospastic cerebral arteries was
significantly elevated (by ~140 nM) compared to normal arteries. This elevation in
[Ca2+]i was correlated with a marked increase in myosin light chain phosphorylation.
Another study using the ratiometric Ca2+-sensitive fluorescent dye fura-2 also suggested
that impaired regulation of smooth muscle [Ca2+]i may contribute to vasospasm following
SAH (Kim et al., 1996b). Conversely, reports have also suggested contribution of Ca2+independent contractile pathways (i.e. Rho-kinase mediated inhibition of myosin light
chain phosphatase) to the development of vasospasm following SAH (Laher and Zhang,
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2001; Nishizawa and Laher, 2005).

Thus, the role of increased [Ca2+]i in the

pathogenesis of cerebral vasospasm remains unclear.

Role of voltage-dependent Ca2+ channels
Inhibitors of VDCCs are used clinically and provide a modest beneficial effect in SAH
patients (Treggiari-Venzi et al., 2001). Following SAH, elevated vascular smooth muscle
[Ca2+]i may result from increased density of VDCCs, a direct alteration of VDCC gating,
or indirect increase in channel activity via membrane potential depolarization. Aihara et
al. found no change in mRNA expression of CaV1.2 in basilar arteries from a canine SAH
model (Aihara et al., 2004).

However, whether expression of CaV1.2 is altered in

resistance sized cerebral arteries and arterioles following SAH is not known. In addition,
no studies to date have measured expression of auxiliary VDCC β subunits, which are
critical for membrane insertion of α1 subunits (Chien et al., 1995), in cerebral arteries
from SAH animals. A study by Ishiguro et al. used patch clamp electrophysiology to
measure whole cell VDCC currents in cerebral artery myocytes from SAH rabbits
(Ishiguro et al., 2005). These experiments found that VDCC currents in cerebral artery
myocytes from SAH animals were increased by ~40% and were partially resistant to Ltype VDCC inhbitiors.

The selective R-type VDCC blocker SNX-482 abolished

nifedipine-insensitive VDCC currents in myocytes from SAH animals. Consistent with
this, small diameter cerebral arteries from SAH animals were found to express mRNA
and protein for both Cav1.2 (L-type) and CaV2.3 (R-type), whereas arteries from control
animals expressed only CaV1.2. Upregulated expression and function of R-type VDCCs
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in cerebral arteries was also demonstrated following incubation for 5 days with the blood
component oxyhemoglobin (Link et al., 2008). Thus, although oxyhemoglobin does not
appear to directly increase VDCC activity (Kim et al., 1996a), this spasmogen may lead
to enhanced membrane Ca2+ currents via upregulation of R-type channels following
SAH. Further, vasoactive blood components released into the CSF following SAH, such
as norephinephrine, serotonin, and 20-hydroxyeicostetraenoic acid (20-HETE), are
reported to increase the VDCC activity in vascular smooth muscle and have been
implicated in the development of cerebral vasospasm (Gebremedhin et al., 1998; Nelson
et al., 1988; Svendgaard et al., 1977; Takeuchi et al., 2006; Worley et al., 1991). Thus,
substantial evidence supports the hypothesis that elevated smooth muscle [Ca2+]i
following SAH may result from increased VDCC activity.

Role of K+ channels
Smooth muscle membrane potential depolarization may lead to increased Ca2+ influx in
cerebral artery myocytes via increased VDCC Popen. Harder and colleagues were the first
to propose that membrane potential depolarization of vascular smooth muscle following
SAH may result from decreased K+ conductance (Harder et al., 1987). In this study, it
was shown that vasospasm could be reversed by hyperpolarization induced by application
of the K+ channel opener nicorandil.

Since then, others have also reported that

vasospastic cerebral artery myocytes from SAH model animals are more depolarized
compared with controls (Harder et al., 1987; Waters and Harder, 1985; Zuccarello et al.,
1996a) and that dilations in response to synthetic K+ channel activators are enhanced in
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arteries from SAH animals (Sobey et al., 1997; Zuccarello et al., 1996b). It is becoming
increasingly clear that components of blood can constrict cerebral arteries via suppression
of smooth muscle K+ channel activity.

KV channels: Quan and Sobey first provided evidence that voltage-dependent K+
channels were suppressed following SAH with the finding that constrictions to the nonselective KV channel blocker 4-aminopyridine were reduced in basilar arteries from SAH
rats compared with controls (Quan and Sobey, 2000). Molecular assessment of Kv
channel expression has revealed that mRNA for KV2.1 and KV2.2 are downregulated in
canine basilar arteries following SAH (Aihara et al., 2004) and is correlated with ~50%
decrease in KV2 currents (Jahromi et al., 2008a). Additionally, studies in our laboratory
have also demonstrated that KV1.5 channels are suppressed in cerebral artery myocytes
following SAH by a mechanism involving oxyhemoglobin-induced activation of the
tyrosine kinase EGF receptor and channel endocytosis (Ishiguro et al., 2006; Koide et al.,
2007). Thus, suppression of KV channel activity is likely to contribute to membrane
potential depolarization and enhanced arterial constriction following SAH.

BKCa channels: BK channels act as an important feedback mechanism to limit membrane
potential depolarization and elevated [Ca2+]i in cerebral artery myocytes. Studies have
shown that mRNA and protein for BK α and β1 subunits are unchanged following SAH
(Aihara et al., 2004). A later study found no significant differences between normal and
vasospastic myocytes in BK current density, kinetics, Ca2+- or voltage-sensitivity, or
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single channel conductance (Jahromi et al., 2008b). However, BK channel activity may
be suppressed in vivo following SAH due to increased levels of the endogenous BK
channel inhbitor 20-HETE in the CSF (Poloyac et al., 2005; Roman et al., 2006).
Further, studies in our laboratory have discovered decreased spontaneous transient BKCa
currents and Ca2+ spark frequency in cerebral artery myocytes from SAH model rabbits
(Koide, 2009).

This decrease in Ca2+ spark frequency may be caused by reduced

expression of ryanodine receptor type 2 (RyR2) and increased expression of the RyR2
stabilizing protein FKBP12.6 in cerebral arteries from SAH animals (see Appendix C).
In addition, incubation of cerebral arteries in purified oxyhemoglobin also reduces the
frequency of Ca2+ sparks, leading to decreased outward BKCa currents, depolarization and
enhanced constriction (Jewell et al., 2004). Therefore, although BKCa channel density
and functional properties may be unchanged following SAH, factors regulating the
activation of these channels may be altered causing decreased activity of this vasodilator
pathway.

KIR channels: Few studies have directly examined the expression and function of smooth
muscle KIR channels in the cerebral vasculature following SAH. However, Aihara et al.
found a ~350% increase in KIR2.1 protein in vasospastic canine basilar arteries compared
with normal arteries (Aihara et al., 2004). Consistent with this, a subsequent study by
Weyer et al. found that depolarization and constriction in response to Ba2+ in the presence
of 4-aminopyridine (KV blocker) and paxilline (BKCa blocker) were greater in myocytes
from vasospastic arteries from SAH animals compared with controls (Weyer et al., 2006).
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Further, patch-clamp electrophysiology demonstrated significantly increased KIR currents
in canine basilar artery myocytes following SAH (Weyer et al., 2006). The authors of
this report proposed that upregulation of KIR channels following SAH may represent a
potential compensatory mechanism to counteract sustained arterial constriction.
However, unpublished observations from our laboratory found no significant effect of
SAH on the magnitude of KIR currents in myocytes from small diameter cerebral arteries
arteries in rats and rabbits (Koide and Wellman, unpublished observations). Thus, the
impact of SAH on the function and expression of KIR channels in the cerebral vasculature
may vary with vessel caliber or species.

KATP channels: Studies have shown that dilations induced by activators of KATP channels
are enhanced following SAH (Sugai et al., 1999; Zuccarello et al., 1996b), suggesting
that these channels remain functional in the cerebral vasculature. However, other reports
have demonstrated a decrease in the levels of the endogenous activator of KATP channels
calcitonin gene-related peptide (CGRP) following SAH (Edvinsson et al., 1991;
Edvinsson et al., 1994)

suggesting that decreased KATP activity may contribute to

cerebral vasospasm in vivo. Implantation of CGRP tablets in the subarachnoid space of
SAH model animals was shown to reverse vasospasm (Inoue et al., 1996). However, the
use of CGRP in SAH patients did not improve patient outcome in a multi-center singleblind trial (1992). Hypotension was reported as a common limiting side effect in this
study, most likely due to activation of KATP channels in the systemic circulation.
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Role of Protein Kinase C
Activation of PKC leads to increased smooth muscle contractility by several Ca2+dependent and Ca2+-independent mechanisms (see “second messenger pathways involved
in smooth muscle contraction” above). Activation of the PLC/PKC pathway may also
contribute to the pathophysiologic regulation of vascular tone following SAH (Matsui et
al., 1991; Nishizawa et al., 1996; Nishizawa et al., 1995; Shiota et al., 1996). Levels of
diacylglycerol, an endogenous activator of PKC, are elevated in basilar arteries following
SAH on days 2, 4, and 7 but is reduced to normal levels on day 14 (Matsui et al., 1991).
Several studies suggest significantly increased membrane bound activated PKCα and
decreased cytosolic PKCα which is correlated with angiographic vasospasm on days 4
and 7 following SAH (Matsui et al., 1991; Matsui et al., 1993; Nishizawa et al., 1992;
Takuwa et al., 1993).
The use of PKC inhibitors to relieve vasospasm has yielded inconsistent results.
The PKC inhibitors staurosporine and H-7 reversed vasospasm on day 7 in a canine
double hemorrhage SAH model (Matsui et al., 1991). However, application of the PKC
inhibitor staurosporine failed to reverse vasospasm in rabbit basilar arteries whereas the
KATP channel opener cromakalim completely relaxed these vessels (Zuccarello et al.,
1996b). Thus, it is possible that the contribution of PKC activation leading to enhanced
vasoconstriction following SAH varies between species and experimental SAH models.
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Role of Rho/Rho kinase
Activation of the small GTPase RhoA and subsequent activation of Rho kinase leads to a
decrease in myosin light chain phosphatase activity and sensitization of smooth muscle
contractile filaments. Increased mRNA for RhoA and Rho kinase were demonstrated in
arteries exhibiting vasospasm from a rat double hemorrhage SAH model (Miyagi et al.,
2000).

Increased Rho-kinase and myosin light chain phosphorylation were also

demonstrated in canine basilar arteries following experimental SAH (Sato et al., 2000).
Topical application of the Rho-kinase inhibitor Y-27632 caused a dose-dependent
decrease in myosin light chain phosphorylation and dilation in spastic canine basilar
arteries on day 7 following hemorrhage (Sato et al., 2000). The partially selective
inhibitor of Rho-kinase fasudil is approved for use in SAH patients in Japan and provides
slight improvement in clinical outcome (Nakashima et al., 1998; Tachibana et al., 1999).

Effect of SAH on the endothelium
NO: Tonic NO release is an important regulator of cerebrovascular tone.

The

bioavailability of this potent vasodilator may be reduced following SAH due to the high
affinity binding of NO by hemoglobin following erythrocyte lysis (Edwards et al., 1992).
Many reports suggest that SAH can also disrupt the NO→cGMP feedback process to
cause enhanced cerebral artery constriction.

In support of this hypothesis, mRNA

encoding eNOS was significantly decreased in vasospastic cerebral arteries from a
primate SAH model (Hino et al., 1996). However, the contribution of decreased NO
release to enhanced cerebral artery constriction following SAH is controversial, as other
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studies have demonstrated normal eNOS expression and activity in basilar arteries from
SAH dogs (Kasuya et al., 1995; Kim et al., 1989; Naveri et al., 1994). Some, but not all
studies have also indicated diminished vasodilator response to exogenous NO after SAH
(Afshar et al., 1995; Nakao et al., 1996; Pluta et al., 2000). This may result from
decreased expression or functionality of smooth muscle soluble guanylate cyclase or
protein kinase G, or via increased phosphodiesterase activity in vascular smooth muscle,
leading to reduced steady-state cGMP levels. In addition, normal basal NO release prior
to SAH may also function to inhibit PKC activation (Nishizawa et al., 1996). Therefore,
diminished release of NO or decreased cGMP levels may also lead to enhanced PKCdependent vascular smooth muscle contraction following SAH.

Endothelin-1: In addition to decreased NO release following SAH, other observations
suggest that increased endothelial release of the potent vasoconstrictor ET-1 may be a
major contributor to vasospasm. Several studies have demonstrated increased ET-1
levels in basilar arteries and CSF following SAH (Hirose et al., 1995; Kobayashi et al.,
1991; Kraus et al., 1991). In a study by Itoh et al., mRNA encoding ET A receptors was
not detected in basilar arteries from control animals but was markedly increased in
vessels 3 days following SAH in dogs (Itoh et al., 1994).

Activity of endothelin

converting enzyme (ECE), which converts preproendothelin-1 to active ET-1, is also
increased 3-fold in basilar arteries from SAH model animals (Roux et al., 1995). Further
supporting a role for ET-1 in vasospasm, ETA receptor antagonists, ECE inhibitors, and
antisense oligonucleotides against preproendothelin-1 mRNA substantially attenuate
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vasospasm and constriction in response to hemolysate application (Itoh et al., 1994;
Matsumura et al., 1991; Onoda et al., 1996). In addition to increasing intracellular Ca2+,
increased levels of ET-1 following SAH may also lead to enhanced vascular smooth
muscle contraction via activation of PKC (Murray et al., 1992).

Impact of SAH on the cerebral microcirculation
Following angiographic demonstration of SAH-induced arterial narrowing in 1951,
extensive clinical research has aimed at preventing enhanced constriction of large
diameter conduit cerebral arteries in SAH patients. Overall, clinical trials have been
ineffective at reducing angiographic vasospasm.

However, one recent trial using a

selective ETA receptor antagonist, clazosentan, demonstrated a significant dosedependent reduction in moderate to severe angiographic vasospasm at day 9 following
aneurysm rupture (Macdonald et al., 2008). Despite approximately 50% decrease in the
occurrence of vasospasm, clazosentan did not significantly reduce the rate of poor
clinical outcome based on the modified Rankin scale. On the other hand, clinical use of
the VDCC blocker nimodipine produces a modest improvement in clinical outcome in
SAH patients (Petruk et al., 1988). However, studies suggest that nimodipine does not
significantly influence the incidence of moderate or severe angiographic vasospasm
(Petruk et al., 1988). Thus, large artery vasospasm does not always correlate with the
occurrence of ischemia-related neurological deficits in SAH patients.
Recently emerging evidence suggests that small diameter cerebral arteries and
arterioles, which are critical for autoregulation of cerebral blood flow may be more
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constricted following SAH. Takeuchi and colleagues made the observation that cerebral
blood flow was significantly reduced at mean arterial blood pressures from 40 to 100
mmHg in SAH model primates (Takeuchi et al., 1991). This finding suggests that SAH
may impair cerebral autoregulation such that physiological increases in intravascular
pressure lead to greater constriction of resistance arteries and arterioles in the cerebral
circulation, thus reducing cortical blood flow. Consistent with this hypothesis, Ishiguro
et al. demonstrated enhanced pressure-dependent constriction of small diameter (100-200
µm diameter) cerebral arteries from a rabbit SAH model at physiological intravascular
pressures in vitro (Figure 7) (Ishiguro et al., 2002). Decreased cerebral circulation time
and regional cerebral blood flow measurements in humans 5 and 7 days after SAH
(Ohkuma et al., 2000) also suggests decreased luminal caliber of intracerebral arterioles.
Furthermore, Knuckey et al. observed decreased cerebral blood flow in SAH patients
which was not secondary to increased intracranial pressure or angiographic vasospasm
(Knuckey et al., 1985). Although various histological studies of parenchymal arterioles
from SAH model animals have suggested enhanced constriction of these vessels
following SAH (Ohkuma et al., 1997; Ohkuma and Suzuki, 1999), the function of
isolated parenchymal arterioles following SAH has not been investigated.

Summary
The cerebral circulation is exquisitely regulated by numerous mechanisms to ensure
adequate delivery of oxygen and nutrients to the brain.

Under normal conditions,

cerebral artery diameter is largely controlled by vascular smooth muscle membrane
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potential and the activity of voltage-dependent Ca2+ channels, which represent a splice
variant of the gene CaV1.2. Following SAH, factors released into the cerebrospinal fluid
exert a profound influence over vascular smooth muscle leading to enhanced contraction
and decreased blood flow. Although decades of research has focused on the impact of
SAH on large diameter arteries on the brain surface, evidence suggests that small
diameter arterioles within the brain parenchyma may be more constricted and reduce
local cerebral blood flow.

Part 3: Hypotheses

1.

Increased L-type VDCC activity causes enhanced pressure-dependent

constriction of parenchymal arterioles following experimental SAH.
The overall objective in Chapter 2 of this dissertation was to examine the relationship
between intravascular pressure, smooth muscle intracellular Ca2+ ([Ca2+]i), membrane
potential and diameter of isolated parenchymal arterioles from unoperated, shamoperated and SAH model rats. A combination of techniques were used to test the
hypothesis that increased activity of smooth muscle L-type VDCCs (CaV1.2) leads to
elevated [Ca2+]i and enhanced pressure-induced constriction of parenchymal arterioles
from SAH animals.

Therefore, it was also predicted that enhanced constriction of

parenchymal arterioles following SAH was primarily the result of elevated [Ca2+]i, rather
than Ca2+ sensitization of the smooth muscle contractile machinery (i.e. via increased
PKC or Rho kinase activation). Examination of the relationship between [Ca2+]i and
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constriction revealed that enhanced arteriolar tone was due to increased Ca2+ influx via Ltype channels and elevated [Ca2+]i. We also hypothesized that increased L-type VDCC
activity following SAH may result from either increased VDCC expression or membrane
potential depolarization. We provide evidence suggesting that L-type VDCC mRNA and
protein expression is not altered in parenchymal arterioles from SAH animals. However,
parenchymal arteriolar myocytes were significantly depolarized at physiological
intravascular pressures.

Our data support the hypothesis that membrane potential

depolarization causes increased L-type VDCC-mediated Ca2+ influx and enhanced
constriction following SAH.

We propose enhanced constriction of parenchymal

arterioles may contribute to reduced cerebral blood flow and neurological deficits in SAH
patients.

2. The smooth muscle selective L-type VDCC splice variant containing exon 9* is
dominant in cerebral artery constriction.
Oral administration of voltage-dependent Ca2+ channel antagonists is standard treatment
in SAH patients and provides a modest beneficial effect (Treggiari-Venzi et al., 2001).
However, these agents can also act on VDCCs in the systemic circulation leading to
drastic reductions in vascular resistance and blood pressure. Thus, the use of VDCC
antagonists in SAH patients has been greatly limited by hypotension. Therefore, the
overall objective in Chapter 3 of this dissertation was to develop a strategy to suppress
VDCC activity specifically in the cerebral vasculature. We hypothesized that targeting a
population of CaV1.2 splice variants specifically expressed by smooth muscle with
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antisense oligonucleotides may provide a means of cerebral artery dilation while avoiding
suppression of neuronal channels. In addition, future administration of antisense into the
cerebrospinal fluid of SAH model animals should limit effects to the cerebral vasculature.
Previous studies demonstrate that inclusion of the smooth muscle-selective
alternatively-spliced exon 9* in CaV1.2 channels causes a shift in voltage-dependent
activation towards more negative potentials (Liao et al., 2004). Therefore, inclusion of
exon 9* may be important for development of tone at physiological membrane potentials
in vascular smooth muscle. This finding led us to hypothesize that exon 9* CaV1.2 splice
variants play a critical role in the regulation of cerebral artery diameter. Data presented
in Chapter three of this dissertation suggest that suppression of CaV1.2 channels
containing exon 9* results in markedly reduced cerebral artery constriction in response to
K+-induced membrane depolarization in vitro.

Our results suggest that exon 9*

containing Cav1.2 channels are functionally dominant in cerebral artery constriction and
may provide a novel target for prevention of elevated [Ca2+]i and enhanced constriction
following SAH.
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Figures

Figure 1: Cerebral blood supply.
Illustration of major arteries on the base of the brain. The
Circle of Willis receives blood from the basilar and internal
carotid arteries. These arteries are connected by the anterior
communicating and posterior communicating arteries. The
major arteries supplying the cerebral hemispheres branch off
of the Circle of Willis. Modified from Gray, Anatomy of the
Human Body: 20th Edition. 2000 with permission.
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Figure 2: Organization of pial and parenchymal vasculature.
Schematic representation showing pial cerebral arteries on the brain surface and
penetrating and parenchymal arterioles within the cortex. Superficially, the
Virchow-Robin space is continuous with the subarachnoid space. Distally, this space
transitions into perivascular space separating astrocytic endofeet and vascular
smooth muscle of parenchymal arterioles. Modified from Edvinsson and Krause,
Cerebral Blood Flow and Metabolism: Second Edition. 2002 with permission from
Wolters Kluwer.
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Figure 3: Regulation of intracellular Ca2+.
Major pathways for Ca2+ influx and extrusion are shown.
SERCA:
2+
sarcoplasmic/endoplasmic reticulum Ca ATPase; PMCA: plasma membrane Ca2+
ATPase; NCX: Na+/Ca+ exchanger; CaM: calmodulin; MLC: myosin light chain;
MLCK: myosin light chain kinase.
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Figure 4: Role of VDCCs in pressure-induced constriction.
Elevation of Intravascular pressure results in increased cytosolic Ca2+
and decreased diameter (constriction). This response to increased
pressure is abolished by the dihydropyridine L-type VDCC inhibitor
nisoldipine or removal of Ca2+ from the bath solution. Modified from
Knot HJ and Nelson MT, Regulation of arterial diameter and wall
[Ca2+]i in cerebral arteries of rat by membrane potential and
intravascular pressure. J. Physiol., 1998 with permission.
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Figure 5: Voltage-dependence of VDCC open-state probability.
Top- On-cell patch recording from rabbit mesenteric artery myocytes. Traces
show single Ca2+ channel openings at -60 and -40 mV from holding potential
of -95 mV, using Ba2+ as a charge carrier in the presence of the
dihydropyridine L-type VDCC agonist Bay R 5417. Bottom- Steady state
Popen (from single channel openings during 1 second voltage pulses) over
physiological range of membrane potentials. Inset shows Popen over a wider
range of voltages. Modified from Nelson MT et al., Calcium channels,
potassium channels and voltage dependence of arterial smooth muscle tone.
Am J Physiol., 1990 with permission from American Physiological Society.
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Figure 6: Alpha 1 pore-forming subunit of CaV1.2 VDCCs.
The α1 subunit consists of four homologous domains (I-IV). Each domain
contains six transmembrane segments (S1-S6). The S4 segments of each domain
confers voltage-sensitivity to the channel. Exons encoding the α1 subunit are
numbered. Boundaries between exons are denoted by perpendicular lines.
Modified from Liao P. et al., Splicing for alternative structures of CaV1.2
calcium channels in cardiac and smooth muscles., Cardiovasc Res., 2005 with
permission from Oxford University Press.
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Figure 7: Impact of SAH on cerebral artery tone.
Enhanced pressure-induced constriction of small diameter cerebral
arteries from SAH model rabbits. Representative diameter traces from
arteries isolated from control unoperated (Control, A) and SAH model
animals (B). Solid lines represent active constrictions in response to
elevated pressure. Dashed lines represent passive diameter obtained in
Ca2+-free physiological saline solution containing the L-type VDCC
inhibitor diltiazem. Modified from Ishiguro M. et al., Enhanced
myogenic tone in cerebral arteries from a rabbit model of subarachnoid
hemorrhage, Am J Physiol., 2002 with permission from American
Physiological Society.
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Abstract
Intracerebral (parenchymal) arterioles are morphologically and physiologically unique in
comparison to pial arteries and arterioles.

The ability of subarachnoid hemorrhage

(SAH) to induce vasospasm in large diameter pial arteries has been extensively studied,
although the contribution of this phenomenon to patient outcome is controversial.
Currently, little is known regarding the impact of SAH on parenchymal arterioles, which
are critical for regulation of local and global cerebral blood flow. Here, diameter, smooth
muscle intracellular Ca2+ ([Ca2+]i) and membrane potential measurements were used to
assess the function of intact brain parenchymal arterioles isolated from unoperated
(control), sham-operated and SAH model rats. At low intravascular pressure (5 mmHg),
membrane potential and [Ca2+]i were not different in arterioles from control, sham and
SAH animals.

However, raising intravascular pressure caused significantly greater

membrane potential depolarization, elevation in [Ca2+]i and constriction in SAH
arterioles. This SAH-induced increase in [Ca2+]i and tone occurred in the absence of the
vascular endothelium and was abolished by the L-type voltage-dependent calcium
channel (VDCC) inhibitor nimodipine. Arteriolar [Ca2+]i and tone were not different
between groups when smooth muscle membrane potential was adjusted to the same
value.

mRNA and protein levels of the L-type VDCC, CaV1.2, were similar in

parenchymal arterioles isolated from control and SAH animals, suggesting SAH did not
cause VDCC upregulation. We conclude that enhanced parenchymal arteriolar tone
following SAH is driven by smooth muscle membrane potential depolarization, leading
to increased L-type VDCC-mediated Ca2+ influx. We propose that inhibition of VDCCs
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by calcium channel antagonists or hyperpolarizing vasodilators may be therapeutic
strategies to enhance cortical blood flow in SAH patients.

Keywords: voltage-dependent calcium channels, vascular smooth muscle, cerebral blood
flow, endothelium, ion channels
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Introduction
Cerebral blood flow is regulated by the diameter of resistance arteries and arterioles both
on the surface of the brain and within the brain parenchyma. Parenchymal arterioles,
unlike pial arteries and arterioles, lack extrinsic innervation and are encased by astrocytic
processes (“endfeet”) (20, 28). The close association of this microvasculature with
astrocytic endfeet is essential for functional hyperemia, whereby focal increases in
neuronal activity are coupled to vasodilation of nearby arterioles and increased blood
flow (7, 18, 28, 42). In addition to their role in neurovascular coupling, parenchymal
arterioles also contribute significantly to autoregulation of global cerebral blood flow and
account for approximately 40% of total cerebral vascular resistance (16).

Thus,

parenchymal arterioles are a unique vascular bed, central in the regulation of both local
and global cerebral blood flow.
Pial arteries and arterioles constrict to physiological increases in intravascular
pressure via a process involving vascular smooth muscle membrane potential
depolarization, activation of voltage-dependent Ca2+ channels (VDCCs), and increased
global intracellular Ca2+ ([Ca2+]i) (2, 17, 21, 33, 41). Recent work has established that
pressure-dependent constriction, or myogenic tone, is significantly greater in isolated
parenchymal arterioles than pial arteries (4). The cellular basis for enhanced pressuredependent myogenic tone in the parenchymal vasculature is unclear.

Further, the

relationship between intravascular pressure, membrane potential, [Ca2+]i and diameter of
isolated parenchymal arterioles is not known.
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Dysfunction of the cerebral microcirculation, including parenchymal arterioles,
has been implicated in a number of brain pathologies, including vascular dementia,
Alzheimer’s disease and the development of delayed neurological deficits associated with
cerebral aneurysm rupture and subarachnoid hemorrhage (SAH) (27, 58). A number of
studies have suggested that SAH causes enhanced constriction of the microcirculation to
limit parenchymal blood flow (35, 44, 51, 52, 58).

However, the small size of

parenchymal arterioles (maximum lumenal diameter: 30-60 µm) poses a significant
technical challenge to directly examine their function (45, 53). Consequently, the impact
of SAH on the regulation of parenchymal arteriolar diameter is unknown.
The objective of the present study was to elucidate the relationship between
intravascular pressure, [Ca2+]i, membrane potential and diameter of isolated parenchymal
arterioles from unoperated, sham-operated and SAH model rats. In unoperated animals,
membrane potential depolarization and elevations in [Ca2+]i are enhanced at lower
intravascular pressures in parenchymal arterioles compared with pial arteries. Our results
are consistent with the concept that intravascular pressure constricts parenchymal
arterioles through smooth muscle depolarization, activation of VDCCs, and elevation of
intracellular calcium. Furthermore, our data indicate that following SAH, intravascular
pressure

causes

greater

membrane

depolarization,

vasoconstriction.
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which leads

to

enhanced

Methods
Animals.

Sprague Dawley rats (males, 300-350 g, 10-15 weeks; Charles River

Laboratories, Saint Constant, Quebec, Canada) were used in this study. All experiments
were conducted in accordance with the Guidelines for the Care and Use of Laboratory
Animals (NIH Publication 85-23, Revised 1996) and followed protocols approved by the
Institutional Animal Use and Care Committee of the University of Vermont.

Rat SAH model. Animals were initially anesthetized by isoflurane (5%) using an
induction chamber, then maintained on isoflurane (2-2.5%) anesthesia with the aid of a
nose cone. A small (0.5-1.5 cm), longitudinal, midline suboccipital incision was centered
over the foramen magnum, and the neck muscles were dissected until dura was
visualized. Autologous unheparinized blood (0.5 ml) drawn from the tail artery was
injected into the cisterna magna (day 0) using a 25-guage butterfly needle (38). The
animal was then positioned on an incline board at a 45° angle with the head down in
neutral position for 30 min. Twenty four hours later, a second injection of blood was
delivered by repeating the above procedure. Sham-operated animals were treated in a
similar manner except: injection of 0.5 ml of saline was substituted for injection of 0.5 ml
of unheparinized blood. Buprenorphine (0.01 mg/kg) was given every 12 h (for 36 h,
then as needed) as an analgesic.

On day 4, animals were euthanized under deep

pentobarbital anesthesia by decapitation and parenchymal arterioles (30-60 μm in
diameter) were dissected from the middle cerebral artery territory (8) in cold (4˚C)
MOPS-buffered saline solution of the following composition (in mM): 145 NaCl, 5 KCl,
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1 MgSO4, 2.5 CaCl2, 1 KH2PO4, 0.02 EDTA, 3 3-(N-morpholino)propanesulfonic acid, 2
pyruvate, 5 glucose, 1% bovine serum albumin (pH 7.4).
Measurement of intracellular Ca2+ concentration and diameter.

Freshly isolated

parenchymal arterioles were cannulated on glass micropipettes mounted in a 5 ml
myograph chamber (University of Vermont Instrumentation and Model Facility) as
described previously (8, 30). Vascular endothelium was removed from some arterioles
by passing an air bubble through the lumen following cannulation of one end (55).
Following cannulation, arterioles were loaded with the ratiometric Ca2+-sensitive dye
fura-2 (acetoxymethyl (AM) ester membrane-permeable form) by incubating in MOPS
buffered saline solution containing fura-2 AM (5 μM) (Invitrogen, Carlsbad, CA) with
pluronic acid (0.1%) (Invitrogen, Carlsbad, CA) at room temperature (~22˚C) for 45
minutes. Next, the myograph chamber was mounted on a Nikon TE2000-S inverted
fluorescence microscope. To allow for equilibration and de-esterification of fura-2 AM,
arterioles were pressurized to 5 mmHg and continuously superfused (37˚C, 30 min) with
artificial cerebrospinal fluid (aCSF) of the following composition (in mM): 125 NaCl, 3
KCl, 18 NaHCO3, 1.25 NaH2PO4, 1 MgCl2, 2 CaCl2, 5 glucose aerated with 5% CO2,
20% O2, 75% N2. Bath pH was closely monitored and maintained at 7.30-7.35 (11).

Following the equilibration period, studies were performed in which intravascular
pressure was increased to 10, 20, 40 and 60 mmHg or extracellular K+ was increased
from 3 mM to 60 mM using aCSF made by isosmotic replacement of NaCl with KCl.
Fluorescence ratio was obtained from background corrected ratio of the 510 nm emission
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from arterioles alternately excited at 340 and 380 nm with hardware and software
developed by IonOptix (Milton, MA). [Ca2+]i was estimated using the following equation
(19): [Ca2+] = Kd × β× (R

Rmin)/(Rmax

R).

Rmin and Rmax, the ratios of emission

signals under Ca2+-free and Ca2+-saturated conditions, respectively, were measured from
a separate set of ionomycin-treated arterioles, and β was determined. Calibration values
were not significantly different between arterioles obtained from either healthy or SAH
animals (Table 1) and were pooled for calculations of [Ca2+]i, using an apparent
dissociation constant (Kd) of 282 nM of fura-2 for Ca2+ (33). Total fluorescence counts
(photomultiplier signal at F340 + F380) measured immediately following the equilibration
period were not significantly different between endothelium intact (539 ± 66 counts) and
denuded arterioles (532 ± 40 counts), suggesting endothelial loading with fura-2 was
negligible.
Luminal diameter of arterioles was simultaneously recorded with [Ca2+]i using a CCD
camera and the edge-detection function of IonOptix software. Constriction is presented
as a decrease in arterial diameter relative to the maximum diameter at a given pressure
obtained at the end of each experiment using Ca2+-free aCSF containing nimodipine (300
nM) (30, 59).

Measurement of membrane potential: Arterioles were cannulated as described above
and pressurized to either 5 or 40 mmHg. Smooth muscle membrane potential was
measured by insertion of a sharp glass microelectrode ( 100-MΩ resistance) filled with
0.5 M KCl into the vessel wall. The criteria for successful impalement was 1) an abrupt
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negative potential deflection upon entry, 2) a stable membrane potential for ≥30 seconds,
and 3) an abrupt positive potential deflection upon removal (33, 46). Measurements were
made using an electrometer (World Precision Instruments), and recorded via computer
using Axotape and Dataq software.

RT-PCR: Total RNA was extracted using RNA STAT-60 total RNA/mRNA isolation
reagent (Tel-test, Friendswood, TX) and reverse transcribed to cDNA using SuperScript
First-Strand synthesis system (Invitrogen, Carlsbad, CA) (43). Polymerase chain reaction
was performed using primers detecting CaV1.2 (Genbank accession No. X55763)
[forward

(5’-CAGCAGGTCCTATGTCAGCA-3’),

reverse

(5’-

CCGACAGCAGTGAATGAAGA-3’)], and 18S (Genbank accession No. M11188)
[forward (5’-AGTCGCCGTGCCTACCAT-3’), reverse (5’-GCCTGCTGCCTTCCTTG3’)]. Amplification was performed with a taq core PCR kit (Qiagen, Valencia, CA) using
a thermocycler (Techne, Burlington, NJ).

Band intensity in the linear range of

amplification (CaV1.2: 29 cycles; 18S rRNA: 30 cycles) was quantified using Quantity
One 1-D Analysis software (Bio-Rad, Hercules, CA). Expression levels were normalized
to band intensity values for 18S rRNA.

Western blot analysis: Parenchymal arterioles were pooled from two animals per sample
(n). Whole parenchymal arteriole lysates were prepared by sonication (20 min, 4˚C) in a
triton lysis buffer solution containing (in mM): 50 HEPES, 150 NaCl, 1 EGTA, 1.5
MgCl2, 1% triton-X, 10% glycerol with protease inhibitors (10 μg/mL of leupeptin,
aprotinin, antipain and 10 mM phenylmethylsulfonyl fluoride). Tissue debris and nuclear
69

fragments were removed by centrifugation at 7000 rpm (10 min, 4°C). The whole cell
lysate was obtained as the supernatant and protein concentration was determined by
Bradford assay. Molecular weight marker (Invitrogen, Carlsbad, CA) was loaded as a
size standard and protein samples (~15 μg total protein) were separated under reducing
conditions on a 7.5% polyacrylamide gel (Bio-Rad, Hercules, CA) by electrophoresis.
Samples were run at 120 V for 1.5 hours on an 8x10-cm electrophoresis cell (BioRad,
Hercules, CA) and electrophoretically transferred to a nitrocellulose membrane at 80 V
for 2 hours (4˚C). The membranes were washed in tris-buffered saline with 0.1% Tween20 (TBS-T), and blocked with 10% nonfat dried milk in TBS-T (1 hour, room
temperature). Membranes were then incubated with the specific polyclonal antibodies
against CaV1.2 (1:200, overnight, 4˚C, Alomone, Jerusalem), or monoclonal antibody
against GAPDH (1:100,000, 30 min, room temperature, Sigma, St. Louis, MO), prepared
in 5% nonfat dried milk in TBS-T. Membranes were then incubated (1 hour; room
temperature) with horseradish peroxidase-labeled donkey anti-rabbit IgG (CaV1.2,
1:5000; GAPDH, 1:10,000, GE Healthcare, Waukesha, WI) in TBS-T containing 5%
nonfat dried milk. Bands were identified by chemiluminescence and exposed to X-ray
films.

Densitometry for immunoreactive bands was performed using NIH software

(ImageJ) and density was expressed as a percent of GAPDH density for each lane.

Statistical analysis.

Values are presented as means ± SEM.

One-way analysis of

variance followed by Tukey multiple comparison test was used in the comparison of
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multiple groups. Student’s t-test was used in the comparison of two groups. Statistical
significance was considered at the level of p < 0.05 (*) or p < 0.01 (**).
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Results
Parenchymal arterioles isolated from SAH model animals exhibit elevated cytosolic
Ca2+ and enhanced tone at physiological intravascular pressures.
To assess the role of cytosolic Ca2+ in pressure-induced parenchymal arteriolar
constriction, simultaneous measurements of [Ca2+]i and diameter were obtained from
freshly isolated parenchymal arterioles loaded with the ratiometric Ca2+ indicator fura-2.
In response to step-wise increases in intravascular pressure, arterioles from unoperated
(control), sham-operated (sham) and SAH animals exhibited graded increases in cytosolic
Ca2+ ([Ca2+]i) and active constriction. At low intravascular pressure (5-10 mmHg),
similar levels of [Ca2+]i and tone were observed in vessels isolated from all groups.
However, as intravascular pressure was increased to physiological levels (i.e. 20 to 60
mmHg) (16, 23), arterioles from SAH animals exhibited markedly enhanced levels of
[Ca2+]i and constriction compared with arterioles from control and sham-operated animals
(Fig. 1A-E). For example, at 40 mmHg, [Ca2+]i was ~33% higher in arterioles from SAH
animals (349 ± 11 nM, n = 5) compared with arterioles isolated from control animals
(261 ± 8 nM, n = 6). Corresponding to this SAH-induced increase in [Ca2+]i, at 40
mmHg, vessels from SAH animals constricted 29 ± 2 μm (53 ± 4% decrease in diameter,
n = 5), compared with a constriction of 14 ± 1 μm in arterioles from control animals (29 ±
2% decrease in diameter, n = 6). Although, [Ca2+]i and tone at a given pressure were
greater in arterioles from SAH model animals, the relationship between [Ca2+]i and
constriction were remarkably similar between arterioles isolated from control and SAH
animals (Fig. 1F). These data suggest that elevated [Ca2+]i is sufficient to account for
72

enhanced pressure-induced constriction of parenchymal arterioles from SAH model
animals.
The role of L-type VDCCs in SAH-induced elevation of [Ca2+]i and arteriolar
tone was examined by applying the dihydropyridine L-type VDCC inhibitor nimodipine
(300 nM) prior to increasing intravascular pressure. Pressure-induced increases in [Ca2+]i
and constriction were abolished by nimodipine in control and SAH groups (Fig. 1D,E)
indicating that Ca2+ influx in parenchymal myocytes from both control and SAH animals
is mediated by L-type VDCCs. These results indicate that elevation of intravascular
pressure leads to greater L-type VDCC-mediated Ca2+ influx, increased [Ca2+]i and
enhanced constriction of parenchymal arterioles from SAH animals.

Increased L-type VDCC activity, rather than increased channel expression, mediates
enhanced parenchymal arteriolar constriction following SAH.
SAH-induced Ca2+ influx via L-type VDCCs could reflect either an increase in the
density of functional channels or a more depolarized membrane potential leading to an
increase in the open-state probability (Popen) of existing channels. To explore whether
upregulation of L-type VDCC expression occurs following SAH, RT-PCR was used to
examine CaV1.2 mRNA, encoding the predominantly expressed L-type VDCC poreforming α1 subunit in vascular smooth muscle (3, 40). Expression of CaV1.2 mRNA,
normalized to 18S rRNA levels, was similar in parenchymal arterioles isolated from
control and SAH animals (Fig. 2A, B). In addition, protein levels of CaV1.2, determined
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by Western blot, were not different between groups (Fig. 2C, D). These data suggest that
upregulation of CaV1.2 does not contribute to elevated [Ca2+]i following SAH.
Based on the above data, we hypothesized that greater smooth muscle
membrane potential depolarization, rather than increased VDCC expression, underlie
enhanced pressure-induced constriction of parenchymal arterioles following SAH. Thus,
at a given membrane potential, similar [Ca2+]i and constriction would be predicted for
arterioles from control and SAH animals. To test this possibility, [Ca2+]i and constriction
were measured when extracellular K+ concentration ([K+]o) was elevated from 3 mM to
60 mM by isosmotic replacement of NaCl with KCl in the bath solution. In pial arteries,
membrane potential closely follows the K+ equilibrium potential (EK) at [K+]o greater
than 16 mM (25, 33). This also appears to be the case with parenchymal arterioles, as
smooth muscle membrane potential in arterioles bathed in 60 mM [K+]o was very close to
theoretical EK (Control: -22 ± 1 mV, n = 4; SAH –21 ± 1 mV, n = 4), predicted by the
Nernst equation (-22 mV; assuming intracellular [K+] = 140 mM) (Fig. 3A). When
smooth muscle membrane potential was “clamped” using 60 mM [K+]o, [Ca2+]i was not
different in parenchymal arterioles isolated from healthy (393 ± 18 nM, n = 7) and SAH
animals (388 ± 14 nM, n = 5) (Fig. 3B). Constriction was also similar for control and
SAH arterioles in the presence of 60 mM [K+]o (Fig. 3C). Elevations in [Ca2+]i and
constrictions in response to 60 mM [K+]o were abolished by nimodipine (300 nM) in
arterioles from both groups (Fig. 3B,C). These findings suggest that enhanced pressureinduced constrictions following experimental SAH likely reflect differences in smooth
muscle membrane potential, rather than increased VDCC expression.
74

Elevation of intravascular pressure leads to greater smooth muscle membrane
potential depolarization following experimental subarachnoid hemorrhage.
To directly assess the impact of SAH on smooth muscle membrane potential, myocytes
of intact parenchymal arterioles were impaled from the adventitial surface using
intracellular microelectrodes.

At low intravascular pressure (5 mmHg), membrane

potential was similar in arterioles isolated from control (-58 ± 2 mV, n = 4) and SAH
animals (-59 ± 2 mV, n = 4) (Fig. 4A). Raising intravascular pressure from 5 to 40
mmHg resulted in membrane potential depolarization in arterioles from both groups.
However, parenchymal arteriolar myocytes from SAH animals were significantly more
depolarized at 40 mmHg (-28 ± 1 mV; n = 4) compared with arterioles from control
animals (-35 ± 1 mV; n = 5) (Fig. 4B,C). These data suggest that greater pressuredependent membrane potential depolarization underlies enhanced parenchymal arteriolar
tone following SAH.

Endothelial function promotes vasodilation in parenchymal arterioles following SAH.
Membrane potential of arteriolar myocytes can be modulated by the vascular
endothelium (17). Previous work has indicated that endothelial SKCa and IKCa channel
activity promotes smooth muscle membrane potential hyperpolarization and plays an
important role in the regulation of parenchymal arteriolar tone and cortical blood flow (5,
14). Thus, to assess endothelial function in parenchymal arterioles following SAH, we
examined the effect of NS309, an opener of endothelial small- (SKCa) and intermediate75

conductance (IKCa) Ca2+-activated K+ channels (26, 50), on arteriolar [Ca2+]i and
diameter. At 40 mmHg intravascular pressure, NS309 (1 μM) caused hyperpolarization
in endothelium-intact arterioles from both control (–67 ± 2 mV, n = 5) and SAH animals
(–67 ± 2 mV, n = 4) (Fig. 5A). Consistent with membrane potential hyperpolarization,
NS309 also caused a significant decrease in [Ca2+]i in arterioles from control (242 ± 7 nM
to 141 ± 15 nM; n = 4) and SAH animals (330 ± 11 nM to 151 ± 14 nM; n = 4) and
induced >90% vasodilation in both groups (Fig. 5B). These results demonstrate that
activation of endothelial SKCa and IKCa channels causes a similar marked membrane
potential hyperpolarization and vasodilation of arterioles from control and SAH animals.
To examine whether altered endothelial function contributes to elevated [Ca2+]i
and enhanced constriction of parenchymal arterioles from SAH animals, [Ca2+]i and
diameter were measured in endothelial-denuded vessels. The endothelium was removed
from parenchymal arterioles by passing an air bubble through the vessel lumen during the
cannulation procedure. Although endothelium-denuded arterioles displayed increased
[Ca2+]i and constriction compared to corresponding endothelium-intact vessels in both
groups, these parameters remained significantly higher in parenchymal arterioles from
SAH animals (Fig. 5C).

Application of NS309 was used to confirm absence of

endothelial function in denuded vessels. Consistent with expression of SKCa and IKCa
channels in endothelial cells but not smooth muscle, NS309 had no effect on [Ca2+]i or
diameter in denuded arterioles from either control or SAH animals (Fig 5D). These
results suggest that SAH-induced elevated [Ca2+]i and enhanced arteriolar tone result

76

from a direct modulation of smooth muscle membrane potential, rather than decreased
endothelial vasodilatory influence.
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Discussion
Here, we report that cytosolic Ca2+ is elevated and pressure-dependent constriction is
enhanced in parenchymal arterioles from experimental SAH animals.

Our data

demonstrate elevations in intravascular pressure cause greater membrane potential
depolarization following SAH, leading to increased activity of L-type VDCCs and
enhanced constriction.

The following observations are consistent with these novel

findings: 1) Increasing intravascular pressure resulted in significantly greater elevation of
[Ca2+]i and enhanced myogenic tone in parenchymal arterioles isolated from SAH model
animals. 2) Pressure-induced elevations in [Ca2+]i and myogenic tone were abolished by
the L-type VDCC inhibitor nimodipine. 3) Arteriolar [Ca2+]i and constriction were
similar in arterioles from control and SAH animals when membrane potential was
clamped at EK (≈ -22 mV) using 60 mM extracellular [K+]. 4) At 40 mmHg, smooth
muscle membrane potential was approximately 7 mV more depolarized in arterioles
isolated from SAH versus control animals. 5) CaV1.2 mRNA and protein expression
were not altered by SAH.
independent

of

vascular

6)

Differences in [Ca2+]i and tone at 40 mmHg were

endothelium.

In

addition,

endothelium-dependent

hyperpolarization of smooth muscle using NS309 reduced [Ca2+]i to basal levels and
dilated parenchymal arterioles from control and SAH animals.
This work also provides novel information regarding the physiological function
of arterioles within the brain parenchyma. Previous studies have found that parenchymal
arterioles develop significantly greater pressure-induced myogenic tone compared with
middle cerebral arteries (4, 5). To assess the contribution of membrane potential and
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[Ca2+]i to these differences, we compared our data presently obtained for isolated
parenchymal arterioles from unoperated rats with data previously reported by Knot and
Nelson (33) for rat middle cerebral arteries. At a given level of intravascular pressure,
parenchymal arterioles display greater [Ca2+]i compared with middle cerebral arteries
(Fig. 6A) (i.e. 267 nM versus ~190 nM, respectively, at 60 mmHg intravascular
pressure). However, the relationships between [Ca2+]i and constriction are remarkably
similar in these vascular beds (Fig. 6B), suggesting that in healthy animals, enhanced
pressure-dependent constriction observed in parenchymal arterioles results from a greater
elevation in [Ca2+]i. A comparison of the relationship between intravascular pressure and
membrane potential indicates that at a given intravascular pressure, smooth muscle
membrane potential is more depolarized in parenchymal arterioles.

For example,

membrane potential measured in parenchymal myocytes was approximately -35 mV at 40
mmHg; however, this level of membrane potential depolarization was not reached in
middle cerebral arteries until intravascular pressure was increased to 80-100 mmHg (33).
Thus, the relationship between intravascular pressure and membrane potential appears to
be shifted towards lower pressures in parenchymal arterioles, thereby accounting for the
similar leftward shift in the pressure versus [Ca2+]i relationship (Fig. 6A). This functional
distinction may be critical for development of parenchymal arteriolar tone at the lower
physiological pressures they experience in vivo.
We also demonstrate that the relationship between intravascular pressure and
[Ca2+]i is further shifted to the left in parenchymal arterioles following SAH. This effect
is

correlated

with

enhanced

pressure-induced
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depolarization

at

physiological

intravascular pressure in arterioles from SAH animals. Hence, increasing intravascular
pressure within the physiological range leads to greater membrane potential
depolarization, increased Ca2+ influx via L-type VDCCS, elevated [Ca2+]i and enhanced
constriction of parenchymal arterioles following experimental SAH. However, when
membrane potential is equalized between SAH and control arterioles using 60 mM [K+]o
or NS309, L-type VDCC-mediated Ca2+ influx and arteriolar [Ca2+]i is similar between
groups.

Thus, our data imply that increased Ca2+ influx following SAH reflects

membrane potential depolarization, rather than increased VDCC density at the plasma
membrane. The membrane potentials reported here for parenchymal arteriolar myocytes
(± SAH) are within the range in which L-type VDCC current is steeply voltagedependent (41). At voltages between -60 and -30 mV, VDCC open-state probability is an
exponential function of membrane potential and it is estimated that depolarization of 7
mV (-35 mV to -28 mV, Fig. 4C) could more than double VDCC Popen from 0.016 to
0.035 (41).

Therefore, the depolarization observed following SAH in this study is

consistent with a substantial increase in VDCC activity, leading to a marked increase in
Ca2+ entry in parenchymal arteriolar myocytes.
Vascular smooth muscle membrane potential can be modulated by vasoactive
factors released by the endothelium. A number of studies suggest that nitric oxidemediated vasodilation is impaired in large diameter cerebral arteries in experimental
models of SAH (6, 17). Similar findings have been reported in basilar arteries of SAH
patients (24). However, the contribution of endothelial dysfunction to cerebral artery
constriction is controversial and others have reported that endothelium-dependent
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relaxation is unchanged following SAH (10, 39).

The relative contribution of

endothelium-dependent vasodilators to vascular tone may depend on vessel size and the
effects of SAH on endothelial function may differ between large and small diameter
vessels. Whereas basal NO production seems to control tone in both cerebral arteries and
arterioles, the contribution of endothelium-derived hyperpolarizing factor (EDHF) to
blood flow regulation may be greater at the level of the microcirculation (57). Previous
studies suggest that EDHF-mediated relaxation requires the activity of endothelial SKCa
and IKCa (13, 60) and these channels are involved in modulating basal tone in
parenchymal arterioles, but not in middle cerebral arteries (5). Here, we show that
activation of endothelial SKCa and IKCa channels with NS309 caused a similar reduction
of [Ca2+]i to basal levels and profound dilation of parenchymal arterioles from both
control and SAH animals. Further, endothelial removal did not ablate SAH-induced
pressure-induced increases in [Ca2+]i and myogenic tone. Therefore, reduced endothelial
vasodilator influence cannot account for enhanced vasoconstriction of parenchymal
arterioles following SAH. These findings are in agreement with previous data for small
diameter brainstem arteries (32) and penetrating arterioles (53) and suggest that a direct
alteration of smooth muscle membrane potential regulation contributes to dysfunction of
cerebral microvessels from SAH animals.
Our results indicate that elevated parenchymal arteriolar [Ca2+]i and tone
following SAH depends on intravascular pressure. At this time, it is unclear how SAH
causes

enhanced

pressure-dependent

depolarization

in

parenchymal

arterioles.

Activation of mechanosensitive non-selective cation channels belonging to the transient
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receptor potential family (i.e. TRPC6,TRPM4) is reported to contribute to membrane
potential depolarization of cerebral artery myocytes to increased pressure (15, 56). Thus,
increased expression or activity of these channels following SAH may lead to membrane
depolarization and enhanced VDCC activity.

On the other hand, SAH-induced

depolarization may also result from suppressed hyperpolarizing influence. For example,
significant voltage-dependent K+ channel (KV)-mediated current is observed at
physiological membrane potentials (47) and activation of these channels represents an
important feedback mechanism in response to pressure-induced depolarization.
Consistent with this hypothesis, inhibition of KV channels with 4-aminopyridine causes
membrane potential depolarization and vasoconstriction (34, 49). Numerous studies have
suggested that substances within blood may lead to membrane potential depolarization of
cerebral artery myocytes via suppression of K+ channel activity (17, 22, 48).

For

example, using pial arteries from a rabbit SAH model, our laboratory has shown that
acute exposure of vascular smooth muscle to the blood component oxyhemoglobin can
cause internalization of (KV1.5) via a mechanism involving protein tyrosine kinase
activation (29, 36). Others have additionally demonstrated that mRNA and protein levels
of KV2.2 channels were decreased in basilar arteries from a canine SAH model (31).
Hence, further studies are required to determine whether KV channel suppression
contributes to enhanced pressure dependent depolarization of parenchymal arteriolar
myocytes in SAH animals.
Enhanced constriction of cerebral arteries and arterioles associated with SAH
requires Ca2+ influx via VDCCs in vascular smooth muscle (54).
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Currently, oral

administration of the L-type VDCC inhibitor nimodipine is regarded as standard therapy
for patients with SAH and is associated with a modest improvement in clinical outcome
(37). The mechanism of the beneficial effects of nimodipine in SAH patients is unclear,
however this agent does not significantly reduce large artery, or “angiographic”
vasospasm (1). Our results are consistent with speculation that nimodipine treatment
may be effective for reversal of enhanced constriction of microvessels within the brain
parenchyma, which are beyond the resolution limits of angiography (12). Although
further studies are required to examine this possibility, such a mechanism would point to
significant role for microcirculatory dysfunction in the development of delayed
neurological deficits in SAH patients.
To summarize, we provide evidence that myocytes of parenchymal arterioles are
more depolarized at physiological intravascular pressures leading to increased L-type
VDCC activity, elevated [Ca2+]i and enhanced constriction.

Furthermore, we

demonstrate that inhibitors of L-type VDCCs (i.e. nimodipine) as well as agents that
cause hyperpolarization (i.e. NS309) are effective in reducing [Ca2+]i and dilating
parenchymal vessels from SAH animals. We propose that therapeutic strategies targeting
this enhanced vasoconstriction of the cerebral microcirculation may be beneficial in
reducing neurological deficits associated with SAH.
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Figure Legends

Figure 1: Elevated cytosolic Ca2+ and enhanced myogenic tone in parenchymal
arterioles from SAH animals. A-C: Representative simultaneous [Ca2+]i and diameter
measurements obtained from intact arterioles isolated from unoperated (control; A),
sham-operated (sham; B) and SAH (C) animals. Recordings were obtained during stepwise increases in intravascular pressure and subsequent nimodipine application (300 nM)
at 60 mmHg.

D,E.

Summary of [Ca2+]i (D) and constriction (E) obtained from

unoperated (control; n = 6), sham-operated (sham; n = 6) and SAH (n = 5) animals in the
absence and presence of 300 nM nimodipine. Myogenic tone is expressed as a percent
decrease from the passive diameter (obtained in Ca2+-free aCSF with 300 nM
nimodipine) of arterioles at a given intravascular pressure. Passive diameters were not
statistically different between groups at any intravascular pressure tested.

*P<0.05,

**P<0.01 vs. control healthy and sham-operated. F. Relationship between [Ca2+]i and
constriction for arterioles isolated from control and SAH animals derived from summary
data depicted in panel D and E. Numbers represent intravascular pressure (mmHg). The
concentration of Ca2+ causing half-maximal arteriolar constriction, obtained from
Boltzmann fit of data (using 60 mM [K+]o as maximum; see figure 3), were similar
between groups (Control: 226 ± 26 nM, n = 5-7; SAH: 240 ± 10 nM, n = 5).

Figure 2: CaV1.2 mRNA and protein expression is unchanged following SAH. RTPCR and Western blotting were used to measure CaV1.2 mRNA and protein,
89

respectively. A. Representative PCR gel showing bands corresponding to CaV1.2 and
18S ribosomal RNA (rRNA). B. Summary of RT-PCR data obtained from quantitative
analysis of band intensities for arterioles isolated from control (n = 6) and SAH (n = 6)
animals. CaV1.2 mRNA is expressed as relative to 18S rRNA. NS: P>0.05 vs. control.
C. Representative Western blot images for CaV1.2 and GAPDH using whole cell lysates
of parenchymal arterioles (each lane represents pooled arterioles from two animals).
CaV1.2 immunoreactivity (~200-240 kDa) was observed as a doublet representing the full
length and truncated forms of CaV1.2 (9). GAPDH (~36 kDa) was used as an internal
standard. D. Summary of Western blot data obtained by densitometry using ImageJ
software (NIH). CaV1.2 protein levels were normalized to GAPDH and expressed as
fold-change compared to corresponding control in each experiment (n = 4). NS: P>0.05
vs. control.

Figure 3:

Elevated arteriolar Ca2+ and enhanced constriction following SAH

depend on membrane potential depolarization. A. Summary membrane potential data
obtained from isolated pressurized (5 mmHg) parenchymal arterioles bathed in 60 mM
extracellular K+ ([K+]o). Membrane potential closely matched the theoretical EK of -22
mV in arterioles from both control (n = 4) and SAH animals (n = 4). B,C. Summary data
showing [Ca2+]i (B) and constriction (C; percent decrease in diameter) in control (n = 7)
and SAH arterioles (n = 5) exposed to aCSF containing either 3 mM or 60 mM [K+]o.
Nimodipine (300 nM) reduced [Ca2+]i to basal levels and dilated arterioles. NS: P>0.05
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Figure 4: Myocytes of pressurized parenchymal arterioles are depolarized following
SAH.

A-B.

Representative smooth muscle membrane potential measurements in

arterioles isolated from control and SAH animals at 5 mmHg (A) and 40 mmHg (B)
intravascular pressure. Scale bars represent 10 seconds. C. Summary of membrane
potential measurements obtained at 5 and 40 mmHg.

At 40 mmHg, myocytes of

arterioles isolated from SAH animals were significantly more depolarized (-28 ± 1 mV, n
= 4) compared with myocytes of arterioles isolated from control animals (-35 ± 1 mV, n
= 5) **P<0.01 vs. control.

Figure 5: Elevated [Ca2+]i and enhanced myogenic tone following SAH is
independent of endothelial function.

A.

Summary of membrane potential

measurements obtained from pressurized (40 mmHg) endothelium-intact parenchymal
arterioles in the presence of NS309 (1 µM). B. Summary of [Ca2+]i and dilation resulting
from NS309 (1 µM) application for endothelium-intact parenchymal arterioles from
control (n = 4) and SAH animals (n = 4). C. Summary of [Ca2+]i and myogenic tone
(percent decrease in diameter) obtained from endothelium-denuded arterioles from
control (n = 5) and SAH animals (n = 5). Endothelium was removed by passing an air
bubble through the vessel lumen for ~30 seconds. **P<0.01 vs. control D. Summary of
[Ca2+]i and dilation resulting from NS309 (1 µM) application for endothelium-denuded
parenchymal arterioles from control (n = 5) and SAH animals (n = 5). **P<0.01 vs.
control.
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Figure 6:

The relationship between intravascular pressure, cytosolic Ca2+ and

diameter of parenchymal arterioles vs. pial arteries from control animals.

A.

Relationship between intravascular pressure and [Ca2+]i for parenchymal arterioles and
middle cerebral arteries (MCA; obtained from results published in Knot et al., 1998) (33)
B. Relationship between [Ca2+]i and constriction for parenchymal arterioles and middle
cerebral arteries (33). Constriction is expressed as a percentage of maximal constriction
obtained in 60 mM [K+]o (see figure 4).

Table 1: Fura-2 Calibration values. Rmin, Rmax and β was determined from a separate
set of arterioles (see Methods). No differences were found among control (n = 4) and
SAH (n = 4) arterioles. Pooled values (n = 8) shown in table were used for analysis of
[Ca2+]i measurements.
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Figure 1: Elevated Ca2+ and enhanced tone in parenchymal
arterioles from SAH animals.

Figures
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Chapter 3 Figure 1: Elevated Ca2+ and enhanced tone in parenchymal arterioles from SAH
animals.

Figure 2: CaV1.2 mRNA and protein expression is unchanged following SAH.
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Figure 3: Elevated arteriolar Ca2+ and enhanced constriction following SAH depend
on membrane potential depolarization.
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Figure 4: Myocytes of pressurized parenchymal arterioles are depolarized following
SAH.
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Figure 5: Elevated [Ca2+]i and enhanced myogenic tone following SAH is independent
of endothelial function.
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Figure 6: The relationship between intravascular pressure, cytosolic Ca2+ and diameter
of parenchymal arterioles vs. pial arteries from control animals.
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Chapter 2 Table 1: Fura-2 Calibration Values.
β

Rmin

Rmax

Control (n = 4)

0.371± 0.008

9.969 ± 0.565

8.031 ± 0.895

SAH (n = 4)

0.378 ± 0.005

10.064 ± 0.795

7.764 ± .370

Pooled

0.374 ± 0.004

10.017 ± 0.483

7.898 ± 0.451

Values are means ± SEM.
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Cav1.2 splice variant with exon 9* is critical for regulation of cerebral
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Abstract
L-type voltage-dependent Ca2+ channels (VDCCs) are essential for numerous processes
in the cardiovascular and nervous systems. Alternative splicing modulates proteomic
composition of Cav1.2 to generate functional variation between channel isoforms. Here,
we describe expression and function of Cav1.2 channels containing alternatively spliced
exon 9* in cerebral artery myocytes. RT-PCR showed expression of Cav1.2 splice
variants both containing (α1C9/9*/10) and lacking (α1C9/10) exon 9* in intact rabbit and
human cerebral arteries. Using laser capture microdissection and RT-PCR, expression of
mRNA for both α1C9/9*/10 and α1C9/10 was demonstrated in isolated cerebral artery
myocytes. Quantitative real-time PCR revealed significantly greater α1C9/9*/10 expression
relative to α1C9/10 in intact rabbit cerebral arteries compared with cardiac tissue and
cerebral cortex. To demonstrate a functional role for α1C9/9*/10, smooth muscle of intact
cerebral arteries was treated with antisense oligonucleotides targeting α1C9/9*/10
(α1C9/9*/10-AS) or exon 9 (α1C-AS), expressed in all Cav1.2 splice variants, by reversible
permeabilization and organ cultured for 1-4 days. Treatment with α1C9/9*/10-AS reduced
maximal constriction induced by elevated extracellular K+ ([K+]o) by approximately 75%
compared with α1C9/9*/10-sense treated arteries. Maximal constriction in response to the
Ca2+ ionophore ionomycin and [K+]o EC50 values were not altered by antisense treatment.
Decreases in maximal [K+]o-induced constriction were similar between α1C9/9*/10-AS and
α1C-AS groups (22.7 ± 9% and 25.6 ± 4% constriction, respectively). We conclude that
although cerebral artery myocytes express both α1C9/9*/10 and α1C9/10 VDCC splice
variants, α1C9/9*/10 is functionally dominant in the control of cerebral artery diameter.
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Introduction
L-type voltage dependent calcium channels (VDCCs) play a crucial role in the
physiological processes of numerous cell types. In the resistance circulation, arterial
constriction is dependent on membrane potential depolarization and Ca2+ entry via Cav1.2
channels in vascular smooth muscle (15, 21). An increase in global cytosolic Ca2+ leads
to Ca2+/calmodulin-dependent activation of myosin light chain kinase, myosin light chain
phosphorylation, increased actin-myosin interaction, smooth muscle contraction and
decreased vessel diameter. This mechanism is essential for proper regulation of organ
perfusion and systemic blood pressure.
VDCCs are multimeric protein complexes comprised of an α1 pore-forming
subunit associated with β and α2δ auxiliary subunits (5, 8, 24). L-type VDCC currents
are distinguished by high activation potentials, slow inactivation of barium currents, and
selective

inhibition

by

dihydropyridines

(DHPs),

phenylalkylamines,

and

benzothiazepines (5). The Cav1.2 gene, CACNA1C consists of 55 exons, 19 of which are
subject to extensive alternative splicing with 40 splice variations found at 12 loci (34).
cDNA library screening studies have allowed the identification of the cardiac and smooth
muscle Cav1.2 isoforms, differing in composition at four alternative splice sites (2, 22,
28, 31). The purported smooth muscle splice combination consists of exons 1/8/+ 9*/32
while the cardiac form consists of exons 1a/8a/- 9*/31. Smooth muscle L-type channels
are reported to activate at more hyperpolarized (~15 mV) membrane potentials (14, 30)
and display greater DHP sensitivity than analogous channels in the heart (35).

A

previous study suggests that the presence of exon 8 rather than 8a to form transmembrane
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segment 6 of domain I (IS6) in smooth muscle channels contributes to differences in
DHP inhibition (36). Other work has shown that the inclusion of the 25 amino acid
insertion exon 9* in the intracellular linker region between homologous domains I and II
affects channel gating properties resulting in a hyperpolarizing shift in activation
potential and current-voltage relationship (26).

The electrophysiological alteration

imposed by the addition of exon 9* to the channel protein structure suggests that
expression of exon 9* may be a critically important mechanism for the fine-tuning of
channel function such that smooth muscle VDCCs activate at physiologically relevant
membrane potentials. Although such a role for Cav1.2 channels expressing exon 9*
would be suitable for proper vascular function, the physiological significance of this
splice variant in the regulation of blood vessel diameter has not been directly
investigated.
Here, the objective was to determine the role of the exon 9* Cav1.2 splice variant
in constriction of resistance size cerebral arteries. Consistent with previous findings by
others (3, 13, 26), we provide evidence for exon 9* expression in cerebral arteries and
further show a significantly higher ratio of exon 9* mRNA relative to total Cav1.2 mRNA
in cerebral arteries compared with cerebral cortex and cardiac tissue. RT-PCR performed
on cDNA obtained from myocytes isolated by laser-capture microdissection found
expression of both splice variants in cerebral artery smooth muscle.

Antisense

oligodeoxynucleotides were used to selectively suppress α1C9/9*/10 in cerebral artery
smooth muscle to examine the functional role for this splice variant in cerebral artery
constriction. Our findings indicate that despite heterogeneous mRNA expression of both
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α1C9/9*/10 and α1C9/10 isoforms by cerebral artery myocytes, α1C9/9*/10 channels play a
dominant role in constriction of these vessels.
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Methods

Animals. New Zealand White rabbits (males, 3.0-3.5 kg) were used in this study. All
experiments were conducted in accordance with the Guidelines for the Care and Use of
Laboratory Animals (NIH Publication 85-23, 1985) and followed protocols approved by
the Institutional Animal Use and Care Committee of the University of Vermont. Animals
were euthanized under deep pentobarbital anesthesia (150 mg/kg iv) by exsanguination
and decapitation. Posterior cerebral and cerebellar arteries were dissected in ice cold
physiological saline solution (PSS) of the following composition (in mM): 118.5 NaCl,
4.7 KCl, 24 NaHCO3, 1.18 KH2PO4, 2.25 CaCl2, 1.2 MgCl2, 0.023 EDTA, and 11
glucose, aerated with 5% CO2, 20% O2, 75% N2 (bath pH: 7.4).

Cerebral artery

myocytes (40-60 cells/sample) were collected from enzymatically dissociated freshly
isolated posterior cerebral arteries (23, 37) using a P.A.L.M. Laser Capture
Microdissection system (Zeiss, Bernried, Germany). Human cerebral arteries, removed
as a necessary part of a required procedure, were obtained from two consenting surgical
patients. Patients were not receiving calcium channel blockers or other antihypertensive
agents at the time of surgery. The University of Vermont has an approved assurance of
compliance on file with the Department of Health and Human Services covering this
activity (Assurance identification number: FWA723; IRB identification number 0485).

RT-PCR. Total RNA was extracted using RNA STAT-60 total RNA/mRNA isolation
reagent (Tel-test, Friendswood, TX) (4). Total RNA was reverse transcribed to cDNA
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using SuperScript First-Strand synthesis system (Invitrogen, Carlsbad, CA).

Semi-

quantitative PCR was performed using primers detecting the region spanning exons 7-11
of Cav1.2 (Genbank accession No. X55763) (Fig. 1a) of the following sequences:
(5’-TGCTTTCGCCATGTTGACG-3’),

forward

reverse

(5’-

GAATTTCGACTTGGAGATCCGG-3’). Amplification was performed with Taq PCR
core kit (Qiagen) using the following protocol: 94˚ C 3 min, 35 cycles of 94˚ C 1 min, 55˚
C 1 min, 72˚ C 1 min, and final extension at 72˚ C for 10 min. PCR products were
separated by electrophoresis using 2% agarose gel. Quantitative real-time PCR was
performed

using

primers

detecting

CTTGCATGCCCAGAAGAAAG-3’),

exons
reverse

9*-10

[α1C9/9*/10

forward

(5’-

(5’-TAGCGGCTGAATTTCGACTT-

3’)], exons 9-10 [α1C9/9*/10 forward (5’-CCCGAAACATGAGCATGC-3’), reverse (5’GCACTTTCTCCTGCAGAACC-3’)] by using a sense primer specific for the boundary
of

exons

9/10

of

Cav1.2

AGTCGCCGTGCCTACCAT-3’),

(Fig.

2A),

reverse

and

18S

[18S

forward

(5’-

(5’-GCCTGCTGCCTTCCTTG-3’)].

Amplification was performed with SYBR Green JumpStart Taq ReadyMix (Sigma, St.
Louis, MO) using a real-time PCR system (Applied Biosystems, Carlsbad, CA).
Quantification was performed using standard curves constructed by amplification of
serially diluted plasmids containing target genes.
Cerebral artery myocytes samples were screened for cell-specific markers using
the following primer sets: smooth muscle myosin heavy chain [forward (5’CACCACACATCTACGCCATC-3’), reverse (5’-TGATGCTCGTGTCCTTCTTG-3’)],
endothelin

1

[forward

(5’-AAAGGCAAAGACTGCTCCAA-3’),
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reverse

(5’-

GCACTCCTTGGTCTCTCCTG-3’)], fibroblast specific protein 1 [forward (5’GGGGTGACAAGTTCAAGCTC-3’), reverse (5’-CTGGAAGTCCACCTCGTTGT-3’)],
and growth associated protein-43 [forward (5’-AGCCAAGGAGGAGCCTAAAC-3’)
reverse (5’-TCAGGCATGTTCTTGGTCAG-3’)]. Nested PCR was performed using
primers for exons 7-11 (above) of Cav1.2 for first round amplification (35 cycles) and
using the following nested PCR primers for 35 cycles of amplification of 1:100 dilution
of first round products: forward (5’-CGTGCTGTACTGGGTCAATG-3’), reverse (5’CAGCCACGTTTTCAGTGTTG-3’).

Immunostaining of isolated cerebral artery myocytes. Dissociated cell suspensions
were fixed with 4% formalin and plated on Superfrost Plus microscope slides (Fisher
Scientific, Waltham, MA) with a cytocentrifuge.

Cells were dried for 10 min and

blocked and permeabilized in 3% milk/0.1% Triton-X 100 phosphate-buffered saline
(PBS) for 20 min. Cells were rinsed with PBS for 30 min and incubated (4˚C/overnight)
in PBS containing mouse monoclonal antibody raised against rabbit smooth muscle
myosin heavy chain 2 (SM-MHC) (1:125 dilution; Abcam, Cambridge, MA) or
monoclonal antibody against α-smooth muscle actin conjugated to Cy3 (1:200; Sigma, St.
Louis, MO). Cells were then rinsed in PBS, and slides treated with anti-SM-MHC were
incubated in anti-mouse IgG conjugated to Cy3 (1:500; Jackson ImmunoResearch
Laboratories, West Grove, PA). Images were taken (40x) using a Zeiss LSM 510 Meta
confocal microscope.
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Use of antisense oligonucleotides.

For suppression of α1C9/9*/10, antisense

oligonucleotides (Operon Biotechnologies, Huntsville, AL) were designed to target a
sequence specific to the coding region of exon 9* of Cav1.2 mRNA transcripts: α1C9/9*/10AS: 5’-A*A*G*C*CCGCTGGAGTGC*C*T*C*T-3’. To suppress the total population
of Cav1.2 channels, antisense oligodeoxynucleotides were designed to target exon 9
which is not alternatively spliced and is expressed in all Cav1.2 transcripts: α1C-AS 5’C*T*C*T*TCCAGCTGCTGCTTC*T*C*C*C-3’. Control sense oligonucleotides of the
following

sequences

were

designed:

A*G*A*G*GCGCTCCAGCGG*G*C*T*T-3’

α1C9/9*/10-sense:

and

α1C-sense:

5’5’-

G*G*G*A*GAAGCAGCAGCTGGA*A*G*A*G-3’. The first and last four bases of
each oligonucleotide were phosphorothioated to prevent degradation by cellular
nucleases (designated by “*”). All oligonucleotides were reconstituted with nucleasefree water at a concentration of 10 mM.

Reversible permeabilization and organ culture of cerebral arteries. The introduction of
oligonucleotides into smooth muscle of intact cerebral arteries was achieved by a
reversible permeabilization (RP) procedure (9, 25).

Arterial segments were first

incubated at 4˚C for 30 min in the following solution (in mM): 120 KCl, 2 MgCl 2, 10
EGTA, 5 NaATP, 20 N-tris-(hydroxymethyl)methyl-2-aminoethanesulfonic acid (pH
6.8). Arteries were then incubated in a similar solution containing oligonucleotide (10
μM) for 90 min at 4˚C and then in a solution containing elevated MgCl2 (10 mM).
Permeabilization of arteries was reversed by incubating arteries for 30 min at room
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temperature in physiological solution containing the following (in mM): 140 NaCl, 5
KCl, 10 MgCl2, 5.6 glucose, 2 3-(N-morpholino)propanesulfonic acid (pH 7.1). Next,
[Ca2+] was gradually increased in this solution from nominally Ca2+-free to 0.01, 0.1, and
1.8 mM over a period of 45 min.

Following reversible permeabilization, arterial

segments were organ cultured by placing the arteries in serum-free DMEM-F12 culture
media (Invitrogen, Carlsbad, CA) and incubating at 37˚C and 5% CO2 for 1 to 4 days (18,
27).

Diameter measurements in isolated arteries. Freshly isolated and cultured cerebral
artery segments were cannulated on glass micropipettes mounted in a 5 ml myograph
chamber (University of Vermont Instrumentation and Model Facility) as described
previously (18, 19, 27). Following cannulation, arteries were pressurized at 20 mmHg
and continuously superfused with aerated PSS at 37˚ C and pH 7.4 for 30 min to allow
equilibration. Arterial diameter was measured with video edge detection equipment and
recorded using data acquisition software (Dataq Instruments Inc., Akron, OH). Arteries
were exposed to PSS containing elevated [K+], made by isoosmotic replacement of NaCl
with KCl.

Arterial constriction was expressed using the following equation: %

Constriction = (1-(D – Dmin/Dmax – Dmin)) X 100 where Dmax is the maximum diameter
obtained in Ca2+-free PSS containing diltiazem (100 μM) and forskolin (1 μM) and Dmin
is the minimum diameter obtained with the Ca2+ ionophore ionomycin (10 μM) at the end
of each experiment.

Ionomycin-induced constrictions (table 1) are presented as a

percentage of maximum diameter (Dmax). Arteries not achieving >70 % constriction in
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response to ionomycin were not used for analysis. Half-maximal effective concentration
(EC50) was determined from each [K+]o concentration-response experiment.

Statistical analysis.

Values are presented as means ± SEM.

One-way analysis of

variance followed by Tukey multiple comparison test was used in the comparison of
multiple groups. Student’s t-test was used in the comparison of two groups. Statistical
significance was considered at the level of p < 0.05 (*) or p < 0.01 (**).
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Results
Cerebral arteries demonstrate enhanced expression of α1C9/9*/10 compared with brain
and heart.
Previous work has shown selective expression of α1C9/9*/10 splice variants by smooth
muscle-containing tissues.

However, mRNA expression of both α1c splice variants

including (α1C9/9*/10) and excluding (α1C9/10) exon 9* has been reported in aorta (3, 13,
26). Therefore, our first objective was to investigate whether small diameter (100-250
μm) cerebral arteries express mRNA for both α1C9/9*/10 and α1C9/10. To detect expression
of α1C9/9*/10, we designed PCR primers to generate products consisting of exons 7-11 of
α1c (Fig. 1A) such that a shift in product size would result if the 75 nucleotide (nt)
insertion for exon 9* was expressed. RT-PCR analysis resulted in two distinct bands
from rabbit cerebral arteries (Fig. 1B; n=7). Sequence analysis confirmed the lower band
of 460 nt represents α1C9/10 while the upper band of 535 nt represents α1C9/9*/10. Human
cerebral arteries were also analyzed and found to express both α1C9/9*/10 and α1C9/10
similar to arteries from rabbit (Fig. 1C). In contrast, cardiac tissue (left ventricle; n=8)
and brain tissue (cerebral cortex; n=5) were found to express one dominant product
corresponding to α1C9/10 (Fig. 1B).
Quantitative real-time PCR was used to evaluate relative expression levels of
α1C9/9*/10 in these tissues. We hypothesized the fraction of mRNA for Ca v1.2 expressing
exon 9* is greater in cerebral arteries than cardiac and brain tissue. α1C9/9*/10 and α1C9/10
expression was measured separately by using either a PCR primer specific for exon 9*
sequence (α1C9/9*/10-specific) or a primer specific for the boundary of exons 9 and 10
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(α1C9/10-specific; Fig. 2A). α1C9/9*/10 and α1C9/10 expression was normalized to 18S
ribosomal RNA levels. This approach allows quantification of the α1C9/9*/10:α1C9/10
mRNA ratio, which is representative of α1C9/9*/10 relative to overall Cav1.2 expression
considering that α1C9/9*/10 and α1C9/10 are mutually exclusive splice variants. We found
that cerebral arteries express significantly higher relative levels of α1C9/9*/10 compared
with brain and heart tissues (Fig. 2B; ~fifty-two fold and ~six fold difference,
respectively). Together, these results demonstrate mRNA for both α1C9/9*/10 and α1C9/10
splice variants in cerebral arteries and enhanced relative expression of α1C9/9*/10 in
cerebral arteries compared with brain and heart.

Isolated cerebral artery myocytes express both α1C9/9*/10 and α1C9/10 splice variants.
We next chose to clarify whether cerebral artery myocytes express mRNA for both splice
variants or if α1C9/10 detection was due to the presence of non-smooth muscle cell types
within the vascular wall, such as fibroblasts or perivascular neurons, which are reported
to express Cav1.2 (10, 13, 17, 32). Live freshly isolated cerebral artery myocytes (~40-60
cells) were collected by laser capture microdissection for RT-PCR analysis (Fig. 3B).
These elongated spindle-shaped cells showed strong immunofluorescent staining for SMMHC or SM-α-actin, markers commonly used to identify smooth muscle (1, 11) (Fig.
3A). RT-PCR was used to examine expression of specific cell markers: smooth muscle
myosin heavy chain (SM-MHC; smooth muscle), endothelin-1 (ET-1; endothelium) (38),
fibroblast specific protein-1 (FSP-1; fibroblast) (33) and growth associated protein-43
(GAP43; neuron) (39) in mRNA isolated from both intact arteries and isolated myocytes.
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The above cell markers all amplified using intact cerebral artery mRNA (Fig. 3C),
consistent with the presence of multiple cell types in intact vessels. However, only the
smooth muscle marker SM-MHC was expressed in freshly isolated myocytes, confirming
purity of our samples. Nested PCR for exons 7-11 of Cav1.2 demonstrated two bands
corresponding to α1C9/9*/10 and α1C9/10 in isolated cerebral artery myocytes, similar to the
intact tissue (Fig. 3D). These data demonstrate heterogeneous mRNA for both α1C9/9*/10
and α1C9/10 in isolated smooth muscle from cerebral arteries.

α1C9/9*/10 plays critical role in depolarization-induced constriction of cerebral arteries.
High expression levels of α1C9/9*/10 in cerebral artery myocytes suggest this splice variant
may have an important role in vascular function. We therefore tested the hypothesis that
α1C9/9*/10 splice variants are an important regulator of cerebral artery diameter. Two
antisense oligonucleotide sequences were designed to examine the functional role of
α1C9/9*/10. First, α1C9/9*/10-AS targeting a sequence specific for exon 9* was used for
selective suppression of the α1C9/9*/10 variant. Second, α1C-AS targeting a sequence
specific for exon 9, which is constitutively expressed in all L-type VDCC splice variants,
was used for non-selective suppression of all Cav1.2 isoforms.

Four days following

treatment, standard RT-PCR and qPCR demonstrated a significant reduction (43 ± 6.9%)
in α1C9/9*/10 expression following treatment with α1C9/9*/10-AS compared with α1C9/9*/10sense treated arteries (Fig. 4A and B). However, suppression of α1C9/10 was not observed
following treatment with α1C9/9*/10-AS. In contrast to the effect of α1C9/9*/10-AS, arteries
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treated with α1C-AS exhibited a significant reduction in expression for both α1C9/9*/10
and α1C9/10 splice variants (Fig. 4A and B).
To examine the effect of suppressing α1C9/9*/10 on arterial constriction, luminal
diameter measurements were performed while increasing external K+ ([K+]o) in the bath
solution over a range of concentrations from 6 to 120 mM following a period of 1 to 4
days in organ culture.

The relationship between extracellular [K+]o and membrane

potential at [K+]o > 16 mM closely follows that which is predicted by the Nernst equation
(16, 21).
Step-wise increases in [K+]o caused graded arterial constriction of control freshlyisolated vessels (Fig. 5 and 6). α1C9/9*/10-AS, α1C9/9*/10-sense and RP only groups all
responded similarly to freshly isolated vessels following one day in culture (Fig. 6).
However, K+-induced constrictions, expressed as a percentage of maximum constriction
caused by ionomycin (see methods), was significantly reduced in α1C9/9*/10-AS arteries
compared with control α1C9/9*/10-sense treated and RP arteries after two days.

For

example, α1C9/9*/10-AS treated vessels exhibited 52 ± 5.9% constriction in response to 60
mM K+ on day 2 compared with 80 ± 2.1% and 75 ± 2.9% constriction in α1C9/9*/10-sense
treated and RP vessels, respectively. Further reductions were observed in α1C 9/9*/10-AS
treated arteries on day 3 (e.g., 26 ± 4.1% in [K+]o = 60 mM) and day 4 (e.g., 23 ± 4.9% in
[K+]o = 60 mM) of organ culture (Fig. 6). α1C9/9*/10-sense treated and RP arteries
constricted to a similar degree as freshly isolated vessels at all time points tested (Fig. 5
and 6). Mean diameters of arteries exposed to these treatments are shown in Table 1. No
significant differences in EC50 values for K+ were observed between groups (Table 1).
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Diameter values and maximal constriction to ionomycin were similar between groups at
all time points tested (Table 1). Fully dilated arterial diameter, obtained in Ca2+-free PSS
containing diltiazem and forskolin, was not significantly different between groups
(α1C9/9*/10-AS: 201 ± 13 μm, n=17; Sense: 214 ± 16 μm, n=17, RP: 199 ± 13 μm, n=16).
Taken together, these data demonstrate an important role for α1C9/9*/10 in the regulation of
cerebral artery constriction.
α1C9/9*/10 is the functionally dominant splice variant in cerebral arterial constriction.
Our data imply that although cerebral artery myocytes express both α1C9/9*/10 and
α1C9/10, α1C9/9*/10 plays a major role in cerebral artery constriction. To examine the role
of α1C9/10 in cerebral artery constriction, we compared the effect of suppressing α1C9/9*/10
to supressing all Cav1.2 splice variants (both α1C9/9*/10 and α1C9/10) using α1C-AS.
Arteries treated with α1C-AS exhibited diminished constriction to 60 mM [K+]o that was
similar to that observed in arteries treated with α1C9/9*/10-AS (Fig. 7; α1C9/9*/10-AS: 23.5
± 3.6%, n=6; α1C-AS: 25.6 ± 4.3%, n=5) suggesting that suppression of all Cav1.2 splice
variants had no greater effect on constriction to 60 mM [K+]o than selectively suppressing
α1C9/9*/10. These data suggest that the isoform containing exon 9* is the functionally
dominant Cav1.2 splice variant in cerebral artery constriction.
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Discussion
Here we demonstrate that cerebral artery myocytes express Cav1.2 splice variants both
containing (α1C9/9*/10) and lacking (α1C9/10) exon 9* and that α1C9/9*/10 plays a dominant
role in cerebral artery constriction. The following observations are consistent with this
novel finding: 1) cerebral arteries have a significantly higher ratio of α1C 9/9*/10 : α1C9/10
mRNA compared with cerebral cortex or cardiac tissue. 2) RT-PCR performed on cDNA
from isolated cerebral artery myocytes confirmed expression of both α1C9/9*/10 and
α1C9/10 in smooth muscle. 3) Selective suppression of the α1C9/9*/10 splice variant
caused a marked reduction in K+-induced arterial constriction. 4) Suppression of all
Cav1.2 splice variants caused no further reduction in K+-induced arterial constriction. In
addition, we found a similar expression profile of α1C9/9*/10 and α1C9/10 splice variants in
cerebral arteries from humans.
This work expands our understanding of the molecular composition of smooth
muscle VDCCs responsible for the control of arterial diameter and blood flow. Unlike
cardiac myocytes, vascular smooth muscle operates in a state of tonic contraction
responding to modest changes in membrane potential caused, for example, by changes in
intravascular pressure, neurotransmitter release, circulating catacholamines, and
endothelial influences.

Thus, L-type VDCCs expressed by vascular smooth muscle

respond to small voltage changes at relatively negative membrane potentials compared to
more depolarized membrane potentials reached during action potentials in cardiac
myocytes or neurons.

Recent studies using cell expression systems have found

expression of the 25 amino acid insertion exon 9* causes a 9 mV hyperpolarizing shift in
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L-type VDCC V0.5, act (6, 26). This hyperpolarizing shift in the activation of this splice
variant would be well-suited to the range of vascular smooth membrane potential in vivo
(-45 to -35 mV) (29). We now report that exon 9*-containing L-type VDCCs are the
dominant Cav1.2 splice variant contributing to cerebral artery constriction.

To our

knowledge, this is the first study directly demonstrating a physiological role for a single
Cav1.2 splice variant.
We have observed that whole arterial tissue containing smooth muscle,
endothelial, fibroblast and perivascular neural cells expresses both α1C9/9*/10 and α1C9/10
splice variants. While endothelial cells are known to lack expression of VDCCs (13),
Cav1.2 expression by fibroblasts and neurons is well documented (10, 17, 32). To further
explore the composition of Cav1.2 splice variants in vascular smooth muscle, we
performed PCR on mRNA obtained from freshly isolated vascular myocytes using laser
capture microdissection. This approach demonstrated mRNA for both α1C9/9*/10 and
α1C9/10 isoforms in a pure population native vascular smooth muscle. Compared to
vascular tissue, we found a relatively low level of α1C9/9*/10 mRNA in heart and cerebral
cortex tissue providing additional support that exon 9* is selectively expressed by smooth
muscle. It is possible that apparent differences in the stoichiometry of α1C9/9*/10 and
α1C9/10 splice variants may reflect discrepancies in total levels of Cav1.2 expressed
between tissues. However, an earlier study by Graf et al. demonstrated that the ratio of
+9*:-9* Cav1.2 is not well correlated with expression levels of total Cav1.2 (13). For
example, it was shown that human cardiac ventricle and aorta express similar levels of
total Cav1.2, although the +9*:-9* ratio is greater in aorta. Increased α1C9/9*/10: α1C9/10
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mRNA ratio observed in vascular smooth muscle is therefore unlikely to be due to
differential expression of total Cav1.2 levels compared with brain and heart.
The use of antisense oligonucleotides to specifically suppress 9*-containing
Cav1.2 channels revealed a substantial decrease in K+-induced constriction supporting a
functional role for this splice variant in vascular physiology.

In fact, antisense

oligonucleotides targeting a region common to all Cav1.2 splice variants (exon 9) caused
no greater decrease in contractility than suppression of only α1C9/9*/10.

These data

suggest exon 9*-containing Cav1.2 channels play a dominant role in regulating smooth
muscle contraction. It should be noted that this conclusion is based on the assumptions
that both antisense oligonucleotides used in this study suppress translation of their target
with similar efficiency and that functional effects are not due to non-specific suppression
of total Cav1.2 levels.

Consistent with these assumptions, we observed a maximal

response using both antisense oligonucleotides at day 4 with no greater suppression
occurring after five days of treatment (data not shown). Further, the EC 50 for [K+]o was
not altered by α1C9/9*/10-AS, consistent with a functional population of Cav1.2 channels
with a uniform V0.5, act. Considering the loss of endothelial function following prolonged
organ culture of arteries (20), it is possible that compensatory changes in Cav1.2 splice
variant expression may occur. However, we have found using RT-PCR that the ratio of
α1C9/9*/10:α1C9/10 does not change following up to four days in culture (data not shown).
Future studies are needed to address whether α1C9/9*/10 also plays a dominant role in
vasoconstriction to endogenous compounds and physiological increases in intravascular
pressure.
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The unique location of exon 9* within the structure of the α1 subunit may also
play a role in post-translational regulation of VDCCs in vascular smooth muscle.
Interestingly, the site of α1/β subunit interaction, known as the alpha interaction domain is
found 18 amino acids upstream of exon 9* within the I-II intracellular linker region of the
α1c protein. It has previously been shown that functional interaction between the α1 and β
subunit is required for correct targeting of the channel to the plasma membrane (12). It
remains possible that α1 subunits expressing exon 9* may differentially bind specific
Cavβ isoforms compared to α1 subunits lacking the insertion, leading to favored
trafficking of α1C9/9*/10 to the membrane and a dominant functional role for this splice
variant. Further research is needed to elucidate whether the presence of exon 9* alters
the binding of β subunit subtypes or splice isoforms. It should be noted that smooth
muscle-selective alternatively spliced exons other than exon 9* could be preferentially
expressed in 9*-containing channels and may also contribute to functional distinction of
vascular smooth muscle VDCCs. For example, it has recently been shown that inclusion
of exon 1c in full length cloned Cav1.2 channels can lead to a hyperpolarizing shift in
V0.5,act in HEK293 cells, similar to inclusion of exon 9*(7).
In summary, this study suggests that the exon 9*-containing Cav1.2 splice variant
controls cerebral artery myocyte Ca2+ influx, arterial diameter and cerebral blood flow.
We propose that α1C9/9*/10 may represent a novel target for therapeutics against vascular
pathologies associated with increased Ca2+ influx in vascular smooth muscle leading to
enhanced arterial constriction. Future genetic or pharmacological strategies targeting
smooth muscle-selective Cav1.2 splice variants could provide a valuable means of
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modulating vascular tone while avoiding widespread effects on VDCC isoforms in
cardiac or nervous systems.
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Figure Legends

Figure 1: Cerebral arteries express α1C9/9*/10. A: PCR primer design for the detection of
α1C9/9*/10 and α1C9/10. Amplification of transcripts containing exon 9* results in 535 nt
product while amplification of transcripts excluding exon 9* results in 460 nt product. B:
Representative gel demonstrating two bands corresponding to both α1C9/9*/10 and α1C9/10
present in whole cerebral arteries (n=7) while α1C9/10 band is most prominent in brain
(n=5) and heart tissue (n=8). C: Resulting RT-PCR gel using cDNA obtained from
whole cerebral arteries from human (n=2) demonstrates presence of two bands
corresponding to α1C9/9*/10 and α1C9/10.

Figure 2: Quantitative real-time PCR (qPCR) shows high expression of α1C9/9*/10 in
cerebral arteries. A: PCR primer sets for the specific detection of α1C9/9*/10 and α1C9/10.
α1C9/9*/10 specific (left) forward primer recognizes sequence specific to exon 9*. α1C9/10
(right) forward primer recognizes sequence of boundary between exons 9 and 10.
Sequence analysis of PCR products confirmed specificity of primers for target sequences.
B: Summary qPCR data for cerebral arteries, brain (cortex) and heart (left ventricle).
The ratio of α1C9/9*/10:α1C9/10 mRNA was significantly greater in cerebral arteries
relative to brain and heart (0.289 ± 0.024; n=7 compared to 0.006 ± 0.001; n=4 and 0.050
± 0.006; n=8, respectively). **p<0.01 vs. brain and heart.
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Figure 3: Cerebral artery myocytes express both α1C9/9*/10 and α1C9/10 splice variants.
A: Immunostaining of isolated cerebral artery myocytes. Red: SM-MHC; Green: SM-αactin (color changed from red to green to distinguish from SM-MHC); Blue: DAPI
nuclear stain. Scale bars represent 10 μm. A lack of staining was observed for SM-MHC
or SM-α-actin by cells incubated without primary antibody (right panel).

B:

Microdissection of isolated cerebral artery myocytes. Live myocytes plated on P.A.L.M.
Duplex dish (Ziess) were identified by cell morphology and the surrounding dish
membrane was cut (i.). Myocytes were then catapulted (ii.) onto P.A.L.M. Adhesivecap
collection tubes (Ziess) for mRNA extraction.

Scale bars represent 25 μm.

C:

Representative gel showing the presence of cell markers: smooth muscle myosin heavy
chain (SM-MHC; smooth muscle), endothelin-1 (ET-1; endothelium), fibroblast specific
protein-1 (FSP-1; fibroblast) and growth associated protein-43 (GAP43; neuronal). All
markers are amplified using cDNA from whole cerebral arteries. cDNA from cerebral
artery myocytes samples collected by laser capture microdissection demonstrate
amplification of SM-MHC while other markers were not detected. D: Results of nested
PCR performed on cDNA from isolated cerebral artery myocytes.

First round of

amplification (35 cycles) was performed using primers for exons 7-11 of Cav1.2 (see Fig.
1A). Second round of amplification (35 cycles) was done using nested primers (see
methods) and 1:100 dilution of first-round PCR products.

Final products represent

expression of α1C9/9*/10 (upper band) and α1C9/10 (lower band) (n=5).
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Figure 4: Selective suppression of Cav1.2 splice variants following antisense treatment
and organ culture for four days. A: RT-PCR was performed on cDNA from arteries
treated with α1C9/9*/10-AS, α1C-AS, and corresponding sense oligonucleotides. Band
intensity corresponding to α1C9/9*/10 was reduced in α1C9/9*/10-AS treated artery samples
following four days in organ culture compared with sense treated arteries (left, n=4).
Lower band, corresponding to α1C9/10, was similar between two groups. RT-PCR gel
demonstrating reduction in both α1C9/9*/10 and α1C9/10 band intensity following treatment
with α1C-AS and organ culture for 4 days (right, n=4). Total RNA used was similar as
shown by endogenous control 18S ribosomal RNA.

B: Quantification of changes in

mRNA levels using qPCR in antisense-treated arteries compared with sense treated
arteries from same animal. *p<0.05 (α1C9/9*/10-AS/S: n=4; α1C-AS/S: n=4).

Figure 5: Representative arterial diameter traces demonstrating important functional role
for α1C9/9*/10 in arterial constriction. All arteries were cannulated, pressurized to 20
mmHg and perfused with PSS for 30 minutes prior to stepwise increases in [K+]o.
Control freshly isolated and sense treated (day 4) arteries responded to increases in [K+]o
by graded constriction.

α1C9/9*/10-AS treated (day 4) arteries exhibited a marked

reduction in [K+]o-induced constriction. Ionomycin (10 μM) was applied at the end of
each experiment.

Figure 6: Time course for α1C9/9*/10-AS effect. Day 1: α1C9/9*/10-AS, α1C9/9*/10-sense
treated (α1C9/9*/10-S), and RP arteries exhibit constriction similar to freshly isolated
129

cerebral arteries (day 0). Day 2-4: α1C9/9*/10-AS arteries exhibit significantly reduced
arterial constriction in response to increased [K+]o with constrictions nearly abolished
following four days in organ culture compared with α1C9/9*/10-sense and RP arteries
organ cultured for the same period of time. *p<.05, **p<.01. No significant differences
were observed in arterial constriction between α1C9/9*/10-sense treated artery groups (days
1-4, n=4-5) and freshly isolated arteries (day 0, n=5). * p<0.05; **p<0.01.

Figure 7: α1C9/9*/10 plays a dominant role in cerebral artery constriction.

A:

Representative diameter traces showing response to 60 mM [K+]o followed by application
of 10 μM ionomycin. B: Summary of 60 mM [K+]o for antisense-treated arteries. All
constrictions were normalized to minimum diameter obtained in ionomycinand maximum
diameter obtained in Ca2+-free PSS with diltiazem (100 μM) and forskolin (1 μM). After
four days in organ culture following oligonucleotide treatment, arteries treated with α1CAS exhibited similar response to 60 mM [K+]o as arteries treated with α1C9/9*/10-AS.
α1C9/9*/10-AS and α1C-AS groups were significantly decreased compared with
corresponding sense-treated groups. No significant difference was observed between
α1C9/9*/10-AS and α1C-AS groups (*p<0.05; α1C9/9*/10-sense, n=4; α1C9/9*/10-AS, n=6;
α1C-sense, n=5; α1C-AS, n=5).

Table 1: Diameter values are shown for α1C9/9*/10-AS, α1C9/9*/10-S, and RP arteries in
PSS (6 mM [K+]o), 80 mM [K+]o, and 120 mM [K+]o containing 10 μM ionomycin
(ionomycin group) for all time points tested. Also shown is ionomycin constriction,
130

expressed as % decrease from maximum diameter and EC50 values calculated from [K+]o
concentration-response curves. *p<0.05, **p<0.05 vs. α1C9/9*/10-sense and RP groups.
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Figures

Figure 1: Cerebral arteries express exon 9*.
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Figure 2: Selective expression of exon 9* in cerebral arteries.
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Figure 3: Cerebral artery myocytes express mixed population of CaV1.2 splice variants.
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Figure 4: Selective suppression of CaV1.2 splice variants.
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Figure 5: Representative constriction in response to increasing extracellular K+.
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Figure 6: Time course for exon 9*-antisense effect.
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Figure 7: Exon 9* plays a dominant role in cerebral artery constriction.
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Table 1: Diameter values for K+ concentration-response experiments.

Day 1
Diameter (μm)
+
6 mM [K ]o
+
80 mM [K ]o
Ionomycin
Ionomycin-induced
Constriction (% of
maximum diameter)
+
[K ]o EC50
Day 2
Diameter
+
6 mM [K ]o
+
80 mM [K ]o
Ionomycin
Ionomycin-induced
Constriction (% of
maximum diameter)
+
[K ]o EC50
Day 3
Diameter
+
6 mM [K ]o
+
80 mM [K ]o
Ionomycin
Ionomycin-induced
Constriction (% of
maximum diameter)
+
[K ]o EC50
Day 4
Diameter
+
6 mM [K ]o
+
80 mM [K ]o
Ionomycin
Ionomycin-induced
Constriction (% of
maximum diameter)
+
[K ]o EC50

RP

α1C9/9*/10Sense

α1C9/9*/10-AS

170 ± 27.8
62 ± 16.1
37 ± 13.1
81 ± 4.

186 ± 18.7
66 ± 9.2
37 ± 7.5
80 ± 3.1

182 ± 21.8
63 ± 7.6
29 ± 2.6
85 ± 2.7

35 ± 3.5

4 ± 1.2

34 ± 2.3

194 ± 28.2
85 ± 11.7
53 ± 9.7
72 ± 5.2

217 ± 34.7
87 ± 23.0
49 ± 16.4
80 ± 3.7

165 ± 25.5
87 ± 12.5
31 ± 5.6
83 ± 2.7

32 ± 7.4

31 ± 1.3

33 ± 2.0

201 ± 20.4
81 ± 10.3
42 ± 11.4
80 ± 4.1

216 ± 50.7
89 ± 14.3
51 ± 15.5
86 ± 3.4

194 ± 13.0
149 ± 13.0**
45 ± 8.9
81 ± 3.4

31 ± 3.0

30 ± 2.1

32 ± 3.0

230 ± 25.5
78 ± 12.1
37 ± 12.7
85 ± 4.9

205 ± 42.0
89 ± 14.3
51 ± 15.5
75 ± 6.9

188 ± 4.6
155 ± 20.3**
50 ± 15.3
73 ± 3.0

33 ± 2.3

31 ± 2.3
30 ± 2.8
** p< 0.05 vs. sense and RP groups.
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CHAPTER 4: CONCLUSIONS AND FUTURE DIRECTIONS
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In Chapter one of this dissertation, it is demonstrated that constriction of parenchymal
arterioles are markedly enhanced following SAH at physiological intravascular pressures.
Evidence is provided suggesting that enhanced constriction results from greater pressuredependent depolarization of parenchymal arteriolar myocytes, increased activity of Ltype VDCCs and elevated [Ca2+]i. One major aim of future work will address the
mechanisms by which SAH causes membrane potential depolarization of parenchymal
arteriolar myocytes. As discussed in Chapter 2, this may result from increased activity of
ion channels involved in pressure-dependent depolarization (i.e. transient receptor
potential channels) or decreased activity of negative feedback pathways controlling
vascular tone (i.e. K+ efflux).

Importantly, whether altered parenchymal arteriolar

function results from exposure to spasmogens within blood, or vasoactive substances
released from the brain parenchyma following SAH should also be addressed. For
example, studies have demonstrated that intracisternally injected biotinylated
oxyhemoglobin is capable of penetrating to deeper layers of the cortex of the rat (Turner
et al., 1998) suggesting that parenchymal arterioles may be exposed to this spasmogen
following erythrocyte lysis in SAH patients. Oxyhemoglobin has been shown to cause
membrane potential depolarization of cerebral artery myocytes via reduction of Ca2+
spark frequency (Jewell et al., 2004; Koide, 2009) and suppression of KV channel
currents (Ishiguro et al., 2006; Koide et al., 2007). In addition, purified oxyhemoglobin
was shown to induce expression of R-type VDCCs (CaV2.3) in rabbit pial cerebral artery
myocytes (Link et al., 2008). Although we did not test whether CaV2.3 is expressed in
parenchymal arteriolar myocytes following SAH, our data demonstrating similar [Ca2+]i
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and tone in the presence of the L-type VDCC inhibitor nimodipine argue against a
significant contribution of R-type channels in parenchymal vessels from SAH animals.
These differing results may reflect variation between species or vascular beds with
respect to environment and functional regulation.
Previous studies suggest that parenchymal arterioles contribute significantly to
cerebrovascular resistance and autoregulation of cerebral blood flow (Faraci and Heistad,
1990; Harper et al., 1984). The relative contributions of large diameter vasospasm and
enhanced constriction of parenchymal vessels to ischemia-related deficits in SAH
patients remains unclear.

It is plausible that in the absence of microcirculatory

dysfunction, constriction of large diameter surface vessels following SAH may cause
little reduction in regional perfusion due to compensatory redistribution of blood flow in
downstream vessels (Schaffer et al., 2006). Conversely, a significant reduction in cortical
blood flow and focal neuronal infarction may follow SAH-induced constriction of
parenchymal arterioles, which display little communication with parallel arterioles and
represent a bottleneck in blood supply to the cortex (Nishimura et al., 2007). Hence,
enhanced pressure-dependent constriction of parenchymal arterioles may severely limit
downstream blood flow and lead to significant neuronal damage after SAH.
In addition to their function in regulating global cerebral blood flow, parenchymal
arterioles are also an essential component of the neurovascular unit which functions to
couple blood flow with local neuronal activity and metabolic demands. Under normal
physiological conditions, an increase in local neuronal activity signals release of
vasodilatory substances from the astrocytic endfeet to cause vasodilation and increased
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local blood flow (Iadecola and Nedergaard, 2007). This process is critical for sufficient
delivery of oxygen and nutrients to active regions of the brain. Given the impact of blood
on the function of arterioles deep within the cortex of SAH model animals shown in this
study, future work should address the impact of SAH on neurovascular coupling
mechanisms. Brain slice experiments have suggested that the magnitude and polarity of
diameter change to increases in neuronal activity are dependent on the level of vascular
tone (Blanco et al., 2008). For example, arterioles displaying greater myogenic tone
exhibit more pronounced dilations in response to electrical field stimulation (neuronal
activation). Thus, enhanced arteriolar tone following SAH may be localized to less
active brain regions in vivo if functional hyperemic phenomena remain unaltered.
However, studies in our laboratory have found a fundamental change in the
neurovascular response in brain slices from SAH model rats. Whereas electrical field
stimulation activates neurons and evokes parenchymal arteriolar dilation in brain slices
from control animals, similar stimulation causes constriction in brain slices from SAH
animals (Koide and Wellman, unpublished observations). These findings indicate that
SAH causes a remarkable shift in the polarity of vascular response from dilation to
constriction following increased neuronal activity. Therefore, impairment of mechanisms
coupling neuronal activity with localized increases in blood flow may act in concert with
enhanced pressure-dependent constriction to severely limit local cerebral blood flow
following SAH. These findings suggest that neuronal infarction may be more severe in
active brain regions in SAH patients.
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Enhanced

parenchymal

arteriolar

constriction

following

extracellular Ca2+ entry via smooth muscle L-type VDCCs.

SAH

requires

Antagonists of L-type

VDCCs are standard therapy for prevention of cerebral vasospasm and neurological
deficits in SAH patients. Although nimodipine treatment has been indicated to reduce the
severity of ischemic deficits (Tomassoni et al., 2008; Treggiari-Venzi et al., 2001), these
positive effects do not depend on reversal or prevention of angiographic vasospasm
(Petruk et al., 1988).

Alternatively, consistent with our data is the hypothesis that

nimodipine may increase blood flow to ischemic brain regions by preferential dilation of
small diameter resistance arteries and arterioles.

However, systemic nimodipine

administration also inhibits smooth muscle VDCCs in the peripheral vasculature and use
of this agent in SAH patients has been limited by hypotension (Treggiari-Venzi et al.,
2001). Therefore, it is clear that future efforts should focus on improving strategies to
suppress L-type VDCC activity in both pial and parenchymal myocytes, while avoiding
effects on systemic targets.
L-type channels in the vasculature represent a mixed population of splice
variations of the gene CaV1.2 (Cheng et al., 2009). In Chapter three of this dissertation,
data is shown supporting an essential role for CaV1.2 containing the alternatively-spliced,
smooth muscle-selective exon 9* (α1C9/9*/10) in cerebral artery constriction. In this study,
antisense oligonucleotides and organ culture were used to specifically reduce the
expression of exon 9* channels in myocytes of small diameter pial arteries. Following
suppression of this splice variant, we observed dramatically reduced cerebral artery
constriction to K+-induced depolarization in vitro. We conclude that α1C9/9*/10 is the
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major route of Ca2+ entry required for cerebral artery constriction resulting from
membrane depolarization.

Future experiments will aim to transfer this strategy of

suppressing cerebrovascular VDCCs into the live animal. Information gained from this
work will not only test the feasibility of reducing VDCC expression in vivo, but may also
lead to new information regarding the function of VDCC splice variants in the control of
cerebral blood flow. Preliminary RT-PCR experiments have revealed similar expression
profile of α1C9/9*/10 and α1C9/10 splice variants in rat pial and parenchymal arterioles
(Figure 1). Therefore, we hypothesize that suppression of α1C9/9*/10 channels in the
cerebral vasculature will lead to significantly increased cerebral blood flow.
In summary, it is clear that long-term exposure of tissues within the central
nervous system to whole blood causes a myriad of changes in multiple cell types. While
some of these effects may be beneficial, most are detrimental to neuronal viability. As
whole blood is a complex mixture of vasoactive substances, delayed neurological deficits
in patients surviving aneurysm rupture caused by enhanced cerebral artery constriction
are likely to result from a complex combination of factors. In this dissertation, data is
presented in support of increased Ca2+ influx via L-type VDCCs as a major cause of
enhanced constriction of parenchymal arterioles following SAH.

In addition, smooth

muscle-selective L-type VDCC splice variants may represent a novel target for the
prevention of delayed neurological deficits in SAH patients.
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Figure 1: Similar expression of CaV1.2 splice variants in
pial and parenchymal vasculature.
RT-PCR gel demonstrating expression of CaV1.2 splice
variants containing and lacking exon 9* ((+)9*CaV1.2 and
(-)9*CaV1.2, respectively). Similar expression of both
splice variants was observed in both pial and parenchymal
arterioles from rat. Conversely, rat brain expressed only (-)
9*CaV1.2 splice variants.
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Abstract
Vascular tone and consequently, cerebral blood flow, are regulated by the concentration
of global cytosolic Ca2+ (global [Ca2+]i) in vascular smooth muscle. Global [Ca2+]i is, in
part, regulated by discrete Ca2+ release events from the sarcoplasmic reticulum (Ca2+
sparks) which activate plasma membrane large conductance Ca2+-activated K+ channels
to cause membrane potential hyperpolarization, decreased global [Ca2+]i, and
vasodilation. We have previously observed decreased Ca2+ spark frequency and elevated
global [Ca2+]i in cerebral artery myocytes using a rabbit model of subarachnoid
hemorrhage. Here, we describe and discuss laboratory methods and procedures using the
fluorescent Ca2+ indicator dyes fura-2 and fluo-4 to assess global and local Ca2+ signaling
in cerebral arteries and isolated vascular myocytes.

Keywords: Fura-2, Fluo-4, Ca2+ sparks, vascular smooth muscle, subarachnoid
hemorrhage.
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1. Introduction
The cerebral circulation delivers constant blood flow to the brain over a broad range of
physiological blood pressures. To achieve this remarkable phenomenon, cerebral arteries
must actively constrict to elevations in blood pressure and dilate when blood pressure
drops. In cerebral resistance arteries and arterioles, the constriction (myogenic tone)
response to graded increases in intravascular pressure is dependent on membrane
potential depolarization, enhanced Ca2+ influx via L-type voltage-dependent Ca2+
channels (VDCCs) and elevated global cytosolic Ca2+ (global [Ca2+]i) [1-2]. Global
[Ca2+]i represents average Ca2+ levels throughout the cytoplasm and mediates contraction
of smooth muscle via Ca2+/calmodulin-dependent activation of myosin light chain kinase,
myosin light chain phosphorylation and actin-myosin interaction [3]. Thus, global [Ca2+]i
directly regulates the contractile state of vascular smooth muscle and therefore dictates
cerebral vascular tone and blood flow.

The discovery of spatially localized, transient calcium release events (“Ca2+ sparks”) has
altered the view that an elevation of global [Ca2+]i is the only effective mode of calcium
signaling in smooth muscle [4-6]. Calcium sparks result from the opening of a cluster of
ryanodine receptors in the sarcoplasmic reticulum (SR) membrane, causing a highly
restricted (1% of the cell volume) and large (µM) increase in local Ca2+ with little direct
effect on global [Ca2+]i [5, 7]. In vascular smooth muscle, Ca2+ sparks are functionally
coupled to nearby large conductance Ca2+-activated K+ (BK) channels located on the
plasma membrane [6, 8]. Elevation of intracellular Ca2+ causes a shift in the voltage-
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dependence of BK channel activation to more negative membrane potentials effectively
leading to increased channel open probability [9]. Increased Ca2+ spark activity therefore
leads to enhanced BK channel activity, membrane potential hyperpolarization, decreased
global [Ca2+]i, and smooth muscle relaxation.

Ca2+ spark activity is increased by

vasodilators such as nitric oxide and forskolin and by elevations in cytosolic and SR
calcium [10-11]. Thus, Ca2+ sparks act as an important negative feedback mechanism to
oppose vasoconstriction by promoting a reduction in VDCC activity and a decrease in
global [Ca2+]i.

Considering the pivotal role that vascular smooth muscle Ca2+ plays in the regulation of
cerebral blood flow, precise measurement of local and global Ca2+ signaling in these cells
is essential for understanding pathologies characterized by abnormal vascular tone, such
as aneurysmal subarachnoid hemorrhage (SAH).

With respect to SAH-induced

“classical” or “angiographic” vasospasm, observed in large diameter conduit arteries on
the brain surface, the role of elevated global [Ca2+]i is unclear and controversial [12].
However, recent evidence suggests that enhanced constriction of much smaller
“resistance” arteries and arterioles (< 200 μm in diameter) following SAH is associated
with increased global [Ca2+]i and enhanced VDCC activity [13]. Further, Ca2+ spark
activity is decreased in cerebral arteries by the blood component oxyhemoglobin [14] and
Ca2+ spark frequency is reduced in cerebral artery myocytes isolated from SAH model
animals [13, 15]. In this chapter, we discuss the properties of two fluorescent Ca2+
indicator dyes, fura-2 and fluo-4, that enable the measurement of global [Ca2+]i and Ca2+
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sparks, respectively, in cerebral artery myocytes. Further, we provide details of specific
protocols used in our laboratory to assess global and local signaling in the cerebral
vasculature.
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2.1 The use of fura-2 to measure global [Ca2+]i in cerebral artery smooth muscle.

The most popular technique for quantifying intracellular free Ca2+ is by monitoring the
fluorescence of Ca2+-sensitive indicator dyes [16].

The dual-wavelength ratiometric

indicator fura-2 is currently the most widely used indicator for measurement of global
[Ca2+]i in isolated cerebral artery myocytes and intact pressurized vessels. Fura-2 shows
1:1 Ca2+ binding stoichiometry and undergoes a significant shift in excitation spectra
depending on whether or not Ca2+ is bound (λbound = 340 nm; λfree = 380 nm) while
emission spectra (510 nm) is independent of Ca2+ binding to the dye [17]. Changes in
fluorescence ratios are therefore independent of intensity, eliminating potentially
confounding factors such as differential dye loading, photobleaching or time-dependent
explusion of the dye by the cell. As a result, fura-2 is preferred over single-wavelength
intensity-modulating indicators for quantification of absolute intracellular Ca2+
concentrations. In this section, we describe techniques used for measuring global [Ca2+]i
in intact pressurized cerebral arteries using fura-2.
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2.2 Materials and Instruments



5 ml myograph chamber (Fig. 1A) (Living Systems Instrumentation)



Fine-tipped forceps (Fine Science Tools)



Cell-permeant fura-2 AM (Invitrogen)



Calcium and diameter recording system (e.g. IonOptix Inc.)
 Hyperswitch light source
 Xenon arc lamp
 IonWizard-Core and Analysis Soft Edge software
 Fluorescence system interface
 Myocam-S digital CCD video camera
 Photomultiplier tube (PMT) sub-system
 Dichroic mirror
 Photon-to-voltage converter



Inverted fluorescence microscope



20X/0.50 NA objective lens



Peristaltic pump (Ismatec Inc.)



PS-200 pressure servo controller with peristaltic pump (Living Systems
Instrumentation)



Dark room/red light
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2.3 Procedures

Tissue preparation and dye loading:
Cerebral arteries and arterioles (50-200 μm in diameter) are dissected from the brain and
kept in ice cold artificial cerebral spinal fluid (aCSF) of the following composition (in
mM): 125 NaCl, 3 KCl, 18 NaHCO3, 1.25 NaH2PO4, 1 MgCl2, 2 CaCl2, 5 glucose aerated
with 5% CO2, 20% O2, 75% N2 (pH, 7.30-7.35).

Freshly isolated cerebral artery

segments are cannulated on glass micropipettes mounted in a 5 ml myograph chamber
(Fig. 1) [18]. Following cannulation, blood vessels are incubated with previously aerated
aCSF containing fura-2 AM (acetoxymethyl ester membrane-permeable form; 5 μM;
Invitrogen, Carlsbad, CA) and pluronic acid (0.1%; Invitrogen, Carlsbad, CA) at room
temperature (~22˚C) for 45 minutes in the dark. The myograph chamber is then mounted
on an inverted fluorescence microscope and arteries are pressurized and continuously
superfused with aCSF (37˚C, 30 min) to allow equilibration and deesterification of fura2.
It has previously been demonstrated that Ca2+ can be selectively measured in vascular
smooth muscle or endothelium by loading fura-2 from the extraluminal or luminal side of
the vessel, respectively [19]. However, the specific loading time and dye concentration
described above may need to be slightly adjusted based on the specific tissue studied to
enable sufficient permeation of dye into smooth muscle while avoiding loading of the dye
into the endothelium.

To examine whether dye loading is smooth muscle-specific,

studies can be performed on arteries in which the endothelium is physically removed by
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luminal passage of an air bubble [2]. Endothelial removal can be confirmed by lack of
response to endothelium-specific pharmacological agents (e.g. acetylcholine, bradykinin,
NS309) [20-21].
Data acquisition and estimation of intracellular Ca2+:

First, an aperture located adjacent to the dichroic mirror is adjusted so that the blood
vessel completely fills the rectangular field of view in the data acquisition software. This
minimizes the contribution of extraneous light to the fluorescence signal. The dichroic
mirror reflects fluorescence emission to the photomultiplier tube (PMT) while the use of
a red filter in the microscope condenser allows the vessel image to be transmitted to the
CCD camera. Thus, the image collected by the CCD camera for diameter measurement
represents the same field from which fluorescence is detected by the PMT.

Following equilibration, fluorescence ratio (F340:F380) is obtained from backgroundcorrected 510 nm emission from arteries alternately excited at 340 and 380 nm (Fig. 2)
using software developed by IonOptix (Milton, MA). Arterial wall [Ca2+] is estimated
using the following equation [17] [Ca2+] = Kd × β× (R

Rmin)/(Rmax

R).

Rmin and Rmax values represent the ratios of emission signal under Ca2+-free and Ca2+saturated conditions, respectively. To obtain these values, arteries are first loaded with
fura-2 and equilibrated as described above. Arteries are then perfused (10 min, 37˚C)
with a baseline solution containing the following (in mM): 5 NaCl, 140 KCl, 5 HEPES, 1
MgCl2 (pH 7.4). Next, to obtain Rmin, arteries are perfused (30 min) with baseline
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solution that includes EGTA (5 mM), ionomycin (10 μM) and nigericin (5 μM).
Recording at the end of this period allows determination of Rmin. EGTA is then washed
from the bath by perfusion of baseline solution for 15 min. To obtain R max, arteries are
then perfused (15 min) with baseline solution containing CaCl2 (10 mM), ionomycin (10
μM) and nigericin (5 μM) for 10 min. The ratio of calcium-free over calcium-bound
fluorescence intensities at F380 (β) is determined from these values. In our studies, we
have used an apparent dissociation constant (Kd) of 282 nM of fura-2 for Ca2+ determined
by Knot and Nelson using rat cerebral arteries [2].

Measurement of arterial diameter

Luminal diameter is simultaneously recorded throughout the entire experiment using a
CCD camera and the length-calibrated video edge detection function of IonOptix
software (Fig. 1D and 2). Constriction is analyzed as the decrease in arterial diameter
relative to the passive diameter using the following equation [22]:

%constricti on 

DP  DA
X 100
DP

where DP is the passive (fully-dilated) diameter of the artery in Ca2+-free aCSF
containing a VDCC blocker (e.g. 100 μM diltiazem or 300 nM nifedipine) and a second
vasodilator such as forskolin (1 μM) and DA is the active diameter of the artery in
response to the stimulus in aCSF. Percent dilation can be obtained using the following
formula [22]:
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% Dilation 

DV  DA
X 100
DP  DA

where DV is the arterial diameter in the presence of vasodilator, DA is the active arterial
diameter before application of vasodilator, and DP is the passive arterial diameter.

Variations in measurement of global [Ca2+]i
Most investigators obtain ratiometric measurements of fura-2 in isolated arterial segments
or dissociated cerebral artery myocytes by collecting emitted photons using a
photomultiplier tube (PMT). Fluorescence detection may also be achieved using electron
multiplying CCD or intensified CCD cameras along with quantitative ratio imaging
software for analysis and estimation of intracellular Ca2+ [2]. However, high sensitivity
cameras required for these measurements are expensive and do not offer significant
spatial information when used with wide-field microscopy.

In cases where an

investigator wishes to measure fura-2 fluorescence in a specific layer of the vascular wall
(smooth muscle or endothelium), fluorescent imaging over photometric methods may be
advantageous.
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3.1 The use of fluo-4 to measure Ca2+ sparks in cerebral artery myocytes.

Single-wavelength Ca2+ indicators such as fluo-4, or its analogue fluo-3, have become
widely used for imaging of fast, small volume Ca2+ signaling events such as Ca2+ sparks
[23].

One advantage of fluo-4 over ratiometric indicators (e.g. fura-2) in the

measurement sub-cellular Ca2+ signaling events is superior signal-to-noise ratio. Fluo-4
is excited at 488 nm and exhibits increased fluorescence intensity (>100 fold) upon
binding Ca2+ without a shift in absorption or emission spectra [24]. Moreover, fluo-4 has
a lower affinity for Ca2+ than fura-2 (Kd ≈ 400 nM compared with Kd ≈ 282 nM for fura2) and fast binding and unbinding kinetics, making it suitable for tracking rapid Ca2+
signaling events [24].

Ca2+ sparks can be measured using a number of imaging

approaches including single photon and multiphoton confocal microscopy, total internal
reflection fluorescence (TIRF) microscopy, and wide-field microscopy using low-noise
CCD cameras [23].

Previously, the temporal resolution of laser-scanning confocal microscope systems
sufficient to measure Ca2+ sparks could only be achieved using line-scan mode, as
opposed to two-dimensional (2-D) x-y image scanning [5]. However, the interpretation
of images obtained using line-scanning is complicated by uncertainties in the position of
the scan line with regard to the center of the Ca2+ release event resulting in a loss of
spatial information such as accurate determination of Ca2+ spark area.

Another

disadvantage of this method is the inability to measure the total number of active spark
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sites within a cell. Currently, a number of laser-scanning confocal microscope systems
with sufficient 2-D sampling frequency (>30 Hz) are available. The following section
provides a detailed description of protocols that we have used to measure Ca2+ sparks in
cerebral artery myocytes using fluo-4 and two-dimensional (2-D) laser-scanning confocal
microscopy.

3.2 Materials and Instruments



Cell chamber with glass coverslip bottom



Cell-permeant fluo-4 AM (Invitrogen)



Laser scanning confocal system (e.g. Oz, Noran Instruments)



Inverted fluorescence microscope (Nikon Diaphot)



60X/1.2 NA water-immersion objective lens



Krypton/argon laser (480 nm is used to excite fluo-4)



Dark room

3.3 Procedures
Isolation of cerebral artery myocytes:
Cerebral arteries are enzymatically dissociated to obtain individual smooth muscle cells
(Fig. 3) [25]. After dissection, cerebral arteries are incubated in a glutamate-containing
isolation solution (GIS) of the following composition (in mM) : 55 NaCl, 5.6 KCl, 80 Lglutamic acid (mono-sodium salt), 2.0 MgCl2, 2 CaCl2, 10 HEPES, 10 glucose (pH 7.3;
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37 °C; 30 min) using a 1 ml vial placed in a water bath. Arteries are then transferred to a
Ca2+-free GIS containing papein (0.3 mg/mL) and 1,4-dithioerythriol (0.7 mg/mL; 37°C;
17 min) using a fire-polished Pasteur pipette.

Next, arteries are incubated in GIS

containing collagenase type F (0.7 mg/mL), collagenase type H (0.3 mg/mL) and 100 µM
CaCl2 (37 °C; 20 min). Finally, arteries are incubated in GIS containing 2 mM CaCl 2 on
ice (3x; 10 min) and gently triturated into individual cerebral artery myocytes using a
small bore fire-polished Pasteur pipette.

Cerebral artery myocytes can easily be

identified by characteristic spindle-shaped morphology (Fig. 3). The cells are kept on ice
and used within six hours of isolation.

Dye loading:
Isolated myocytes are loaded with fluo-4 by mixing equal volumes (e.g. 250 μl) of cell
suspension and HEPES buffered physiological saline solution (HEPES-PSS) of the
following composition (in mM): 134 NaCl, 6 KCl, 1 MgCl2, 1.8 CaCl2, 10 glucose, 10
HEPES (pH 7.4) containing fluo-4 AM (20 µM) and pluronic acid (0.072%). The cell
suspension containing a final concentration of 10 μM fluo-4 and 0.036% pluronic acid is
placed in the recording chamber to allow cells to attach to the glass coverslip on the
bottom of the chamber during the 30 minute loading/deesterification period at room
temperature. Cells are then washed three times with HEPES-PSS.
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Ca2+ spark measurement:
Initially, cells are located using bright field illumination. Once a myocyte has been
centered in the scan field, images of emitted light (wavelengths >500 nm) are acquired at
a frequency of 58 Hz (every ~ 17 msec, 256 pixels x 256 pixels), and magnified (2X) by
acquisition software (68 µm for 256 pixels). Images are usually acquired for a period of
10-20 seconds and saved for future analysis (Fig. 4). Laser exposure can lead to cell
damage which typically causes the cells to become much brighter in appearance and
abolish Ca2+ spark activity. Excessive laser exposure can also lead to photo-bleaching of
the indicator dye. Thus, it is recommended to combine the lowest laser intensity that
provides good cell visualization with relatively short (10-20 seconds) periods of laser
exposure.

Measurement of Ca2+ sparks can also be performed in intact pressurized cerebral arteries
(Fig. 5) [11, 14, 26]. After dissection, intact arteries are loaded with fluo-4 AM (10 µM
at room temperature for 1 hr, with 0.036% pluronic acid) followed by brief washes with
aCSF (see section 2.3). Arteries are then cannulated, pressurized (see section 2.3) and
Ca2+ sparks imaged using 2-D laser-scanning confocal microscopy as described above for
isolated myocytes.

Measurement of Ca2+ sparks in the intact tissue provides the

ability to simultaneously examine events in multiple cells under more physiological
conditions (i.e. at physiological intravascular pressures). However, due to the presence of
connective tissue and multiple cell layers, the signal-to-noise ratio is decreased in images

197

from intact tissue compared to isolated cells. Thus, imaging performed on isolated cells
is preferred for detailed analysis of the spatio-temporal properties of Ca2+ sparks.

Analysis of Ca2+ sparks:
A variety of custom-written software packages provide the ability to detect and analyze
Ca2+ sparks. Ca2+ sparks are typically assessed using 2.1 μm X 2.1 μm analysis areas
(centered over the Ca2+ spark-induced peak in fluorescence intensity) and defined as
fractional fluorescence changes (F/F0) greater than 1.3 [5, 25]. Background fluorescence
intensity (F0) is determined within analysis areas by averaging the first 30 consecutive
images without Ca2+ spark activity (for example, see Fig. 4B). Frequency is the most
commonly used parameter to describe Ca2+ spark activity. In isolated myocytes, Ca2+
spark frequency, expressed in Hz, represents the total number of events occurring in a
cell divided by the sampling period (in seconds). In cerebral artery myocytes, Ca2+ spark
frequency is increased by vasodilators acting via increased cyclic AMP-dependent
protein kinase, cyclic GMP-dependent protein kinase and/or increased levels of cytosolic
or SR Ca2+ [6, 10-11]. Conversely, enhanced cerebral artery constriction following
subarachnoid hemorrhage is associated with a reduction in Ca2+ spark frequency in
cerebral artery myocytes [13, 15]. Ca2+ spark amplitude is frequently expressed as the
maximum fractional fluorescence (F/F0) increase (Fig 5C). Using Ca2+ spark-induced
large conductance Ca2+-activated K+ (BK) channel activity as a biological Ca2+ indicator,
Perez et al. have estimated that local increases in Ca2+ during a Ca2+ spark are in the
range of 4-30 μM [7].

Although Ca2+ concentrations can be estimated using non-
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ratiometric Ca2+ indicator dyes such as fluo-4, using the equation: [Ca2+] = Kd * F /(FmaxF) [23], given the Kd of fluo-4 is ≈ 0.4 μM, this approach may underestimate local Ca2+
concentrations attained during Ca2+ sparks. Other frequently reported spatio-temporal
characteristics of Ca2+ sparks include spark size or area (defined as the area measured at
50% peak amplitude), rise time (measured from 10-90% rise in signal), decay time
constants and half-time to decay [27].

4.1 Conclusions
In this chapter, we provide a description of procedures used to assess both global and
local Ca2+ signaling in cerebral artery myocytes using the Ca2+-sensitive fluorescent dyes
fura-2 and fluo-4. The ratiometric Ca2+ sensitive dye fura-2 is considered the indicator of
choice for measurement of global cytosolic Ca2+, or averaged Ca2+ levels throughout the
cytoplasm. On the other hand, transient Ca2+ release events from the SR (Ca2+ sparks)
require the use of single-wavelength Ca2+ indicators such as fluo-4.

A thorough

knowledge of these Ca2+ signaling processes is imperative for understanding mechanisms
contributing to cerebral vascular pathologies such as subarachnoid hemorrhage.
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Figure Legends

Figure 1: Arteriograph chamber for intact pressurized cerebral arteries.

A.

Overhead view of 5 mL arteriograph chamber used for cannulation of cerebral artery
segments.

B. Glass micropipettes are pulled from capillary tubes and mounted in an

arteriograph chamber. C. Image of a rat posterior cerebral artery (~150 μm diameter)
cannulated on glass micropipettes. Suture thread is used to tie each end of the artery
segment onto the micropipettes.

D. Image of rat parenchymal arteriole (~60 μm

diameter). Video edge detection (black horizontal lines) is used for measurement of
arterial diameter.

Figure 2: Simultaneous measurement of global [Ca2+]i and diameter of an intact
pressurized cerebral artery. Fluorescence intensity (photomultiplier tube counts) at
340 nm and 380 nm excitation (F340 and F380, respectively), F340/F380 ratio,
calculated free [Ca2+]i and arterial diameter from a pressurized rabbit cerebellar artery.
Smooth muscle membrane potential depolarization induced by elevating extracellular K+
from 3 mM to 60 mM caused an increased in F340/F380 ratio (i.e. increased free [Ca2+]i)
and vasoconstriction. The response to 60 mM K+ was reversed by application of the
VDCC blocker nifedipine (1 μM).

Figure 3: Freshly isolated native cerebral artery myocytes. A. Cerebral arteries were
enzymatically dissociated to obtain isolated vascular smooth muscle cells. Image shows
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individual smooth muscle cells using differential interference contrast microscopy (40X).
B. Vascular smooth muscle can be identified by spindle-shaped cell morphology as well
as immunostaining of smooth muscle alpha actin and smooth muscle myosin heavy
chain. Scale bars represent 10 μm. From Nystoriak et al., Am. J. Physiol., 2009 [28] with
permission.

Figure 4: Ca2+ sparks in isolated cerebral artery myocytes. A. Original images of a
Ca2+ spark recorded every 17 msec from an isolated cerebral artery myocyte. White scale
bar represents 10 µm. Red arrow indicates a Ca2+ spark. B. F0 image obtained by
averaging 30 consecutive images without a Ca2+ spark. Trace represents time course of
fractional fluorescence changes (F/F0) during the Ca2+ spark shown in panel A using the
analysis area (2.1 μm x 2.1 μm) depicted as a red square in the F0 image. Gray bar
represents time elapsed during the images shown in panel A. C. Pseudo-colored images
of the same Ca2+ spark depicted in panels A and B. Each pixel is converted to pseudocolor shown in the color bar to the right of the images. White scale bar represents 10 µm.

Figure 5: Ca2+ sparks in intact pressurized cerebral arteries.

Ca2+ sparks were

recorded in 56 µm x 53 µm areas of intact pressurized mouse cerebral arteries in the
absence (A) and presence (B) of forskolin (10 μM), an activator of adenylyl cyclase.
During a 10 second recording period, a total of 13 Ca2+ sparks were observed in the
image depicted in panel A, and a total of 38 Ca2+ sparks were observed in the image
depicted in panel B. White boxes represent sites where Ca2+ sparks occurred. Three
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representative F/F0 records (a-c) corresponding to three Ca2+ sparks sites (a-c) from each
artery are displayed below their corresponding artery image. Horizontal scale bars
represent a time of 1 second, and vertical scale bars represent a fractional fluorescence
(F/F0) change of 0.5. From Wellman et al., Am. J. Physiol. Cell Physiol., 2001 [11] with
permission.
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Figures

Figure 1: Arteriograph chamber for intact pressurized cerebral arteries.
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Figure 2: : Simultaneous measurement of global [Ca2+]i and diameter of an intact
pressurized cerebral artery.
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Figure 3: Freshly isolated native cerebral artery myocytes.
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Figure 4: Ca2+ sparks in isolated cerebral artery myocytes.
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Figure 5: Ca2+ sparks in intact pressurized cerebral arteries.
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Summary
Background: Ca2+ signaling mechanisms are crucial for proper regulation of vascular
smooth muscle contractility and vessel diameter. In cerebral artery myocytes, a rise in
global cytosolic Ca2+ concentration ([Ca2+]i) causes contraction while an increase in local
Ca2+ release events from the sarcoplasmic reticulum (Ca2+ sparks) leads to increased
activity of large-conductance Ca2+-activated (BK) K+ channels, hyperpolarization and
relaxation. Here, we examined the impact of SAH on Ca2+ spark activity and [Ca2+]i in
cerebral artery myocytes following SAH.
Methods: A rabbit double injection SAH model was used in this study. Five days after
the initial intracisternal injection of whole blood, small diameter cerebral arteries were
dissected from the brain for study. For simultaneous measurement of arterial wall [Ca2+]i
and diameter, vessels were cannulated and loaded with the ratiometric Ca2+ indicator
fura-2.

For measurement of Ca2+ sparks, individual myocytes were enzymatically

isolated from cerebral arteries and loaded with the Ca2+ indicator fluo-4. Sparks were
visualized using laser scanning confocal microscopy.
Results: Arterial wall [Ca2+]i was significantly elevated and greater levels of myogenic
tone developed in arteries isolated from SAH animals compared with arteries isolated
from healthy animals. The L-type voltage-dependent Ca2+ channel (VDCC) blocker
nifedipine attenuated increases in [Ca2+]i and tone in both groups suggesting increased
VDCC activity following SAH. Membrane potential measurement using intracellular
microelectrodes revealed significant depolarization of vascular smooth muscle following
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SAH. Further, myocytes from SAH animals exhibited significantly reduced Ca2+ spark
frequency (~50%).
Conclusions: Our findings suggest decreased Ca2+ spark frequency leads to reduced BK
channel activity in cerebral artery myocytes following SAH. This results in membrane
potential depolarization, increased VDCC activity, elevated [Ca2+]i and decreased vessel
diameter. We propose this mechanism of enhanced cerebral artery myocyte contractility
may contribute to decreased cerebral blood flow and development of neurological deficits
in SAH patients.

Key words: Ca2+ channels, K+ channels, Ca2+ sparks, vascular smooth muscle, vasospasm
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Introduction
Intracellular Ca2+ is a ubiquitous second messenger, playing critical roles in a wide array
of physiological processes including muscle contraction (2). In the cerebral vasculature,
average intracellular Ca2+ concentration or global cytosolic Ca2+ ([Ca2+]i) dictates smooth
muscle contraction (and arterial diameter) via regulation of myosin light chain kinase
activity (4).

Thus, an elevation in global cytosolic Ca2+ leads to enhanced

vasoconstriction and potentially a decrease in cerebral blood flow (12). Paradoxically,
localized intracellular Ca2+ release events, termed Ca2+ sparks, promote a decrease in
[Ca2+]i and relaxation of cerebral artery myocytes (15, 27). Ca2+ sparks are generated by
the coordinated opening of ryanodine receptors (RyRs) located on the sarcoplasmic
reticulum of smooth muscle cells and activate plasmamemmal large conductance Ca2+activated K+ (BK) channels leading to membrane potential hyperpolarization, decreased
activity of voltage-dependent Ca2+ channels (VDCCs), decreased [Ca2+]i, and
vasodilation. Currently, the impact of subarachnoid hemorrhage on local and/or global
Ca2+ signals in myocytes from small diameter cerebral arteries is unclear (24).

Methods
SAH model:
A rabbit double-injection model of SAH was used in this study. Briefly, anesthetized
New Zealand white rabbits (males, 3.0-3.5 kg) received an intracisternal injection of
autologous arterial blood (2.5 ml) using a previously described surgical procedure (8, 9).
Forty-eight hours after the initial injection, the procedure was repeated with animals
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receiving a second injection of 2.5 ml of arterial blood. Five days after the initial
surgery, rabbits were euthanized and posterior cerebral and cerebellar arteries (100-200
µm diameter) were dissected for in vitro studies.

All protocols were conducted in

accordance with the guidelines for the care and use of laboratory animals (NIH
publication 85-23, 1985) and followed protocols approved by the Institutional Animal
Use and Care Committee of the University of Vermont, USA.

Simultaneous measurement of global cytosolic Ca2+ and arterial diameter:
Intact cerebral arteries were cannulated on glass micropipettes mounted in a Living
Systems Inc. (Burlington, VT) arteriograph chamber. Arteries were loaded, in the dark,
with the ratiometric Ca2+ indicator fura-2-AM (5 μM) in a MOPS solution containing
pluronic acid (0.05%) for 45 minutes at room temperature. The MOPS loading solution
had the following composition (in mM): 145 NaCl, 5 KCl, 1 MgSO4, 2.5 CaCl2, 1
KH2PO4, 0.02 EDTA, 3 3-(N-morpholino)propanesulfonic acid (MOPS), 2 pyruvate, 5
glucose, 1% bovine serum albumin (pH 7.4). Arteries were then continuously superfused
with aerated artificial cerebral spinal fluid (aCSF) at 37° C for the remainder of the
experiment. The composition of the aCSF was (in mM): 125 NaCl, 3 KCl, 18 NaHCO 3,
1.25 NaH2PO4, 1 MgCl2, 2 CaCl2, 5 glucose aerated with 5% CO2, 20% O2, 75% N2 (pH
7.35). Ratio images of the arterial wall were obtained from background corrected images
of the 510 nm emission from arteries alternately excited at 340 and 380 nm using
software developed by IonOptix Inc. (Milton, MA).

Arterial wall [Ca2+] is calculated

using the following equation (3): [Ca2+] = Kd x  x (R-Rmin)/(Rmax-R). An apparent Kd of
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282 nM of fura-2 for Ca2+ was used (12). Arterial constriction was expressed as a
percent decrease from the maximal (fully dilated) diameter obtained at the end of each
experiment in Ca2+-free aCSF containing the vasodilators nifedipine (1 μM) and forskolin
(1 μM). In some studies intracellular microelectrodes were used to measure smooth
muscle membrane potential in intact pressurized arteries, as described previously (25).
Measurement of Ca2+ sparks in isolated cerebral artery myocytes:
Individual smooth muscle cells were enzymatically isolated from posterior cerebral and
cerebellar artery segments (26).

Isolated myocytes were then loaded with fluo-4-AM

(10 µM) for 60 minutes (21˚ C) in a HEPES-buffered physiological saline solution (PSS)
containing pluronic acid (0.05%). The HEPES-PSS had the following composition (in
mM): 135 NaCl, 5.4 KCl, 1.8 CaCl2, 1 MgCl2, 10 HEPES, 10 glucose (pH 7.4 with
NaOH).

Myocyte images were acquired with a Noran Oz laser scanning confocal

microscope (19). Fluo-4 was excited using the 488 nm line of a krypton/argon laser and
the light emitted by this dye (520 nm) was separated from the excitation light and
collected. Images were acquired at a frequency of ≈ 60 Hz for a period of 20 seconds.
Ca2+ sparks are detected and analyzed using custom software (written by Dr. Adrian
Bonev, University of Vermont, using IDL 5.0.2; Research Systems Inc., Boulder, CO).
Baseline fluorescence (Fo) was determined by averaging 10 images without Ca2+ spark
activity. Fractional fluorescence increases (F/Fo) are determined in areas (2.1 μm  2.1
μm) where Ca2+ sparks were observed. Ca2+ sparks are defined as local fractional
fluorescence increases greater than 1.3.

All measurements were recorded at room

temperature.
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Results
Elevated global cytosolic Ca2+ and enhanced myogenic tone in small diameter
cerebral arteries following SAH:
The relationship between intravascular pressure, arterial Ca2+ and myogenic tone was
examined in small diameter (150-200 μm) cerebral arteries isolated from healthy control
and SAH model rabbits. Arterial wall Ca2+ and constriction increased as intravascular
pressure was elevated within the range (60-100 mmHg) typically experienced by these
arteries in vivo. Arteries from SAH animals exhibited significant elevations in both
arterial wall Ca2+ and constriction compared to similar arteries from control animals
(Figure 1A). For example, at 100 mmHg, arterial wall Ca2+ was ~26% higher in arteries
isolated from SAH animals (231 ± 17 nM, n = 4) compared with arteries isolated from
healthy (184 ± 12 nM, n = 4). The level of constriction (myogenic tone) at 100 mmHg
was ~1.5 fold higher in arteries isolated from SAH animals (39 ± 3 % decrease in
diameter, n = 4) compared with arteries isolated from healthy animals (27 ± 2 % decrease
in diameter, n = 4). In the presence of the L-type VDCC blocker nifedipine (1 μM),
arterial Ca2+ was greatly reduced in arteries from both SAH (141 ± 15 nM) and control
(118 ± 7 nM) rabbits. Nifedipine (1 μM) also reduced pressure-induced constrictions by
92 ± 1 % and 93 ± 1 % in arteries from SAH and control animals, respectively. These
data suggest that increased VDCC activity underlies enhanced pressure-induced
constriction observed in small diameter cerebral arteries from SAH.
Increased VDCC activity could reflect either increased L-type VDCC expression or
enhanced VDCC activation due to smooth muscle membrane potential depolarization
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following SAH. Quantitative real-time PCR was used to assess L-type VDCC expression
encoded by the gene CaV1.2 (17). Using this approach, no significant difference in
CaV1.2 mRNA levels was detected in cerebral artery homogenates from control and SAH
animals (Figure 1B). Next, we used intracellular microelectrodes to directly measure
vascular smooth muscle membrane potential from intact pressurized cerebral arteries. At
80 mmHg, smooth muscle membrane potential was significantly depolarized by
approximately 8 mV in arteries isolated from SAH animals compared with arteries from
control animals (Figure 1C).

These findings suggest that membrane potential

depolarization of vascular smooth muscle leads to increased VDCC activity, elevated
global cytosolic Ca2+ and enhanced constriction of small diameter cerebral arteries
following SAH.

Ca2+ spark frequency is decreased in cerebral artery myocytes from SAH animals:
A decrease in Ca2+ spark frequency and associated BK activity promotes membrane
potential depolarization, elevated global cytosolic Ca2+, and vasoconstriction (15, 27).
To explore whether decreased Ca2+ spark frequency may contribute to enhanced cerebral
artery constriction, Ca2+ sparks were measured in isolated cerebral artery myocytes using
laser scanning confocal microscopy and the Ca2+ indicator dye fluo-4. As illustrated in
figure 2, Ca2+ sparks were observed in cerebral artery myocytes obtained from both
control and SAH animals. However, Ca2+ spark frequency was markedly decreased (by
approximately 50%) in myocytes isolated from SAH animals.

Consistent with the

observed decrease in Ca2+ spark frequency, the frequency of transient BK currents
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detected using patch clamp electrophysiology was also reduced by approximately 50 % in
freshly isolated cerebral artery myocytes from SAH animals (Koide and Wellman,
unpublished observations). These data suggest that a decrease in the frequency of Ca2+
sparks and their associated BK channel currents may contribute to enhanced constriction
of small diameter cerebral arteries following SAH.

Discussion
Aneurysmal SAH is associated with high rates of morbidity and mortality (1). It has been
a long-held belief that delayed and sustained large diameter (conduit) cerebral artery
vasospasm (“angiographic vasospasm”) is a major contributor to SAH-induced death and
disability. However, there is a growing appreciation that a host of other factors are also
likely involved in the pathological consequences associated with cerebral aneurysm
rupture (5, 20). Here, we provide evidence that SAH enhances the dynamic constriction
of small diameter pial arteries in response to physiological increases in intravascular
pressure, an effect that could have a pronounced influence to decrease cerebral blood
flow. Our findings indicate that this augmented constriction is associated with enhanced
smooth muscle contraction due to membrane potential depolarization, enhanced voltagedependent Ca2+ channel activity and elevated global cytosolic calcium. Further, our
recent findings suggest a decrease in the frequency of Ca2+ sparks and associated BK
channel activity may contribute to enhanced cerebral artery constriction and elevated
global cytosolic Ca2+ (figure 3).
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The cerebral circulation maintains a constant level of blood flow to the brain despite
physiological fluctuations in cerebral perfusion pressure (14). To achieve stable cerebral
blood flow in the face of changes in blood pressure, cerebral arteries must constrict in
response to increased intravascular pressure and dilate when intravascular pressure is
reduced. In pial arteries from healthy animals, physiological increases in intravascular
pressure lead to smooth muscle membrane potential depolarization, an increase in the
activity of L-type CaV1.2 channels (encoded by the gene CACNA1C), and increased
global cytosolic Ca2+ (12, 17). The open-state probability of CaV1.2 is steeply voltagedependent (16); thus, small changes in membrane potential can have a profound impact
on smooth muscle Ca2+. Our present results suggest membrane potential depolarization
and enhanced L-type VDCC activity in small diameter arteries is likely to contribute to
SAH-induced impairment in the autoregulation of cerebral blood flow reported by others
(18, 23).

Our evidence also suggests enhanced activity of L-type VDCCs play a large

part in the SAH-induced elevation in global cytosolic Ca2+. However, in the presence of
the L-type VDCC blocker nifedipine, global Ca2+ remained elevated (by approximately
20%) in arteries from SAH animals. This nifedipine-resistant increase in global Ca2+ in
cerebral arteries from SAH animals may reflect the emergence of R-type VDCC channels
(9), or the possible upregulation of additional Ca2+ entry pathways.
Our present findings suggest decreased Ca2+ spark and associated BK channel activity
contribute to SAH-induced membrane potential depolarization and enhanced VDCC
activity in cerebral artery myocytes. Harder and colleagues (6) were the first to report
that the membrane potential of cerebral artery myocytes is depolarized following SAH
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and a number of subsequent studies have provided further evidence for decreased
voltage-dependent K+ (KV) channel activity in pial arteries following SAH (7, 10, 11, 13,
21, 22, 24). Interestingly, BK channel activity and expression have been reported to be
unchanged in basilar artery myocytes obtained from a canine SAH model (11).

Our

current work demonstrates that decreased BK channel activity following SAH results
from a decrease in local Ca2+ signaling from the SR to the plasma membrane (i.e.
decreased Ca2+ spark activity), rather than a direct effect on BK channel properties or
expression.

Conclusions
In this study, we examined global and local Ca2+ signaling in cerebral artery myocytes
following SAH. As for global Ca2+, we observed a significant increase in averaged
cytosolic Ca2+ and constriction in cerebral arteries from SAH animals at physiological
intravascular pressures.

Regarding local Ca2+ signaling, we report a decrease in the

frequency of Ca2+ sparks and associated transient outward BK currents, which likely
contribute to membrane potential depolarization, increased VDCC activity and enhanced
cerebral constriction artery following SAH. These data suggest that increased global
Ca2+ and impaired local Ca2+ signaling may contribute to decreased cerebral blood flow
and the development of neurological deficits frequently observed following aneurysmal
SAH.
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Figure Legends:
Figure 1: Elevated global cytosolic Ca2+ following SAH: A. Summary data from
simultaneous measurement of arterial wall Ca2+ (using fura-2) and diameter. Arterial
wall Ca2+ and tone were significantly increased at intravascular pressures between 60 and
100 mmHg in arteries isolated from SAH animals compared with controls. B. Summary
data using quantitative real-time PCR. Total RNA was collected from posterior cerebral
arteries.

CaV1.2 expression was not altered following SAH.

NS: not statistically

significant. C. Summary data from membrane potential measurement using intracellular
microelectrodes. Vascular smooth muscle membrane potential in arteries from SAH
animals was significantly depolarized following SAH. * P<0.05.

Figure 2: Decreased Ca2+ spark frequency in cerebral myocytes from SAH animals:
Imaging of Ca2+ sparks in cerebral artery myocytes loaded with the fluorescent Ca2+
indicator fluo-4.

Fluorescent images were detected using laser scanning confocal

microscopy with Ca2+ sparks defined as a fractional fluorescent increase of greater than
30% within 2.1 μm by 2.1 μm analysis areas. Large size images represent an average of
30 images in gray scale without Ca2+ spark activity.

White crosses depict where

individual Ca2+ sparks occurred during the 20 sec recordings. Scale bars represent 10
µm.

Smaller images illustrate the time course of Ca2+ sparks in control and SAH

myocytes. Images were obtained every 19 msec.

228

Figure 3: Summary cartoon: In control cerebral artery myocytes, local Ca2+ release
events from the sarcoplasmic reticulum (Ca2+ sparks) activate large conductance Ca2+
activated (BK) K+ channels, causing membrane potential hyperpolarization, decreased
voltage-dependent Ca2+ channel (VDCC) activity and decreased global cytosolic Ca2+.
Following SAH, the frequency of Ca2+ sparks and therefore BK channel activity is
decreased, promoting membrane potential depolarization, increased VDCC activity and
increased global cytosolic Ca2+ levels.
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Figures

Figure 1: Elevated global cytosolic Ca2+ following SAH.
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Figure 2:

Decreased Ca2+ spark frequency in cerebral myocytes from SAH animals.
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Control

SAH

Figure 3: Summary cartoon.
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APPENDIX C: JOURNAL ARTICLE

My contribution to the following journal article comprises acquisition and analysis of arterial
[Ca2+]i data and caffeine-induced Ca2+-transient data shown in figure 5.
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Abstract
Intracellular Ca2+ release events (“Ca2+ sparks”) and transient activation of largeconductance Ca2+-activated potassium (BK) channels represent an important vasodilator
pathway in the cerebral vasculature. Considering the frequent occurrence of cerebral
artery constriction following subarachnoid hemorrhage (SAH), our objective was to
determine if Ca2+ spark and BK channel activity were reduced in cerebral artery
myocytes from SAH model rabbits. Using laser scanning confocal microscopy, we
observed ≈50 % reduction in Ca2+ spark activity, reflecting a decrease in the number of
functional Ca2+ spark discharge sites.

Patch clamp electrophysiology demonstrated a

similar reduction in Ca2+ spark-induced transient BK currents, but no change in BK
channel density or single channel properties. Consistent with a reduction in active Ca2+
spark sites, quantitative real-time PCR and western blotting revealed decreased
expression of ryanodine receptor type 2 (RyR-2) and increased expression of the RyR-2
stabilizing protein, FKBP12.6, in cerebral arteries from SAH animals.

Further,

inhibitors of Ca2+ sparks (ryanodine) or BK channels (paxilline) constricted arteries from
control, but not SAH animals. This work demonstrates that an SAH-induced decrease in
sub-cellular Ca2+ signaling events disables BK channel activity leading to cerebral artery
constriction. This phenomenon may contribute to decreased cerebral blood flow and the
high rate of poor outcome following aneurysmal SAH.

Key Words:

cerebral

aneurysm, FKBP12.6, potassium channels, ryanodine receptors, vascular smooth
muscle, vasospasm.
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Introduction
Cerebral aneurysm rupture and the ensuing subarachnoid hemorrhage (SAH) has an
enormous impact on individuals and society, with 30-day mortality rates approaching 50
% and the majority of survivors left with moderate to severe disability (Hop et al 1997).
For decades, “angiographically-defined” cerebral vasospasm of conduit arteries (> 1 mm
in diameter) has been thought to be the major contributor to death and disability in SAH
patients surviving the initial intracranial bleed. However, recent evidence indicates that
factors other than large artery vasospasm contribute to SAH-induced pathologies
(Macdonald et al 2007). Additional factors contributing to the deleterious consequences
of aneurysmal SAH may include global transient ischemia, early brain injury, disruption
of the blood-brain barrier, and activation of inflammatory pathways (Ostrowski et al
2006; Prunell et al 2005). It is now appreciated that SAH may also impact small
diameter arteries and arterioles, i.e. those involved in the autoregulation of cerebral blood
flow (Hattingen et al 2008; Ishiguro et al 2002; Ohkuma et al 2000).
In resistance arteries from healthy animals, vasoconstrictor stimuli such as
physiological increases in intravascular pressure lead to smooth muscle membrane
potential depolarization, increased voltage-dependent Ca2+ channel (VDCC) activity, and
elevated global cytosolic calcium (Knot and Nelson 1998).

Global cytosolic Ca2+

represents averaged Ca2+ levels throughout the cytoplasm and is a key regulator of
smooth muscle contraction. One important dynamic negative feedback mechanism to
limit vasoconstriction is the activation of large-conductance Ca2+- and voltage-sensitive
potassium (BK) channels by Ca2+ sparks. Ca2+ sparks are localized Ca2+ release events
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occurring through ryanodine receptors (RyRs) in the sarcoplasmic reticulum (SR)
abutting the plasma membrane. Ca2+ sparks oppose the contractile actions of global
cytosolic Ca2+ by promoting smooth muscle relaxation via activation of plasmalemmal
BK channels leading to membrane potential hyperpolarization and decreased Ca2+ influx
through VDCCs (Nelson et al 1995; Wellman and Nelson 2003). In the vasculature,
functional BK channels are composed of pore-forming α1 subunits, encoded by the gene
KCNMA1 and regulatory β1 subunits, encoded by the gene KCNMB1 (Tanaka et al
1997). Loss-of and gain-of function polymorphisms of KCNMA1 and KCNMB1 have
been linked to asthma and blood pressure regulation in humans (Kelley-Hedgepeth et al
2009; Tomas et al 2008). Further, decreased KCNMB1 expression causes reduced BK
channel Ca2+ and voltage sensitivity, and is linked to enhanced vasoconstriction,
hypertension and diabetes (Amberg and Santana 2003; Brenner et al 2000; Dong et al
2008). These vascular pathologies have all been associated with a decrease in BK
channel activity in response to Ca2+ sparks, rather than a reduction in Ca2+ spark activity.
Decreased BK channel activity following SAH could lead to vasoconstriction
and compromise cerebral autoregulation.

However, BK channel properties and

expression appear to be unaffected in basilar arteries obtained from a canine SAH model
(Jahromi et al 2008b). In the present study, we demonstrate that decreased BK channel
activity does contribute to enhanced pressure-dependent constriction of resistance-sized
cerebral arteries from SAH model rabbits. However, rather than reduced BK channel
activity resulting from decreased KCNMA1 or KCNMB1 expression, we provide
evidence that impaired BK channel activity results from a decrease in sub-cellular Ca2+
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signaling from the SR to BK channels, i.e. reduced Ca2+ spark frequency.

To our

knowledge, these findings represent the first demonstration of a vascular pathology due
to a decrease in Ca2+ spark activity. This SAH-induced reduction in Ca2+ spark frequency
reflects a decrease in the number of functional Ca2+ spark discharge sites caused by a
decrease in the expression of SR RyR-2 Ca2+-release channels and an increase in the
expression of the RyR-2 stabilizing protein, FKBP12.6. This novel pathway of decreased
vascular BK channel activity may contribute to impaired autoregulation, reduced cerebral
blood flow and the development of neurological deficits frequently observed in patients
following aneurysmal SAH.

Materials and Methods
Rabbit SAH model
New Zealand White rabbits (males, 3.0-3.5 kg; Charles River Laboratories) were used for
a double injection SAH model using surgical procedures described previously (Ishiguro
et al 2002; Ishiguro et al 2005). Briefly, under isoflurane anesthesia, a small midline
suboccipital incision was centered over the foramen magnum and neck muscles dissected
until dura was visualized. Unheparinized autologous blood (2.5 ml) was then injected
into the subarachnoid space via the cisterna magna. The animal was then positioned on
an incline board at a 45 degree angle with the head down in neutral position for 30
minutes.

To minimize increases in intracranial pressure, a similar volume of cerebral

spinal fluid was removed prior to the injection of blood. Forty-eight hours later, the
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above procedures were repeated. Buprenophine (0.01 mg/kg) was given every 12 hours
for 36 hours after each surgery as an analgesic. Five days after the initial surgery, rabbits
were euthanized by exsanguination under deep pentobarbital anesthesia (i.v.; 60 mg/kg),
and posterior cerebral and cerebellar arteries (100-250 μm diameter) were dissected for in
vitro studies in cold (4°C), oxygenated (20 % O2 / 5 % CO2 / 75 % N2) physiological
saline solution (PSS) of the following composition (in mmol/L): 118.5 NaCl, 4.7 KCl, 24
NaHCO3, 1.18 KH2PO4, 2.5 CaCl2, 1.2 MgCl2, 0.023 EDTA, 11 glucose. Age-matched
animals that did not undergo surgical procedures were used as controls. All protocols
were conducted in accordance with the guidelines for the care and use of laboratory
animals [National Institutes of Health (NIH) publication No. 85-23] and followed
protocols approved by the Institutional Animal Care and Use Committee of the
University of Vermont.

Electrophysiology
Transient BK currents: Arteries were enzymatically dissociated to obtain individual
smooth muscle cells as described previously (Ishiguro et al 2005). Transient BK currents
were measured using the perforated whole-cell patch-clamp technique at room
temperature (Wellman et al 2002). The composition of the HEPES-PSS bath solution
was (in mmol/L): 134 NaCl, 6 KCl, 1 MgCl2, 1.8 CaCl2, 10 glucose and 10 HEPES (pH
7.4). Patch pipettes (8-10 M) were filled with an internal solution that contained (in
mmol/L) 110 K+ aspartate, 30 KCl, 10 NaCl, 1 MgCl2, 10 HEPES, 0.05 EGTA and 0.2
amphotericin B (pH 7.2). Transient outward currents were recorded over a range of
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holding potentials from -40 mV to 0 mV (~5 min at each membrane potential).
Recordings were analyzed with the Mini Analysis 6.0.3 program (Synaptosoft Inc.), to
determine transient BK current amplitude, frequency, rise time (30-70 %) and decay time
(90-10 %). The threshold for current peak detection was set at two and half times the
single channel amplitude of BK channel (e.g. 5.0 pA at -40 mV) (Perez et al 2001).
Single channel BK current recordings: BK single channel currents were recorded in
excised inside-out membrane patches at room temperature (Perez et al 2001). The bath
and pipette solution contained (in mmol/L): 140 KCl, 1 MgCl2, 5 EGTA, 1.9 CaCl2 and
10 HEPES (pH 7.2), with a calculated free Ca2+ concentration of 100 nmol/L (WinMax C
software, http://www.stanford.edu/%7Ecpatton/maxc.html). When CaCl2 was omitted
from the bath solution (“zero” Ca2+), free Ca2+ concentration was calculated to be < 1
nmol/L.

The number of channels per patch was determined at +80 mV in 100 nmol/L

free Ca2+. Ca2+- and voltage-sensitivity of BK channels were determined from Boltzman
fit of data.
Whole-cell voltage-dependent K+ current recordings:

Whole cell K+ currents were

measured using the conventional whole cell configuration of the patch-clamp technique
(Koide et al 2007). The composition of bath solution was the same as the 6 mmol/L K+
HEPES-PSS described above.

The internal solution contained (in mmol/L): 87 K+

aspartate, 20 KCl, 1 CaCl2, 1 MgCl2, 10 HEPES, 10 EGTA and 25 KOH (pH 7.2). From
a holding potential of -70 mV, outward K+ currents were elicited by a series of 500 msec
depolarizing voltage steps followed by a step to -40 mV for 300 msec. Voltage steps
were made at 10 mV increments to +50 mV at intervals of 10 sec from a holding
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potential of -70 mV. All electrophysiological studies were performed using Axopatch
200B, pCLAMP 9.2 and Clampfit 9.2 software (Axon Instruments Inc.).

Ca2+ spark measurements
Freshly isolated cerebral artery myocytes were incubated with the fluorescent Ca2+
indicator fluo-4 AM (10 µmol/L; Ex 488 nm, Em 520 nm; Invitrogen) and 0.036 %
pluronic acid for 30 min at room temperature followed by a brief wash with HEPES-PSS.
Ca2+ sparks were detected as previously described using a Noran Oz laser scanning
confocal system coupled to an inverted Nikon TMD microscope equipped with a 60X
water-immersion lens (N.A.1.2) (Perez et al 2001). Images were acquired at a frequency
of 58.3 Hz (approximately every 17.2 msec) for 20 sec at room temperature. Fractional
fluorescent changes (F/F0) were analyzed in 2.1 μm x 2.1 μm analysis areas using custom
software (SparkAn, written by Dr. Adrian Bonev), and F/F0 changes > 1.3 defined as
Ca2+ sparks. F0 was obtained by averaging 30 images containing no Ca2+ events.

RNA isolation and quantitative real-time RT- PCR
Total RNA was extracted from posterior cerebral arteries (100-250 µm in diameter, ~1
mg wet weight) using RNA STAT-60 (Tel-Test Inc.) and cDNA was synthesized by
SuperScriptTM First-Strand Synthesis System (Invitrogen).

The primer sets were

designed using Primer-BLAST (NIH) for a unique region of targeted mRNA sequence
and are detailed in the online supplementary information (Table 1).

Expression of

mRNA was quantified by real-time PCR using SYBR Green JumpStart Taq ReadyMix

241

and a real-time PCR system (Applied Biosystems). Quantification was performed using
standard curves constructed by amplification of serially diluted plasmids containing
target genes, and the threshold cycle value for each sample used to calculate the initial
quantity of cDNA template. The results of quantitative real-time PCR were normalized
to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) expression.

Western blotting
Freshly isolated cerebral arteries were homogenized in buffer containing (in mmol/L):
100 NaCl, 20 Tris-HCl (pH 7.4), 1 EDTA, 1 EGTA, 5 dithiothreitol, 1
phenylmethylsulfonyl fluoride, 0.1 leupeptin and 1 % Triton-X using glass
microgrinders. After sonication for 10 min on iced water, tissue debris was removed by
centrifugation (8000 x g, 5 min). The protein concentration of lysate was measured by
modified Bradford assay (Coomassie Plus; Pierce) using bovine serum albumin as a
standard. The lysate (20 µg of protein) was mixed with 5X loading buffer (625 mmol/L
Tris-HCl; pH 6.8), 20 % SDS and 25 % glycerol), and incubated at 37 °C for 15 min.
Proteins were separated using 4-20 % acrylamide gradient gels, and electrophoretically
transferred to a nitrocellulose membrane. After blocking the membrane with 5 % non-fat
milk (1 hr at RT), the membrane was incubated with primary antibody at 4 °C over night.
Following incubation with appropriate secondary antibody for 1 hr at RT, signals were
detected by chemiluminescence for RYR-2 or by an Odyssey® infrared imaging system
(LI-COR® Biosciences) for FKBP12.6 and α-smooth muscle actin. Bands depicting each
protein were analyzed using Image J software (NIH). Antibodies were used as follows:
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anti-RyR2 mouse monoclonal antibody (clone C3-33, 1:200; ABR), anti-FKBP12.6 goat
polyclonal antibody (1:200, SantaCruz), anti-α smooth muscle actin mouse monoclonal
antibody (1:100,000, Sigma), peroxydase conjugated sheep anti-mouse IgG (1:5,000, GE
Healthcare), IRdye700® conjugated donkey anti-goat IgG and IRdye800® conjugated
goat anti-mouse IgG (1:10,000, Rockland).

Diameter measurements in isolated arteries
Freshly isolated arteries from control and SAH rabbits were cannulated in a 5 ml
myograph chamber (Living Systems Instrumentation, Inc.) and perfused with PSS (pH
7.4) aerated with 20 % O2 / 5 % CO2 / 75 % N2 at 37˚C, as previously described (Ishiguro
et al 2002). Arterial diameter was measured with video edge detection equipment and
recorded using data acquisition software (Dataq Instruments Inc.).

Arteries were

discarded if an initial constriction representing less than a 50 % decrease in diameter was
observed when arteries were exposed to elevated extracellular K+ (60 mmol/L). Arterial
constrictions to paxilline and ryanodine are expressed as a percent decrease in diameter
from the basal level of pressure-induced myogenic tone at an intravascular pressure of 80
mmHg.

Vasodilation to cumulative additions of acetylcholine (ACh) and sodium

nitroprusside (SNP) are expressed as percent dilation of pressure-induced (myogenic)
tone. Fully-dilated (passive) diameter was determined at the end of each experiment by
exposing arteries to Ca2+-free PSS containing diltiazem (100 μmol/L) and forskolin (1
μmol/L).
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Measurement of cytosolic Ca2+ in pressurized cerebral arteries
Freshly isolated cerebral arteries were cannulated and loaded with the ratiometric Ca2+sensitive fluorescent dye, fura-2 AM (5 µmol/L; Invitrogen), with 0.1 % pluronic acid
for 45 min at room temperature. To allow for equilibration and deesterification of fura-2
AM, arteries were superfused with PSS at 37°C for 30 min. Following the equilibration
period, fluorescent ratio (R) was obtained from background corrected 510 nm emission
from arterioles alternately excited at 340 and 380 nm using software developed by
IonOptix Inc. Cytosolic Ca2+ concentration was estimated using the following equation
(Grynkiewicz et al 1985): [Ca2+] = Kd x ß x (R-Rmin)/(Rmax-R). Calibration values were
not significantly different between arteries from control and SAH animals and were
pooled. Rmin (0.46 ± 0.02) and Rmax (10.80 ± 0.66) represent the ratios of emission signal
under Ca2+-free and Ca2+-saturated conditions, respectively and were obtained from
separate sets of arteries in the presence of ionomycin (10 μmol/L) and nigericin (5
μmol/L). The ratio of Ca2+-free over Ca2+-bound fluorescence intensities at F380, β (11.5
± 0.70), was obtained from Rmin and Rmax measurements. An apparent dissociation
constant (Kd) of 282 nM of fura-2 for Ca2+ was used (Knot and Nelson 1998).

Statistical Analysis
Data are expressed as mean ± SEM, and analyzed by Student’s unpaired t-test or Oneway ANOVA followed by Tukey multiple comparison test. Statistical significance was
considered at the level of p < 0.05 (*) or p < 0.01 (**).
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Results
Transient BK channel currents are decreased following SAH.
At physiological membrane potentials (e.g. -40 mV), micromolar increases in cytosolic
Ca2+ are required to induce significant BK channel activation (Perez et al 2001). In
cerebral artery myocytes, sub-cellular Ca2+ signaling events (Ca2+ sparks) lead to
localized elevations of Ca2+ sufficient to cause the transient activation of nearby BK
channels. Ca2+ spark-induced transient BK currents were recorded using the perforated
patch whole-cell configuration of the patch clamp technique (Figure 1). At -40 mV,
transient BK current frequency, but not amplitude, was decreased by approximately 60 %
in cerebral artery myocytes freshly isolated from SAH model rabbits.

Membrane

potential depolarization increased the frequency and amplitude of transient BK currents
to a similar extent in myocytes from both control and SAH animals, i.e. frequency was
about 60 % lower at all voltages in cells from the SAH group. Temporal characteristics
of these events (rise time and decay time) were similar between groups, as was cell size
as indexed by cell capacitance (online supplementary information, Table 2). These data
demonstrate a dramatic decrease in the frequency of Ca2+ spark-induced BK channel
activity following experimental SAH.

Maintained expression and properties of BK channels in cerebral artery myocytes
following SAH.
The apparent SAH-induced decrease in transient BK current frequency could conceivably
reflect a fundamental change in the voltage or Ca2+ sensitivity, or expression of the BK
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channel following SAH.

To address this issue, single BK channel currents were

measured in excised “inside-out” membrane patches. BK channel open-state probability
(PO) and voltage-dependence with 100 nmol/L intracellular free Ca2+ were not altered
following SAH and a similar right-ward shift in voltage-dependent activation was
observed in BK channels from both groups exposed to intracellular solution containing <
1 nmol/L free Ca2+ (Figure 2A, B). Single channel slope conductance was similar for
channels from control (231.7 ± 3.6 pS, n = 9) and SAH (231.6 ± 3.5 pS, n = 9) animals,
consistent with previous reports for BK channels (Perez et al 2001). Further, the density
of functional BK channels detected in membrane patches was not different between
groups (Figure 2C).

To view the ensemble behavior of BK channels across the

membrane of the entire cell, voltage-dependent K+ currents were measured during
depolarizing voltage steps using conventional whole-cell patch-clamp electrophysiology.
Here, [Ca2+]i was maintained below 25 nmol/L by cell dialysis with 10 mmol/L of the
Ca2+ chelator, EGTA, included in the intracellular (pipette) solution. Ca2+ spark or RyR
activation of BK currents does not occur using this approach and the amplitude of
conventional whole-cell BK currents reflects plasma membrane BK channel density and
their open-state probability at the applied voltage and [Ca2+]i. Steady-state outward
currents sensitive to the BK channel blocker paxilline (1 mol/L, 10 min) were similar in
myocytes from control and SAH animals (Figure 2D). To confirm that expression of BK
channel pore-forming α-subunits and regulatory β1-subunits are maintained in our SAH
model, quantitative real-time PCR was performed on RNA extracted from intact cerebral
arteries. BK channel α and β1 subunit mRNA, expressed as a ratio to glyceraldehyde 3-
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phosphate dehydrogenase (GAPDH) mRNA, were not significantly different between
control and SAH animals (Figure 2E, n = 6 for each group). These data suggest that the
SAH-induced decrease in the frequency of transient BK currents is not due to a decrease
in the number or functionality of BK channels.

Ca2+ spark frequency is decreased in SAH model animals.
BK channel properties and expression appear unaltered in smooth muscle cells from
cerebral arteries of SAH animals. We therefore explored the possibility that the lower
transient BK current frequency reflects a fundamental decrease in Ca2+ spark activity.
Ca2+ sparks were optically measured in freshly isolated cerebral artery myocytes from
control and SAH rabbits using laser scanning confocal microscopy and the fluorescent
Ca2+ indicator, fluo-4. Ca2+ sparks were observed in cells from both control and SAH
animals (Figure 3A, also see movies included within the online supplementary data).
However, as with the frequency of transient BK currents, whole cell Ca2+ spark
frequency was dramatically lower (≈50 %) in myocytes isolated from SAH animals
(SAH: 0.38 ± 0.04 Hz; Control: 0.76 ± 0.05 Hz, Figure 3B). Although frequency was
decreased, Ca2+ spark amplitude, expressed as a fractional change in fluorescence
intensity (F/F0), was similar in myocytes isolated from control and SAH animals (Figure
3C). Other spatio-temporal characteristics such as rise-time, duration, size, and decay
were similar for Ca2+ sparks recorded from myocytes of control and SAH animals (online
supplementary information, Table 2).
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A reduction in functional Ca2+ spark sites underlies decreased Ca2+ spark frequency
in SAH model animals.
In smooth muscle, Ca2+ sparks tend to occur repeatedly within a limited number of
distinct areas, or spark sites (Janiak et al 2001; Pucovsky and Bolton 2006). The SAHinduced decrease in Ca2+ spark frequency could reflect either a reduction in the number
of functional spark sites or a decrease in the frequency of events occurring at all spark
sites throughout the cell. Spark sites were defined as regions where one or more Ca2+
sparks were observed during a 20 second imaging period (Figure 4A-C). Two or more
Ca2+ sparks were considered to originate from the same spark site if these events
exhibited greater than 50 % overlap of their spatial spread (determined at 50 % peak
amplitude). In 45 cerebral artery myocytes from five control animals, a total of 1,082
Ca2+ sparks were observed with an average of 7.9 ± 0.6 spark sites per cell. However, in
myocytes from SAH animals, the number of active spark sites was decreased by
approximately 43 % to 4.5 ± 0.4 (n = 594 sparks in 48 cells from 6 animals, Figure 4D).
Although the number of functional spark sites was decreased, Ca2+ spark frequency at
individual sites was similar in cells isolated from control and SAH animals (Figure 4E).
Further, the correlation between the number of functional spark sites and whole cell Ca2+
spark frequency was similar between groups (Figure 4F). These data suggest SAHinduced decreased Ca2+ spark frequency reflects a reduction in the number of functional
spark sites.
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RyR-2 expression is decreased and FKBP12.6 expression is increased in cerebral
arteries from SAH animals.
It is conceivable that the SAH-induced decrease in functional spark sites could reflect
either an increase in the activation threshold of RyRs or decreased SR Ca 2+ load. To
assess RyR activity, Ca2+ sparks were examined in the presence of a relatively low
concentration (10 μmol/L) of the RyR activator, caffeine. Caffeine lowers the luminal
Ca2+ threshold for RyR activation (Kong et al 2008) and at micromolar concentrations
causes an increase in both Ca2+ spark frequency and the number of active spark sites in
smooth muscle (Janiak et al 2001; Wellman et al 2001). In absolute terms, the number of
active Ca2+ spark sites and whole-cell Ca2+ spark frequency in the presence of caffeine
(10 μmol/L) remained decreased in myocytes isolated from SAH animals (Figure 5A-C;
control n = 7 cells from 3 animals, SAH n = 14 cells from 3 animals). However, on a
relative basis, i.e. when expressed as a percent of basal activity, treatment with caffeine
(10 μmol/L) increased the number of active spark sites by approximately 50 % in cerebral
artery myocytes from both control and SAH animals. Corresponding to the increase in
the number of active spark sites, caffeine (10 μmol/L) also caused a similar percent
increase in whole cell Ca2+ spark frequency in cerebral artery myocytes from both
groups. SR Ca2+ content was also examined in cerebral arteries isolated from control and
SAH animals using the ratiometric fluorescent Ca2+-sensitive dye, fura-2. Decreased SR
Ca2+ content has been reported to decrease whole cell Ca2+ spark frequency and reduce
the amplitude of individual Ca2+ sparks (ZhuGe et al 1999). Rapid application of high
concentrations (millimolar) of caffeine leads to a significant release of Ca2+ from the SR
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through activation of RyRs. The relative amplitude of these caffeine-induced global Ca2+
transients has been used as an index of SR Ca2+ content (Santana et al 1997; Wellman et
al 2001) .

The amplitudes of caffeine-induced global Ca2+ transients were not

significantly different in cerebral arteries from control and SAH model animals (Figure
5D).

Further, quantitative real-time PCR demonstrated that mRNA levels of the SR

Ca2+-binding proteins calsequestrin-2 and calreticulin and the smooth muscle
sarco/endoplasmic reticulum Ca2+-ATPase, SERCA-2 were not significantly different in
arteries from control and SAH animals (Figure 5E; n = 6 for each group). These data
suggest RyR activation properties and SR Ca2+ load in myocytes from SAH animals are
unaltered, and that increasing RyR activity does not restore the number of functional
spark sites to control levels.
The RyR-2 subtype is the dominantly expressed RyR isoform in arterial smooth
muscle, and is thought to underlie Ca2+ spark activity in these cells (Ji et al 2004). RyR-2
activity is modulated by the FK506-binding protein, FKBP12.6, that stabilizes RyR-2
channels in the closed state (Zalk et al 2007). Conditional overexpression of FKBP12.6
has been reported to decrease Ca2+ spark frequency in cardiac myocytes (Gellen et al
2008).

Thus, decreased expression of RyR-2 or increased expression of FKBP12.6 may

contribute to a reduction in Ca2+ spark activity following SAH. To examine whether
RyR-2 expression was decreased following SAH, quantitative real-time RT-PCR was
performed on RNA extracted from intact cerebral arteries (Figure 6A). When normalized
to GAPDH, RyR-2 expression was decreased by approximately 65 % in cerebral arteries
from SAH animals compared to controls (n = 6 for each group). Protein levels of RyR-2,
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detected by western blot, were also decreased by approximately 50 % in cerebral artery
homogenates from SAH rabbits (Figure 6B, C; n = 4 for each group). Interestingly, we
also observed that FKBP12.6 mRNA expression was increased two-fold (n = 5) and
protein levels were over four-fold greater (n = 4) in cerebral artery homogenate from
SAH compared to control animals (Figure 6). These data are consistent with decreased
RyR-2 expression and increased FKBP12.6 expression contributing to a reduction in
functional spark sites and decreased Ca2+ spark frequency in myocytes from SAH
animals.

Decreased RyR and BK channel activity contribute to enhanced cerebral artery
constriction following SAH.
At physiological intravascular pressures (e.g. 80 mmHg), constriction was greater in
cerebral arteries isolated from SAH (34.7 ± 2.7 % decrease in diameter, n = 9) compared
to control (18.5 ± 2.6 % decrease in diameter, n = 9) animals. To examine whether SAHinduced decreased Ca2+ spark and transient BK current activity contribute to enhanced
cerebral artery constriction, arterial diameter measurements were made in the presence
and absence of paxilline, a blocker of BK channels and ryanodine, a blocker of RyRs
(Figure 7A-C and online supplementary information, Table 3).

At an intravascular

pressure of 80 mmHg, paxilline (1 μmol/L) caused a robust constriction in arteries from
control animals, decreasing diameter from 94.6 ± 10.2 µm to 78.4 ± 8.4 µm, or by 17.1 %
(Figure 7B). Thus, with arteries from control animals, BK channel block mimicked SAH
to enhance constriction. In contrast, paxilline did not significantly constrict arteries from
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SAH animals (diameter prior to paxilline: 96.6 ± 8.1 µm; diameter in the presence of
paxilline 95.5 ± 8.6 µm), consistent with SAH causing a decrease in Ca2+ spark-induced
BK channel activity.

In a similar manner, the inhibitor of Ca2+ sparks, ryanodine (10

μmol/L), caused a significantly greater constriction in arteries from control compared to
SAH animals (Figure 7C).

Also consistent with SAH-induced decreased BK channel

activity and enhanced vasoconstriction, global cytosolic Ca2+, measured using fura-2, was
elevated in cerebral arteries from SAH animals (F340/F380: 1.18 ± 0.04; estimated Ca2+:
222 ± 12 nM, n = 4) compared to control animals (F340/F380: 1.00 ± 0.07; estimated Ca2+:
175 ± 12 nM, n = 4). In contrast to the SAH-induced disruption of the Ca2+ spark/BK
channel dilator pathway, dilations to the endothelial-dependent agonist, acetylcholine,
and the endothelial-independent dilator, sodium nitroprusside, were similar in arteries
from control and SAH animals (Figure 7D, E). These data are consistent with decreased
Ca2+ spark-induced BK channel activity contributing to enhanced constriction of cerebral
arteries from SAH animals.

Discussion
Here, we provide evidence that a reduction in subcellular Ca2+ release events (i.e. Ca2+
sparks) underlies decreased BK channel activity and enhanced cerebral artery constriction
following SAH. The following observations support this concept: 1) cell-wide Ca2+
spark frequency is decreased in cerebral artery myocytes from SAH animals, reflecting a
decrease in active Ca2+ spark discharge sites; 2) mRNA and protein levels of RyR-2, the
SR Ca2+ release channel responsible for Ca2+ sparks in smooth muscle, is reduced in
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cerebral artery myocytes following SAH; 3) mRNA and protein levels of the RyR-2
stabilizing protein, FKBP12.6, is increased in cerebral arteries from SAH animals; 4) the
frequency of Ca2+ spark-induced transient BK currents is decreased in cerebral artery
myocytes from SAH animals, with no change in BK channel properties, whole-cell BK
currents or BK subunit expression; 5) constriction caused by inhibitors of Ca2+ sparks
(ryanodine) or BK channels (paxilline) is decreased in cerebral arteries from SAH
animals. Together, these data suggest that SAH-induced decreased Ca2+ spark frequency
and the resulting decrease in transient BK channel activity promotes membrane potential
depolarization, enhanced Ca2+ influx via VDCCs and cerebral artery constriction.
To our knowledge, these findings represent the first demonstration of a vascular
pathology due to a decrease in Ca2+ spark frequency. Although altered frequency of Ca2+
spark-induced transient BK currents has been reported in other cardiovascular diseases
such as hypertension and hypovolemic shock, these phenomena have been attributed to
altered BK channel function/expression.

Enhanced constriction associated with

hypertension and diabetes has been linked to decreased expression of the BK channel β1
subunit (Amberg and Santana 2003; Brenner et al 2000; Dong et al 2008) while an acute
upregulation of BK channel β1 subunit contributes to vasodilation and the drop in
peripheral resistance associated with hemorrhagic shock (Zhao et al 2007). In the above
pathologies, Ca2+ spark activity was unaltered.

In marked contrast, we observed a

parallel decrease in the frequency of Ca2+ sparks and Ca2+ spark-induced transient BK
currents following SAH. Notably, experimental SAH did not directly alter BK channel
properties or expression. Our observed lack of direct effect of SAH on BK channels in

253

pial arteries obtained from SAH model rabbits is consistent with observations using
basilar artery myocytes obtained from a dog SAH model (Jahromi et al 2008b).
We found that the overall decrease in Ca2+ spark frequency in myocytes from
SAH animals reflected a decrease in the number of functional spark sites. Both the
number of functional spark sites and whole cell Ca2+ spark frequency were reduced by
approximately 50 % in myocytes following SAH. Although the RyR activator, caffeine
(10 μmol/L), caused proportionately the same increase in the number of functional spark
sites and Ca2+ spark frequency in myocytes from control and SAH animals, both
parameters remained approximately 50 % lower in SAH animals. Spark sites within
arterial myocytes are comprised of a variable number of RyRs, and functional spark sites
require the activity of a critical number of RyRs for Ca2+-induced Ca2+ release and Ca2+
sparks to occur (Janiak et al 2001; Pucovsky and Bolton 2006). Using quantitative realtime PCR and western blot, we observed a significant reduction in mRNA and protein
levels of RyR-2 in cerebral arteries following SAH. A decrease in RyR-2 expression has
been previously reported in cardiac myocytes following heart failure (Go et al 1995) and
in vascular smooth muscle undergoing phenotypic changes during cell culture (BerraRomani et al 2008). It is conceivable that the SAH-induced decreased RyR-2 expression
caused some, but not all, spark sites to no longer have the threshold number of RyRs
required for Ca2+ spark initiation.
In addition to decreased RyR-2 expression, increases in the relative expression of
proteins that reduce RyR-2 activity may also contribute to the observed decrease in the
number of functional Ca2+ spark sites. For example, we observed increased mRNA and
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protein levels of the RyR-2 regulatory protein, FKBP12.6.

Binding of FKBP12.6

stabilizes RyR-2 in the closed state (Zalk et al 2007). Ablation of the gene encoding
FKBP12.6 has been reported to increase Ca2+ spark frequency in smooth muscle (Ji et al
2004) and conversely, conditional overexpression of FKBP12.6 has been linked to
decreased Ca2+ spark frequency in cardiac myocytes (Gellen et al 2008). Our current
data suggest that increased FKBP12.6 expression acting in concert with decreased RyR-2
expression underlie the decrease in active Ca2+ sparks in cerebral artery myocytes from
SAH model animals. Based on the present study, the relative contribution of decreased
RyR-2 expression versus increased FKBP12.6 expression to the observed SAH-induced
reduction in Ca2+ spark activity is unclear.
Decreased SR Ca2+ content has also been linked to decreased Ca2+ spark
frequency and amplitude in smooth muscle (ZhuGe et al 1999), thus, reduced SR Ca2+
could potentially contribute to decreased Ca2+ spark frequency following SAH.
However, our data argue against this possibility. First, we observed no difference in the
amplitude of global Ca2+ transients induced by rapid application of a high concentration
(10 mmol/L) of caffeine following SAH. Secondly, we observed a reduction in the
number of functional Ca2+ spark sites, rather than a uniform reduction in Ca2+ spark
frequency, and Ca2+ spark amplitude was similar in myocytes from control and SAH
animals. Further, mRNA levels of SR-Ca2+-ATPase (SERCA-2) and the SR Ca2+ binding
proteins, calsequestrin-2 and calreticulin, were similar in cerebral arteries from control
and SAH animals. It is possible that additional factors such as RyR-2 phosphorylation
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(Zalk et al 2007) could contribute to a reduction in functional Ca2+ spark sites in cerebral
artery myocytes following SAH.
The present work may help to explain the impact of SAH leading to enhanced
constriction of small diameter cerebral arteries and decreased cerebral blood flow. We
have previously reported an increase in VDCC current density, in part due to the
emergence of R-type VDCCs encoded by the gene CaV2.3, in cerebral artery myocytes
from SAH model rabbits (Ishiguro et al 2005). Membrane potential depolarization
caused by a decrease in Ca2+ spark-induced transient BK currents would be predicted to
cause an increase in the open-state probability of VDCCs and combined with enhanced
VDCC expression would increase global cytosolic Ca2+ leading to enhanced contraction
of cerebral artery myocytes.

Additional mechanisms such as decreased voltage-

dependent potassium (KV) channel expression (Jahromi et al 2008a) and activity
(Ishiguro et al 2006; Koide et al 2007; Quan and Sobey 2000) and increased protein
kinase C activity (Nishizawa et al 2000) are also likely to contribute to enhanced cerebral
artery constriction following SAH.
In conclusion, we report that the frequency of Ca2+ sparks and associated
transient BK currents were significantly decreased in cerebral artery myocytes following
SAH, contributing to enhanced vasoconstriction. Our findings suggest this SAH-induced
decrease in Ca2+ spark frequency results from a reduction in RyR-2 expression and
increased FKBP12.6 expression leading to a decrease in the number of functional spark
sites within these myocytes. This mechanism may contribute to a reduction in cerebral
blood flow and the development of neurological deficits experienced by patients
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following cerebral aneurysm rupture. Further, this mechanism of decreased vascular BK
channel activity may also contribute to other types of brain pathologies, including
traumatic brain injury.
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Figure Legends

Figure 1: Decreased frequency of transient outward BK currents in cerebral artery
myocytes from SAH model rabbits. (A) Representative traces of transient BK currents
in cerebral artery myocytes from control and SAH rabbits.

Holding potential was

changed in 10 mV increments every ~5 min. (B) Expanded traces are from the region
denoted by black bars in panel A. (C) Average traces were obtained from all events at 40 mV shown in panel A (control: 52 events, SAH: 18 events). (D, E) Summarized data
of transient BK current frequency and amplitude, respectively. Control: n = 9 cells from
6 animals; SAH: n = 8 from 6 animals. * p < 0.05, ** p < 0.01

Figure 2: Maintained expression and properties of BK channels in cerebral artery
myocytes following SAH.

(A) Representative BK single channel recordings from

inside-out membrane patches in the presence of 10-7 mol/L free Ca2+. Closed state (C)
and individual channel open states (O1-O5) are included in each record. (B) Ca2+- and
voltage-sensitivity of BK channels in control (n = 6-16 patches from 4 animals) and SAH
myocytes (n = 12-19 patches from 4 animals). Free Ca2+ concentration calculated for the
“Zero” Ca2+ solution was < 1 nmol/L. Open-state probability curves were obtained from
Boltzman fit of data. (C) BK channel densities shown as channel number per patch at
+80 mV in control (n = 25) and SAH cerebral myocytes (n = 27). NS: p > 0.05. (D)
Current-voltage relationship of paxilline-sensitive currents in myocytes from control
(open circles, n = 5) and SAH rabbits (closed circles, n = 6).
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(E)

Summary of

quantitative real-time PCR for α and β1 subunits of the BK channel, normalized to
GAPDH.

Figure 3: Decreased Ca2+ spark frequency, but not amplitude, in cerebral artery
myocytes from SAH animals. (A) Representative Ca2+ spark images and fractional
fluorescent traces from cerebral artery myocytes isolated from control and SAH rabbits.
Gray scale images are an average of 30 images without Ca2+ spark activity (F0 image).
Red crosses depict where individual Ca2+ sparks occurred during the 20 second
recordings. Pseudo-color images illustrate Ca2+ sparks in control and SAH myocytes.
Fractional fluorescent (F/F0) records are from 2.1 μm x 2.1 μm analysis areas (white
boxes in first enlarged images) centered over Ca2+ sparks. White bars represent 10 µm.
(B, C) Summarized data of whole cell frequency and amplitude, respectively, of Ca2+
sparks in cerebral artery myocytes (control: n = 45 cells from 5 animals, SAH: n = 48
cells from 6 animals). ** p < 0.01

Figure 4: Decreased functional Ca2+ spark sites in cerebral artery myocytes from
SAH animals. (A) Gray scale images are an average of 30 images without Ca2+ spark
activity (F0 image) with red crosses depicting the location of individual Ca2+ sparks
during 20 sec recordings. White boxes on pseudo-color images depict distinct spark sites
within each cell. (B) Numbered images depict individual spark sites within each cell. (C)
Corresponding fractional fluorescent (F/F0) traces from spark sites shown in panel B.
Arrows indicate Ca2+ sparks accounted to each site. (D) Summarized data of the number
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of spark sites observed in each cell. (E) Average Ca2+ spark frequency in individual
spark sites. (F) Relationship between the number of spark sites in individual cells and
whole cell Ca2+ spark frequency. Solid lines with symbol color (control: gray, SAH:
black) represent linear regression analysis of data. Data was obtained from 1082 sparks
from 355 spark sites in 45 cells from 5 control animals and 594 sparks from 217 spark
sites in 48 cells from 6 SAH animals. ** p < 0.01

Figure 5: RyR activation properties and SR Ca2+ load in cerebral arteries from SAH
animals. (A-C): The RyR activator, caffeine (10 µmol/L), did not restore the number of
functional spark sites or whole cell Ca2+ spark frequency in cerebral artery myocytes
from SAH animals to control levels. (A) Average of 30 consecutive images without
Ca2+ spark activity, with white crosses depicting the location of Ca2+ sparks observed
during 20 sec recordings in the absence and presence (+Caffeine) of caffeine. White
bars represent 10 µm. (B, C) Summary of the effect of caffeine on the number of
functional spark sites per cell (B) and whole cell Ca2+ spark frequency (C). Control: n =
7 cells from 3 animals, SAH: n = 14 cells from 3 animals.

* p<0.05, ** p<0.01 control

vs SAH. (D) Estimated Ca2+ content in sarcoplasmic reticulum (SR) of cerebral arteries
from control and SAH animals.

The amplitude of global cytosolic Ca2+ transients

induced by rapid application of a high concentration of caffeine (10 mmol/L) was not
significantly different between groups (control: n = 4, SAH: n = 3). (E) Summarized data
of quantitative real-time PCR for smooth muscle sarco-endoplasmic reticulum Ca2+-
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ATPase (SERCA-2), calsequestrin-2, and calreticulin expressed as a ratio to GAPDH (n
= 6 for each group). ** p < 0.01

Figure 6: Decreased expression of ryanodine receptor-2 (RyR-2) and increased
expression of FKBP12.6 in cerebral arteries from SAH animals. (A) Summarized
quantitative real-time PCR data for RyR-2 (n = 6) and FKBP12.6 (n = 5). ** p < 0.01
(B) Immunoreactive bands corresponding to RyR-2, FKBP12.6 and α-smooth muscle
actin in cerebral arteries detected by western blot. (C) Summarized RyR-2 and FKBP12.6
protein levels expressed as a ratio to α-smooth muscle actin (n = 4 for each groups). * p <
0.05

Figure 7: Inhibitors of Ca2+ sparks and BK channels constrict cerebral arteries
from control, but not SAH model animals. (A) Diameter recordings of pressurized (80
mmHg) cerebral arteries from control (left) and SAH (right) animals treated with the BK
channel blocker paxilline (1 µmol/L).

Maximum dilation was obtained using a

combination of diltiazem (100 μM) and forskolin (1μM) in Ca2+-free physiological saline
solution. (B, C) Summarized data of constriction caused by paxilline (B, n = 5) or
ryanodine (C, n = 4), expressed as a percent decrease in diameter, of pressurized arteries
isolated from control and SAH animals.

(D) Vasodilation to cumulative additions of

acetylcholine (ACh) are expressed as percent dilation of pressure-induced (myogenic)
tone. Data expressed as mean ± SEM; n = 7 control, n = 5 SAH. (E) Vasodilation to
cumulative additions of sodium nitroprusside (SNP) are expressed as percent dilation of
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pressure-induced (myogenic) tone. Data are expressed as mean ± SEM; n = 4 control, n
= 4 SAH.
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Figures

Figure 1: Decreased frequency of transient outward BK currents in cerebral
artery myocytes from SAH model rabbits.
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Figure 2: Maintained expression and properties of BK channels in cerebral artery myocytes
following SAH.
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Figure 3: Decreased Ca2+ spark frequency, but not amplitude, in cerebral artery
myocytes from SAH animals.
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Figure 4: Decreased functional Ca2+ spark sites in cerebral artery myocytes from SAH
animals.
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Figure 5: RyR activation properties and SR Ca2+ load in cerebral arteries from SAH
animals.
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Figure 6: Decreased expression of ryanodine receptor-2 (RyR-2) and increased
expression of FKBP12.6 in cerebral arteries from SAH animals.
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Figure 7: Inhibitors of Ca2+ sparks and BK channels constrict cerebral arteries from
control, but not SAH model animals.
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Appendix C: Table 1: Primers for quantitative real-time PCR.
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Appendix C: Table 2: Transient BK current and Ca2+ spark characteristics.
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Appendix C: Table 3: Arterial diameter measurements.
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